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ABSTRACT 
The gut microbiome is a complex community featuring a bewildering array of 
microbial species. Over the past couple decades, there has been an explosion of 
research demonstrating that the gut microbiota plays critical roles in a variety of host 
functions, including immune modulation, metabolism, brain function, and behavior. 
Mechanistic approaches such as fecal microbiota transfer from disease models into 
healthy animals have demonstrated direct effects of gut microbiota on host parameters 
but sequencing of fecal samples from similar subjects across different cohorts often 
reveals wide differences in microbial composition. This wide variability is also seen in 
clinical subjects within specific disease states postulated to be influenced by gut 
microbiota. Nevertheless, there are likely core features of the gut microbiota that may 
be modulated across different disease conditions to transmit similar signals to the host. 
     In this dissertation, I focus on potential core features of gut dysbiosis, or alterations 
in gut microbiota associated with various disease states. In Chapter 2, I will explore 
variations in gut microbiota observed across a genetic model exhibiting varying 
behavioral profiles, namely Brattleboro rats. In Chapter 3, I explore the potential 
mechanistic links between gut microbiota and host behavior, using a treatment that 
compromises the integrity of the gut barrier (namely, adding food emulsifiers to the diet). 
Compromising the gut barrier allows increased access of microbial byproducts that 
affect the CNS. I explored this potential mechanism in Chapter 4 by testing the effects 
of gut-derived LPS on host behavior, as LPS can compromise gut barrier integrity even 
further and act on immune cells and vagal gut innervations that communicate with the 
CNS to affect host behavior. In Chapter 5, I discuss the tools and multivariate 
investigative approaches employed in the studies discussed in this dissertation, and 
how multivariate approaches lend required dimensionality to studying a complex gut-
brain signaling axis.  Gut barrier dysfunction is a common theme observed in various 
disorders exhibiting altered anxiety behavior and gut dysbiosis of widely-varying 
microbial compositions. Understanding core functional features of gut dysbiosis will 
provide an important handle on ameliorating the gut environment in future attempts to 
treat CNS disorders.  
 
INDEX WORDS: LPS, TLR4, Immune system, Gut-brain axis, Gut microbiota, 
Discriminant analysis  
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1 INTRODUCTION  
1.1 Microbes and Mammals: A Symbiotic Relationship 
From their earliest origins, eukaryotic cells have had a symbiotic relationship with 
microbes, which in multicellular organisms cover nearly every surface exposed to the 
environment, supporting critical aspects of host metabolism and physiology (Franco-
Obregon and Gilbert, 2017). In humans, an estimated ∼1:1 to 10:1 ratio of microbial 
cells for every human cell resides within the body, with the greatest reservoir being in 
the digestive tract (Sender et al., 2016). This microbial community is not only large by 
absolute number, but by complexity as well, and consists of myriad bacterial, fungal, 
viral, and protozoal species. Bacteria outnumber all other members, and of these, 
the Bacteroidetes and Firmicutes phyla predominate (Rosenbaum et al., 2015). 
However, broad generalizations about their impact on the host cannot easily be made 
as different species, and even strains within a specific phylum can differ markedly in 
physiology and metabolic output (Geva-Zatorsky et al., 2017). In addition, less abundant 
and even rare taxa may regulate overall community structure and function and play 
important roles in host physiology (Jousset et al., 2017; Enaud et al., 2018). 
The largest reservoir of host-associated microbes resides within the gut lumen 
and are both impacted by the host’s diet and play key roles in nutrient processing and 
host metabolism (Ley et al., 2008). Gut microbiota may also play a role in diet selection, 
guiding host preference for high-fat versus low-fat diets, or even inducing specific 
cravings (e.g. chocolate) (Rezzi et al., 2007; Alcock et al., 2014). The importance of gut 
microbiota to digestion is highlighted by the size difference in the cecum in germ-free 
versus conventionally colonized rodents (Savage and Dubos, 1968; Gustafsson and 
2 
Maunsbach, 1971). The cecum is a major nutrient processing center, particularly for 
soluble fibers, connecting the small and large intestines. The enlarged cecum observed 
in germ-free mice is a byproduct of the biomass of undigested fibers found in the host’s 
diet (Iwai et al., 1973). However, the impact of gut microbiota on the host extends far 
beyond nutrient processing. Bacteria within the gut microbiota also produce and release 
important metabolic byproducts critical to maintaining homeostasis within the host 
enteric environment (Lin and Zhang, 2017). Short-chain fatty acids, such as butyrate, 
produced by certain lactic acid-releasing bacteria, is an important energy source for 
intestinal epithelial cells, and also downregulates intestinal inflammation (Ohira et al., 
2017). Bacteria also release neurotransmitters, which likely play critical roles in 
communicating with the enteric nervous system, and perhaps also vagal gut 
innervations (Wall et al., 2014). Finally, of course, microbial components interact with 
the intestinal immune system, which is found in the largest reservoir of mammalian 
immune cells—namely the lamina propria (Shi et al., 2017). Alterations in the 
composition of the gut microbiota confer differential activation of the host intestinal 
immune system, which impacts the hosts varied organ systems (Pickard et al., 2017).  
Over the past two decades, an explosion of research has begun to detail the 
robust relationship between gut microbiota and the CNS. Many of the foundational 
studies investigating the so-called gut-brain axis were made possible by the generation 
of germ-free rodents, which are devoid of microbes from birth. These animals 
demonstrate significant alterations in host physiology and behavior, suggesting that the 
microbiota communicates critical signals required for normal development (Mazmanian 
et al., 2005; Ley et al., 2006; Diaz Heijtz et al., 2011; Neufeld et al., 2011b). Additional 
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studies have manipulated content by either administering probiotics (microorganisms 
that promote host health, administered individually or as a cocktail), or antibiotics, or by 
direct bulk transfer of gut microbiota across model organisms. Such studies have 
revealed fundamental roles for the gut microbiota in modulating complex host 
behaviors, including social, stress-induced, and cognitive behaviors (Sudo et al., 2004; 
Diaz Heijtz et al., 2011; Neufeld et al., 2011b; Clarke et al., 2013). More recent studies 
also point to a role for microbiota in various neurological and psychiatric disorders, 
ranging from autism, Parkinson’s disease, and substance use disorders (Hsiao et al., 
2013; Kiraly et al., 2016; Sampson et al., 2016).  
 
1.2 What Is Dysbiosis? 
Dysbiosis of the gut microbiota, often referred to as “dysbiosis”, and typically 
defined as a shift toward pathological, pro-inflammatory gut microbiota, has been linked 
to neuropsychiatric disorders, including autism (Finegold et al., 2012; Mayer et al., 
2014b; Mayer et al., 2014a), ADHD (Petra et al., 2015), and psychological pathologies 
co-morbid with inflammatory bowel disease (IBD) (Bannaga and Selinger, 2015; Ray 
and Dittel, 2015). However, given the complex ecology of gut microbe-to-microbe and 
microbe-to-host interactions, precisely how changes in the gut microbiota influence 
behavior in these disorders remains largely unknown. To date, gut microbiota research 
involves largely correlational science, with any noted alterations in gut microbiota 
composition observed between healthy and diseased subjects described as “dysbiosis” 
(Olesen and Alm, 2016; Hooks and O'Malley, 2017). This is problematic given wide 
variations in microbial composition between healthy subjects. For example, the Human 
4 
Microbiome Project revealed that it is possible for two healthy individuals to harbor little 
to no overlap in gut microbial composition (Gilbert et al., 2018). A recent literature 
survey revealed that most authors that invoke the term dysbiosis only, at best, provide a 
vague definition. About half used the term to suggest an “imbalance” in the microbiota, 
one-fifth used the term to indicate an unspecified “change” (such as loss of diversity) 
and a quarter indicated specific taxa changes (such as an expansion of Proteobacteria 
and decrease in Firmicutes) (Hooks and O'Malley, 2017). In order for microbiota 
research to evolve into a more explanatory science, core mechanisms of action will 
need to be explored. Identifying common themes and functional consequences of what 
has been termed “dysbiotic” microbiota provides a first step for providing testable 
hypotheses and potential therapeutic targets for gut microbiota-associated disorders 
(Fields et al., 2018).  
While there is currently no consensus on what constitutes dysbiosis, certain 
common themes tend to emerge. Core mechanisms underlying pathogenic actions of a 
dysbiotic microbiota may be breach of the gut barrier, exposure of the intestinal immune 
system to microbial components, and promotion of systemic inflammation. As will be 
described in Chapter 3, transfer of gut microbiota from donor mice exhibiting signs of 
intestinal inflammation induced by food emulsifier treatment into healthy mice induces 
the same breakdown of the gut barrier and intestinal inflammation in the recipient as 
that observed in the donor (Chassaing et al., 2015). There are other factors that may be 
involved in determining the health- or disease-promoting status of gut microbiota. For 
example, some bacterial species have consistently been identified to promote host 
health and have been deemed “probiotic”, including some Lactobacillus species. These 
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tend to downregulate chronic gut inflammation while promoting targeted immune 
responses to invasive pathogens (Dhama et al., 2017; Rocha-Ramirez et al., 2017). 
Other, more pro-inflammatory species such as certain Proteobacteria species may 
promote chronic gut inflammation (Litvak et al., 2017). Diversity within gut microbiota 
also limits the growth of these pathogenic species, and dysbiosis tends to be associated 
with lower levels of diversity of species composition (Morgan and Huttenhower, 2012; 
Weiss and Hennet, 2017). The studies discussed in this dissertation will focus on the 
effects of microbes that modulate gut barrier integrity, including lipopolysaccharide-
shedding bacteria.  
Gut inflammation, triggered by increased levels of LPS, may be a key component 
of gut-brain signaling in dysbiosis-associated disorders. Lipopolysaccharide (LPS) is a 
pathogenic component of gram-negative bacteria and is endogenous to the gut 
microbiota. Approximately half of the gut bacteria belong to the Bacteroidetes phylum, 
which is mostly gram-negative (Knight et al., 2017), and is a constitutive and dominant 
presence in the enteric environment. LPS is a likely candidate for initiating increases in 
intestinal permeability in conditions exhibiting gut dysbiosis. The intestinal epithelium is 
a single-cell layer separating the gut microbiota from the host. Directly underneath this 
epithelium is the lamina propria, housing the intestinal immune system. If the intestinal 
epithelium is breached, gut microbiota can initiate a robust intestinal immune response 
(Thaiss et al., 2016), which may initiate behavioral pathologies associated with gut 
dysbiosis. Therefore, antimicrobial defenses, such as the mucus layer, immunoglobulin 
A, and antimicrobial defense proteins, that are released within the gut lumen, sequester 
gut microbiota away from the intestinal epithelial wall and underlying lamina propria 
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(Takiishi et al., 2017). In addition, the intestinal epithelium and immune cells that reside 
within the lamina propria propagate an immune defense against microbes that breaches 
the mucus layer through activation of the innate immune system, which recognizes the 
presence of microbiota via a system of alarmin detectors, most notably the toll-like 
receptors (TLRs).  
LPS is the primary agonist for TLR4 (Lu et al., 2008), and TLR4 signaling on 
intestinal epithelial cells (IECs) increases intestinal permeability (Li et al., 2013; Guo et 
al., 2015). Commensal gut microbiota express a mixture of both TLR4 agonistic and 
antagonistic LPS species (e.g. R. Spheroides produces an under-acetylated LPS 
species that, although it binds to TLR4, it does not trigger the downstream signaling 
pathways that initiate an immune response, and therefore functions basically as a TLR4 
antagonist) (Hajjar et al., 2002; Martirosyan et al., 2013). However, a gut microbial shift 
toward a higher prevalence of pathogenic gram-negative bacteria, which express LPS 
structures that act as TLR4 agonists, may increase intestinal permeability.  
Gut barrier dysfunction, induced by elevated gut levels of gram-negative bacteria 
and/or increased shedding of pathogenic LPS species, may increase anxiety behavior 
in the host through various pathways. Some of these pathways are illustrated in Figure 
1.1, where microbial components activate gut immune cells that influence vagal and 
CNS circuits. Elevated gut levels of gram-negative bacteria have been reported for 
clinical populations that exhibit elevated anxiety, such as children with autism (Finegold 
et al., 2010) or celiac disease (Nadal et al., 2007). Furthermore, severity of 
gastrointestinal issues, likely linked to gut inflammation, has been reported to correlate 
with levels of anxiety behavior in these disorders (Mazurek et al., 2013; Hsiao, 2014; 
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Gracie et al., 2016; Reigada et al., 2016a). In addition, inflammatory bowel disease 
(IBD), which comprises of a set of diseases characterized by increased gut permeability 
(Michielan and D'Inca, 2015), is highly co-morbid with anxiety disorders (Bannaga and 
Selinger, 2015). This connection between intestinal permeability and anxiety behavior is 
not restricted to clinical populations. Exercise in healthy but untrained individuals 
increases markers of intestinal permeability (Worobetz and Gerrard, 1985; Peters et al., 
1999; Jeukendrup et al., 2000; van Wijck et al., 2011) as well as produces short-term 
symptoms of anxiety (Rhodes et al., 2003; Campbell et al., 2009; Hopkins et al., 2012). 
These correlations between intestinal permeability and anxiety are also observed in 
various rodent disease models. The dextran sodium sulfate model of IBD and the 
maternal immune activation model of autism exhibit increased intestinal permeability 
(Hsiao et al., 2013; Xiao et al., 2016) as well as increased expression of anxiety 
behavior (Hsiao et al., 2013; Hassan et al., 2014). This correlation between increased 
intestinal permeability and anxiety behavior is also observed in other disease models, 
including chronic alcohol exposure (Chen et al., 2015; Pascual et al., 2015) and the 
high-fat diet model of obesity (Bruce-Keller et al., 2015). Interestingly, a probiotic 
treatment that reduces intestinal permeability also reduces anxiety behavior in the 
maternal immune activation model of autism (Hsiao et al., 2013).  
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Figure 1.1 Model for how gut barrier dysfunction impacts the CNS. 
Bacteria from the gut lumen (colored circles) penetrate the mucosal layer to 
interact with intestinal epithelial cells, downregulate intestinal epithelial tight junctions, 
and activate immune cells residing along the lamina propria, such as dendritic cells, 
mast cells, macrophages, T cells, and B cells. Dysbiosis, particularly the increased 
presence of enteropathogenic E Coli and other bacteria that penetrate the mucosal 
lining, triggers the production of IL-33 by intestinal epithelial cells which promotes a type 
2 bias in immune cells in the lamina propria. Inflammatory mediators produced by these 
cells travel through the bloodstream and lymphatic system before reaching the blood-
brain barrier. However, intestinal cytokines may also activate vagal nerves that, in turn, 
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trigger neuroinflammation through trans-synaptic signaling to immune cells resident on 
the brain side of the blood-brain barrier. Inflammatory mediators that reach the blood-
brain barrier can also penetrate and activate brain-resident astrocytes, microgliam, and 
immune receptors expressed on neurons.  
 
1.3 Summary of Chapters 
The studies discussed in this dissertation will explore whether, and if so, how 
shifts in gut microbiota may contribute to anxiety-related behavioral pathologies. To 
approach this question, we needed to widen the tools of analysis typically employed in 
behavioral neuroscience studies to understand the complex implications of a 
multifaceted microbiome on multidimensional host behavior. The current state of 
microbiome analyses routinely uses a big-data approach to describe the composition 
and imputed functional implications of various gut microbial communities (Caporaso et 
al., 2010; Segata et al., 2011). There are two levels of analysis employed in this 
dissertation--one being a comparison of microbial population structure between sample 
groups and another a more microscopic view of the taxa that exhibit the most salient 
differences between sample groups. For the studies presented in this dissertation, we 
chose to employ some of the most robust tools to highlight taxa differences between 
groups, while maintaining a sensitivity to the fact that population differences may lie in 
more complex, nuanced differences between microbial populations that are not typified 
by individual taxa differences. This multi-layered approach to studying the microbiome 
also inspired our use of multidimensional (multivariate) analysis of complex syndromes 
of behavior. The typical approach to behavioral analysis involves looking at single 
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behavioral measures and imputing a larger emotional/motivational state change in the 
animals exhibiting this behavior. For example, the ratio of time spent with familiar vs 
novel conspecifics is the primary screen for social behavior defects designed for the 
three-chamber social interaction test (Nadler et al., 2004; Yang et al., 2011). However, 
social behavior has a number of individual components that make up the 
multidimensionality of these interactions. For example, play behavior is composed of 
locomotor and dyadic interactions, along with vocalizations, all of which combine into a 
recognizable pattern of behavior (Paul et al., 2016). Follow-up studies on genetic 
models of autism often fail to reproduce the core finding of an altered social behavior 
preference in the social interaction assay, such as findings for the Shank3 KO model of 
autism (Dhamne et al., 2017). However, these models may still reveal intricate patterns 
of behavioral alterations that are not apparent from examining any single measure of 
social behavioral. While there are a number of confounds that may explain inconsistent 
findings across studies, examining syndromic effects across multiple behavioral 
measures may yield consistent findings across cohorts. This mirrors the heterogeneity 
of psychiatric populations such as individuals with schizophrenia, wherein no single 
diagnostic test accurately diagnoses all schizophrenic individuals, who display a wide 
range of psychiatric traits (Jablensky, 2010). This has inspired multivariate approaches 
to diagnosis that identifies prodromal symptoms and that more reliably diagnoses 
schizophrenic patients with a combination of brain imaging and behavioral diagnostic 
tools (Davidson et al., 1999; Koch et al., 2015). In this dissertation, I will be applying 
multivariate analysis to study various effects of treatments altering gut microbiota on 
host behavior. 
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In Chapter 2, I performed an association study exploring variations in gut 
microbiota between genetic models where anxiety-related behaviors differ. Specifically, 
I explore the gut microbiota in Brattleboro rats, a model of social behavior disorders. 
Brattleboro rats are arginine-vasopressin knockout (Avp-/-) rats that exhibit lower levels 
of social and anxiety-related behavior relative to their wildtype (WT) counterparts. While 
these effects have been attributed to lack of vasopressin action on brain vasopressin 
receptors found in social and anxiety regulation centers in the brain, as well as on 
systemic physiological and immunological consequences of a lack of vasopressin 
systemically that may feedback on biobehavioral neuroimmune system, work in the past 
20 years has demonstrated robust effects of gut microbiota on behavior. Vasopressin 
may influence gut microbiota composition which may independently influence host brain 
function and behavior. Therefore, we wanted to explore whether there are microbial 
differences across WT and KO Avp genotypes that may contribute to behavioral 
differences observed across these genotypes. For this, we used Quantitative Insights 
Into Microbial Ecology (QIIME) to study microbial population differences between 
homozygous and heterozygous Brattleboro, and wildtype (WT) Long-Evans, rats, 
comparing the evolutionary biomarker 16S rRNA as a marker of bacterial species. To 
identify the bacterial taxa that exhibit the most salient differences between genotype 
groups, we settled on the tool Linear Discriminant Analysis coupled with Effect Size 
(LEfSe). This revealed an interesting taxon, namely the Lactobaccillus genus, that may 
impact gut barrier function and impact how population differences across the three 
genotypes may influence host inflammation and CNS activity along the gut-brain axis. 
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While Chapter 2 is an example of a correlation study, in Chapter 3 we directly 
tested the role of gut dysbiosis by exploring the effects of treatments that affect gut 
microbial composition as well as gut barrier function on host behavior. Here, we added 
two different food emulsifiers to the diet, with similar but slightly diverging effects on gut 
physiology and behavior, i.e., carboxymethylcellulose (CMC) and polysorbate-80 (P80). 
Both emulsifiers reduced the thickness of the intestinal mucus lining and increased gut 
inflammation. We showed, however, that each has unique effects on gut microbiota 
composition and syndromic effects on behavior and physiology. This was a multi-
investigator project, in which I contributed to the design and implementation of the data 
analysis by applying robust tools to identify the gut microbiota composition and 
behavioral syndromic effects, namely LefSe to identify specific taxa affected by 
emulsifier treatment and multiple discriminant analysis to identify syndromic effects 
across multiple behavioral measures. Teasing these CMC- and P80-specific effects 
apart contributed to a fuller understanding of the effects of food emulsifiers on the host. 
The results of this study suggest that alterations in gut microbiota can induce changes 
that affect the gut barrier can have effects on behavior, perhaps by increasing host 
immune interactions to specific “dysbiotic” alterations in gut microbiota. 
In Chapter 4, I explored a potential mechanism of action for gut dysbiosis effects 
on anxiety behavior. Specifically, I studied the effects of the gut bacterial inflammagen 
LPS on behavior. LPS is commonly used to induce the sickness behavior response, 
which is the behavioral arm of systemic immune activation. Typical components of 
sickness behavioral include lethargy, increased anxiety, and social withdrawal, which 
are all adaptive behaviors hypothesized to limit social transmission of disease and to 
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conserve energy, thereby promoting recovery (Dantzer, 2001). In experimental settings, 
the typical mode of administration of LPS to induce this sickness response is via 
intraperitoneal or intravenous injections (Dantzer, 2009; Remus and Dantzer, 2016). 
This mode of administration increases systemic levels at least 150-fold over baseline 
serum endotoxin levels, which resembles LPS levels observed under septic shock 
rather than what is typically observed in conditions exhibiting gut dysbiosis (Hansen et 
al., 2000).  Here, I sought to model “dysbiotic” changes in gut microbiota that exhibit a 
shift to more pathogenic species and thereby an increased shedding of LPS, and 
therefore I studied the effects of enterically-derived LPS on behavior. Here, we see that 
oral administration of LPS has a very specific effect on anxiety-like behavior without 
causing changes in locomotion typically observed in sickness behavior triggered by 
peripheral injections of LPS. Again, while we identified individual changes in behavior, 
we also identified syndromic effects of LPS on behavior, which highlighted the unique 
effects each of the emulsifiers had on sex differences in behavior in Chapter 3, and also 
the unique effects of LPS on mice lacking an important innate immune receptor that is 
the primary sensor of LPS (TLR4) in Chapter 4. As this study only focused on acute 
effects of this treatment on the host, this suggests that fluctuations in enteric endotoxin 
levels may actively modulate anxiety levels in the host. Breakdown of the gut barrier 
would increase enteric LPS exposure to portals of circulation residing in the lamina 
propria (lymph and blood vessels), to vagal afferents, and to lamina propria-resident 
immune cells that all interact with the CNS to induce changes in behavior. 
Combined, these studies suggest that future research that focuses on core 
mechanisms of microbial communication along the gut-brain axis, in addition to 
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identifying specific changes in gut microbiota composition, may accelerate 
understanding of the impact of gut microbiota on the CNS. In Chapter 5, I will discuss 
how the current limitations in gut microbiota analysis can be overcome by exploring gut 
microbiota effects across various different conditions that may converge upon the same 
physiological and CNS/behavioral effects. Multivariate approaches to data analysis 
featured in the studies presented in this dissertation may help to overcome these 
limitations. 
  
15 
2 VASOPRESSIN DELETION IS ASSOCIATED WITH SEX-SPECIFIC SHIFTS IN 
THE GUT MICROBIOME 
Christopher T. Fields, Benoit Chassaing, Matthew J. Paul, Andrew T. Gewirtz, Geert J. 
de Vries 
Previously published in 
Fields, Christopher T., et al. “Vasopressin deletion is associated with sex-specific shifts 
in the gut microbiome” Gut Microbes 9.1 (2018): 13-25. 
 
2.1 Abstract 
Brattleboro rats harbor a spontaneous deletion of the arginine-vasopressin (Avp) gene. 
In addition to diabetes insipidus, these rats exhibit low levels of anxiety and depressive 
behaviors. Recent work on the gut-brain axis has revealed that gut microbiota can 
influence anxiety behaviors. Therefore, we studied the effects of Avp gene deletion on 
gut microbiota. Since Avp gene expression is sexually different, we also examined how 
Avp deletion affects sex differences in gut microbiota. Males and females show modest 
but differentiated shifts in taxa abundance across 3 separate Avp deletion genotypes: 
wildtype (WT), heterozygous (Het) and AVP-deficient Brattleboro (KO) rats. For each 
sex, we found examples of taxa that have been shown to modulate anxiety behavior, in 
a manner that correlates with anxiety behavior observed in homozygous knockout 
Brattleboro rats. One prominent example is Lactobacillus, which has been reported to 
be anxiolytic: Lactobacillus was found to increase in abundance in inverse proportion to 
increasing gene dosage (most abundant in KO rats). This genotype effect of 
Lactobacillus abundance was not found when females were analyzed independently. 
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Therefore, Avp deletion appears to affect microbiota composition in a sexually 
differentiated manner. 
 
2.2 Introduction 
The neuropeptide arginine-vasopressin (AVP) is released from hypothalamic 
neurons into the bloodstream of mammals, where it regulates water balance and other 
autonomic functions (Knepper et al., 2015). However, AVP is also released within the 
brain where it influences social and anxiety-like behavior (Neumann and Landgraf, 
2012) and modulate stress responses (Joels and Baram, 2009). The Brattleboro rat, 
which contains a base-pair deletion in the Avp gene that prevents functional AVP 
expression, is a model for studying the effects of AVP on behavior (Sokol and 
Zimmerman, 1982; Surget and Belzung, 2008). Many of the behavioral abnormalities 
observed in Brattleboro rats, such as decreases in anxiety-like behavior (Balazsfi et al., 
2015) and abnormal social preference (Feifel et al., 2009), are assumed to result from 
the lack of direct activation of AVP-responsive behavioral circuits. However, systemic 
factors that may be influenced by AVP expression may also influence anxiety and social 
behaviors in this model. One such systemic factor may be the gut microbiome, which 
has recently been shown to influence both social and anxiety behaviors (Cryan and 
Dinan, 2012).   
Gut microbial composition has been correlated with AVP expression. Depletion of 
gut micobiota with antibiotics decreases hypothalamic AVP expression (Desbonnet et 
al., 2015). This suggests that microbiota may influence AVP expression. However, there 
are multiple ways in which AVP expression could influence microbiota composition. For 
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example, AVP expression influences stress responses, systemic inflammation, and 
behaviors that could subsequently influence microbiota composition. It is plausible that 
AVP expression and gut microbial compositional changes that are influenced by AVP 
expression could reinforce each other in a positive feedback loop.  
 This study seeks to establish whether there are compositional differences in gut 
microbiota between AVP knockout rats and wildtype (WT) rats. In addition, as AVP 
expression is also sexually dimorphic, with male rodents expressing more than female 
rodents in centrally-releasing projections as well as in neurosecretory cells (de Vries, 
2008; Taylor et al., 2012), we sought to observe the effects of AVP deletion on sex 
differences in gut microbiota. Therefore, the objectives of this study were: i) to compare 
microbiota composition across AVP deletion genotypes (homozygous knockout, 
heterozygous, and wildtype Long Evans rats) and ii) to identify changes in sex 
differences of the microbiota upon haploid or diploid deletion of the AVP gene. 
 
2.3 Materials and Methods 
2.3.1 Experimental design and fecal collection 
Brattleboro rats carrying a homozygous (KO) or heterozygous (Het) deletion of 
the AVP gene against a Long-Evans background, along with wildtype (WT) Long-Evans 
rats, were bred from Het breeding pairs. Offspring from eleven litters resulting from 
eleven separate breeding pairs, all born within a five-day span, were used in this study, 
yielding a total of 42 subjects. Upon weaning, all offspring were genotyped and pair-
housed with the same genotype and sex. Prior to this study, at around 4 weeks of age, 
the rats were used in a play testing study (Paul et al., 2016). These rats endured no 
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further manipulations prior to the study. All of the animals were pair-housed with the 
same genotype and sex at the beginning of the study. We did not want to disturb this 
pairing in order to avoid the additional confound of introducing socially novel cage 
mates, which may independently affect microbial composition. The rats were housed in 
two separate subspaces of a housing room with generally regular exposure to the same 
set of researchers and environmental cues. The rats were housed in cages with 
bedding, fed non-autoclaved rat chow, given one nylabone and plastic shelter per cage 
for enrichment, and kept on a 12L:12D light cycle. 
At twelve weeks of age, subjects from each cage were chosen at random and were 
single-housed into clean cages for 16-24 h. Three to four fecal pellets per cage were 
then collected with ethanol-cleaned forceps and promptly stored at -80°C. From each 
litter, no more than one rat per experimental group was used, with seven of the eleven 
litters producing animals from all three genotypes used in the study. With the exception 
of four animals, cage mates were not used (i.e. only one rat per pair housed cage was 
used in the study). 
2.3.2 DNA extraction and 16s rRNA sequencing 
Fecal microbial 16s rRNA was sequenced according to the protocol outlined in 
(Chassaing et al., 2015). Briefly, total bacterial DNA was isolated from feces using 
QIAamp DNA Stool Mini Kit (Qiagen) according to manufacturer’s instruction and was 
stored at -80°C before further analysis. The 16S rRNA genes, region V4, were PCR 
amplified using the 515F/806R primer set (see ref. Chassaing et al., 2015 for full 
sequence). PCR reactions consisted of Hot Master PCR mix (Five Prime), 0.2 uM of 
each primer, 10-100 ng template, and reaction conditions were 3 min at 95 °C, followed 
19 
by 30 cycles of 45 s at 95 °C, 60 s at 50 °C and 90 s at 72 °C on a Biorad thermocycler. 
PCR products were purified with Ampure magnetic purification beads (Agencourt). 
Sequencing was performed on an Illumina MiSeq sequencer (paired-end reads, 2 x 250 
base pairs) at Cornell University, Ithaca. 
2.3.3 Bioinformatics and statistical analysis 
The sequences were demultiplexed, quality filtered using the Qualitative Insights 
Into Microbial Ecology (QIIME, version 1.8.0) software package, and forward and 
reverse reads were joined using the fastq-join method (http://code.google.com/p/ea-
utils) (Caporaso et al., 2010). Sequences were assigned to OTUs (Operational 
Taxonomic Units, a proxy for species classification, grouping closely related individuals) 
using the UCLUST algorithm with a 97% threshold of pairwise identity, and classified 
taxonomically using the Greengenes reference database (http://greengenes.lbl.gov) 
using uclust method with the suppression of new clusters (closed reference OTU 
picking strategy). FastTree was used to generate a phylogenetic tree and to compute 
unweighted UniFrac distances per sample (http://microbesonline.org/fasttree/). OTUs 
that were assigned to only one read for a sample were excluded from analysis. Principal 
coordinate analysis (PCoA) plots, constructed with weighted UniFrac distances, were 
used to assess the variation between experimental groups (beta diversity) and 
jackknifed beta diversity was used to estimate the uncertainty in PCoA plots. 
Metagenomic data prediction of the functional profiles of fecal microbial composition 
was generated using PICRUSt (Langille et al., 2013).   
Measures of alpha diversity were compared across groups using the Mann-
Whitney U test of significance. Significant tests of beta diversity difference between 
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sample groups were obtained using PERMANOVA in QIIME. The program Linear 
discriminant analysis (LDA) coupled with effect size (LEfSe) was used to identify 
significantly differentiated bacterial taxa (Segata et al., 2011). LEfSe was also used to 
analyze differential abundance in gene pathways between microbial samples predicted 
by PICRUSt. Bootstrap Kruskal-Wallis-test was used to identify taxa or gene pathways 
with significantly differentiated abundance, with the LDA score computed with a 
bootstrapping algorithm repeated over 30 cycles, each sampling two-thirds of the data 
with replacement. Unless otherwise stated, one-against-all multiclass analysis was 
utilized, and posthoc Wilcoxon pairwise comparisons among subclasses were only 
performed among identically named subclasses: in cross-genotype analyses, males 
were only compared with males and females only compared with females; in cross-sex 
analyses, subjects of the same genotype were compared to each other. The one-
against-all algorithm detects whether at least one of the classes is significantly different 
from the other compared classes. However, the all-against-all algorithm detects whether 
all of the classes are significantly different from each other. The threshold on the 
logarithmic LDA (linear discriminant analysis) score for discriminative features was set 
to 2.0 (indicating significant differential abundance between classes), and the alpha 
values for the factorial Kruskal-Wallis test among classes and the pairwise Wilcoxon 
test between subclasses were both set to 0.05. 
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2.4 Results 
2.4.1 Metadata 
Long Evans rats with heterozygous expression of a functional and nonfunctional 
copy of the arginine-vasopressin gene (Avp) were bred to produce subjects expressing 
wildtype (WT), heterozygous (Het) and homozygous knockout (KO) variants of the Avp 
gene deletion.  A total of 42 fecal samples (6 WT male, 8 WT female, 6 Het male, 7 Het 
female, 8 KO male, and 7 KO female) were collected with one sample per subject, from 
which DNA was amplified and sent for sequencing. After OTU picking and checking for 
chimeric transcripts, a total of 1,322,857 reads were assigned to 4,189 OTUs. Each 
sample has an average of 31,497 reads. 
 
2.4.2 Differences in bacterial communities between Avp deletion genotypes 
Gut microbial richness was not statistically different across the three Avp deletion 
genotypes. Between genotypes, we found no difference in any of the three measures of 
alpha diversity, which measures community richness (Shannon’s diversity index, 
observed species and Chao1), when all data points were combined nor when 
genotypes were analyzed for each sex separately (data not shown).  
The relationships between global microbiota composition were examined using 
Principal Coordinate Analysis (PCoA) based on weighted UniFrac distances. With 
males and females combined, weighted UniFrac-based cluster analysis reveals modest 
but differentiated microbiota compositions for each genotype (Figure 2.1A). The 
observed clustering of each group was confirmed by PERMANOVA (p=.024). When 
males and females were analyzed independently, clustering by genotype was observed 
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(Figures 2.1B and 2.1C). With weighted UniFrac distances, there are trends in 
differentiation by genotype for both males and females (p=0.051 and 0.071, 
respectively). These data suggest that the microbial community structures found in the 
guts of WT, Het, and KO Brattleboro rats are differentiated across a limited number of 
taxa.  
We used LEfSe to identify specific bacterial taxa that are significantly 
differentiated between groups. All features identified by LEfSe exceed an LDA score of 
2.0, which indicates significant differences between groups. Figure 2.2 shows bacterial 
taxa differentially represented between genotypes, using the one-against-all algorithm 
which identifies taxa that are only differentiated in one genotype relative to the other two 
genotypes. When both sexes are analyzed together, Lactobacillus spp. are most 
abundant in KO rats and Blautia producta is most abundant in Het rats (Figure 2.2A). 
When male samples were analyzed separately by genotype, the same taxa were 
differentiated, with the addition of Desulfovibrio c21_c20 being more abundant in KO 
rats (Figure 2.2B). When female samples are analyzed independently, Lachnospira 
spp. were most abundant in Het rats while Holdemania spp. were most abundant in WT 
rats (Figure 2.2C). Using the all-against-all algorithm within LEfSe, which identifies 
features that are significantly differentiated among all pairwise comparisons, we found 
zero significantly differentiated taxa between genotypes when both sexes are combined. 
However, when the sexes were analyzed separately, significantly differentiated taxa 
between genotypes are identical to those identified with the one-against-all algorithm. 
For example, Lactobacillus is significantly differentiated between all three genotypes 
among male rats but is not significantly differentiated among female rats (Figure 2.3). 
23 
The all-against-all LEfSe algorithm indicates that the relative abundance of 
Lactobacillus is differentiated across all three genotypes for males (LDA score = 4.6), 
and the average abundance for each class increases with haploid and diploid deletion 
of the Avp gene. In keeping with differentiated clustering of Het animals identified via 
PCoA plots, this LDA analysis suggests that Het rats harbor a microbiota that is 
differentiated from that found in WT and KO rats, particularly for these bacterial taxa.   
Using PICRUSt (Phylogenetic Investigation of Communities by Reconstruction of 
Unobserved States), we explored the predicted functional consequences of these 
compositionally differentiated microbiota for males and females separately. OTU table 
was normalized by 16S rRNA copy number and gene pathways were predicted using 
the Kyoto Encyclopedia of Genes and Genomes (KEGG) database. This generated the 
pathway abundance table that was analyzed by LEfSe. Males show more differentiation 
in pathways between genotypes. In males, 6 pathways were most abundant in KO rats 
(e.g. “Ribosome biogenesis in eukaryotes”, aminoacyl_tRNA_biosynthesis”, “Xylene 
degradation”, etc.), 9 pathways most abundant in Het rats (e.g. “Genetic information 
processing”, “Translation”, and “Ribosome”, etc.) and 8 pathways most abundant in WT 
rats (e.g. “Other glycan degradation”, “Sphingolipid metabolism”, “Biosynthesis of other 
secondary metabolites”, etc.) (Figure 2.4A). Between female rats, “Glycolysis and 
Gluconeogenesis” is most abundant in KO rats, “Amino acid metabolism”, “Valine 
Leucine and isoleucine biosynthesis”, “Pantothenate and CoA biosynthesis” are most 
abundant in Het rats, and “Phenylalanine, tyrosine and tryptophan biosynthesis”, 
“Arginine and proline metabolism”, “C5 branched dibasic acid metabolism” are most 
abundant in WT rats (Figure 2.4B).  
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Figure 2.1 Clustering of gut microbial populations from Brattleboro rats by 
genotype.  
Covariation of community structure using weighted UniFrac distances demonstrates 
limited clustering of samples by genotype when (A) both sexes are analyzed together 
[KO are clustered in upper right, WT are clustered in lower left, while Het are found in 
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the middle; PERMANOVA, p< = 0.05] and when (B) males [PERMANOVA, p = 0.051] 
and (C) females [PERMANOVA, p = 0.071] are analyzed separately. 
 
 
Figure 2.2 Bacterial taxa significantly differentiated between genotypes identified 
by Linear Discriminant Analysis (LDA) coupled with Effect Size (LEfSe).  
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(A) shows differentiated taxa between WT, Het, and KO rats when males and females 
are combined. (B) and (C) show differences between genotypes for males and females, 
respectively. All LDA scores exceed 2.0, which is the threshold for significantly 
differentiated features. 
 
 
Figure 2.3 Relative abundance of Lactobacillus taxon between genotypes.  
All-against-all algorithm of Linear Discriminant Analysis (LDA) coupled with Effect Size 
(LEfSe) identifies this taxon as significantly differentiated between all genotypes [WT, 
Het, and KO] for male rats. (LDA score = 4.6, which exceeds the score threshold of 2.0, 
indicating statistical significance). Neither the all-against-all or one-against-all algorithms 
detect Lactobacillus as a significantly differentiated taxon between genotypes for female 
rats. 
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Figure 2.4 Cladogram of gene pathways significantly differentiated between 
genotypes identified by Linear Discriminant Analysis (LDA) coupled with Effect 
Size (LEfSe).  
The innermost ring represents KEGG Level 1 pathways, the middle ring represents 
KEGG Level 2 pathways, and the outermost ring represents KEGG Level 3 pathways. 
(A) and (B) show predicted functional differences between genotypes [WT, Het, and 
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KO] for males and females, respectively. All highlighted pathways have LDA scores that 
exceed 2.0, which is the threshold for significantly differentiated features. 
 
2.4.3 Differences in bacterial communities between sexes 
When considering overall community composition via PCoA analysis, we observe 
no sex differences in gut microbiota. When comparing alpha diversities between sexes 
with all of the genotypes combined, or between sexes for each separate genotype, no 
significant differences in species diversity were observed. No sex differences in overall 
community composition were identified via PCoA analysis of all of the samples 
combined, or for any of the three separate genotypes (data not shown). 
At the level of individual taxa (as analyzed via LEfSe), we were able to identify 
sex differences across all three genotypes. Between WT males and females, Dorea 
spp. and Ruminococcus spp. are more abundant in female rats (Figure 2.5A). This sex 
difference in community composition is altered in Het and KO rats. Among Het rats, 
Odoribacter spp., Lactobacillaceae spp. and Dehalobacterium spp. are more abundant 
in females, whereas Granulicatella spp. and Blautia producta are more abundant in 
males (Figure 2.5B). Among KO rats, Lactobacillaceae spp., Dehalobacterium spp., 
and Eubacterium dolichum are more abundant in females (Figure 2.5C).   
The metabolic potentials between sexes for each genotype were explored using 
PICRUSt-generated BIOM tables analyzed via LEfSe. We were only able to identify one 
gene pathway category that is sexually differentiated across each of the three distinct 
genotypes. In WT rats, “Secretion Systems” predominate in females (Figure 2.6A), 
whereas in Het rats, “RNA polymerase” pathways are most abundant in males (Figure 
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2.6B). These pathways are not sexually differentiated in KO rats, where an unclassified 
group of pathways is most abundant in females (Figure 2.6C).   
 
 
Figure 2.5 Bacterial taxa significantly differentiated between sexes identified by 
Linear Discriminant Analysis (LDA) coupled with Effect Size (LEfSe).  
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Differentiated taxa between males and females of the (A) WT, (B) Het and (C) KO 
genotypes are shown. All LDA scores exceed 2.0, which is the threshold for significantly 
differentiated features. 
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Figure 2.6 Gene pathways significantly differentiated between sexes identified by 
Linear Discriminant Analysis (LDA) coupled with Effect Size (LEfSe).  
Differentiated taxa between males and females of the (A) WT, (B) Het and (C) KO 
genotypes are shown. All highlighted pathways have LDA scores that exceed 2.0, which 
is the threshold for significantly differentiated features. 
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2.5 Discussion 
 This study is the first to identify differences in gut microbiota between arginine-
vasopressin (AVP) deletion genotypes: namely homozygous (KO), heterozygous (Het) 
and wildtype (WT) Brattleboro rats. We found differences in microbiota across all three 
genotypes, suggesting that Avp is haploinsufficient to restore microbiota observed in 
WT rats. Interestingly, we also found that sex differences in gut microbiota were 
affected by Avp genotype.  
Breeding genetic knockout and WT colonies in isolation may result in 
compositional differences in gut microbiota that are not truly reflective of genotype 
effects on microbiota composition (Ubeda et al., 2012). We avoided this confound by 
generating all genotypes used in this study from heterozygous breeding pairs. In order 
to ensure that fecal samples were only collected from the subject animal and not from a 
cagemate, subject animals were single-housed for 18-24 hours prior to sample 
collection. Single-housing can affect stress reactivity (Das et al., 2015) and chronic 
stress exposure could potentially alter microbiota composition (Stilling et al., 2014). We 
reasoned that 24 hour separation would not significantly alter microbiota composition, 
as large scale differentiation of microbiota composition require several days in other 
models (Mason et al., 2012; Stilling et al., 2014; Chassaing et al., 2015). All animals 
were subjected to the same single-housing protocol.  
 Our data suggest that haploid or diploid expression of the Avp gene differentially 
affects the abundance of specific bacterial taxa, and that it does so in a sex-specific 
manner. Microbial differences were detected with QIIME via PCoA analysis to 
determine whether large scale microbial population differences exist between groups 
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(Navas-Molina et al., 2013) and with LEfSe, a very conservative biomarker discovery 
tool which detects the most robust differences between groups (Segata et al., 2011; 
Paulson et al., 2013), which are likely to be the most influential to explaining differences 
in host physiology and behavior. Both PCoA analysis and LEfSe indicate that each 
genotype is significantly differentiated from the other. Also, females exhibit a separate 
set of differentially abundant taxa between genotypes relative to those found in males. 
Unique findings of sex-specific compositional differences between genotypes are 
supported by analysis of microbiota composition by sex. The sexually differentiated taxa 
found in WT rats are not observed in Het and KO rats, and vice versa. PICRUSt 
analysis, which demonstrates differences in the functional capacity of gut microbiota, 
also suggests a unique microbiota for Het rats and highlights the effects of subject sex 
on genotype differences in microbiota composition. It is important to note that while 
PICRUSt has demonstrated a high level of predictive validity in mammalian microbial 
samples, PICRUSt analyzes data from a “closed-reference” subset of the original 
community composition BIOM table, and the accuracy of PICRUSt predictions still lie 
between 60-90% for mammals (Langille et al., 2013). 
AVP KO rats show less anxiety behavior than WT rats (Balazsfi et al., 2015). Our 
data suggest this may, in part, be driven by the higher abundance of Lactobacillus spp. 
found in the gut microbiota of KO rats relative to WT rats. Oral administration of 
Lactobacillus spp. decreases anxiety behavior in mice and rats (Bravo et al., 2011; 
Mackos et al., 2013; Ohland et al., 2013; Luo et al., 2014; Liang et al., 2015; Liu et al., 
2015; Wang et al., 2015b). Of note, male Het rats show levels of Lactobacillus spp. 
intermediate to those found in male WT and male KO rats. As Avp is haploinsufficient in 
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restoring normal working memory (Aarde and Jentsch, 2006) and in selective 
parameters of developmental behavior (Paul et al., 2016), a thorough investigation of 
differences in other behaviors such as anxiety behavior between Het and WT rats is 
warranted. The anxiety modulating properties of Desulfovibrio spp. and Blautia 
producta, most abundant in KO and Het rats respectively, have not been investigated in 
conventional WT rats. However, a gnotobiotic mouse model solely colonized with a 
Blautia sp. demonstrates decreases in marble burying behavior and moderate 
decreases in time spent in the periphery of the open field test relative to germ-free mice, 
suggesting decreases in repetitive and anxiety-like behaviors in these mice (Nishino et 
al., 2013). This is particularly notable, as germ-free mice show decreased anxiety-like 
behavior with respect to conventionally colonized mice (Diaz Heijtz et al., 2011; Neufeld 
et al., 2011b). 
Some differentiated taxa that have been associated with weakened immune 
systems or with inflammatory states are more abundant in KO or WT rats, respectively. 
AVP is important for shaping immune responses, and rats with a homozygous Avp 
deletion harbor a hyporesponsive immune system, showing deficits in macrophage 
activation, IgG antibody response, a smaller spleen and premature involution of the 
thymus (Khegai et al., 2003). Desulfovibrio c21_c20, found most abundantly in male KO 
rats relative to male WT rats, is a bacterial species of the Proteobacteria phylum, which 
has been found to be highly abundant in mice with a disruption in their innate immune 
system (namely, toll-like receptor 5 which recognizes flagellated bacteria) (Carvalho et 
al., 2012). Between female rats, Lachnospira spp. are most abundant in Het rats and 
Holdemania spp. are most abudnant in WT rats. Holdemania is a genus of the 
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Erysipelotrichales order; Erysipelotrichales bloom in response to a high-fat diet 
(Magnusson et al., 2015), which promotes intestinal inflammation. Children with asthma 
have a lower abundance of Lachnospira spp. in their gut microbiota, and germ-free mice 
colonized with a Lachnospira species show decreases in airway inflammation (Arrieta et 
al., 2015). Given the two-way relationship between microbiota and the immune system 
(Lei et al., 2015; Tomkovich and Jobin, 2015), it is possible that Lachnospira spp. 
suppress inflammation in a commensally beneficial manner that promotes further 
replication of Lachnospira spp. in female KO rats.  
One mechanism by which Avp deletion may alter gut microbiota is via regulation 
of water consumption. Drinking water conditions, such as the pH of consumed water, 
can alter gut microbiota (Sofi et al., 2014; Wolf et al., 2014). As AVP is important for 
water retention, Brattleboro rats display signs of diabetes insipidus, i.e. increased water 
intake and urine output. However, restoring systemic AVP levels via osmotic 
minipumps, which corrects water balance and diabetes symptoms, does not normalize 
anxiety and depressive behaviors in Brattleboro rats (Balazsfi et al., 2015). In addition, 
the heterozygous Brattleboro condition is sufficient to correct for outward signs of 
diabetes insipidus (Laycock, 1977; Opava-Stitzer et al., 1982), but the heterozygous 
condition is still unable to correct working memory deficits that are observed in 
homozygous knockout Brattleboro rats (Aarde and Jentsch, 2006). This suggests 
diabetes symptoms such as water consumption are not the sole driver of behavioral 
differences between Brattleboro and WT rats. 
There are other potential mechanistic links between AVP expression and 
microbiota composition. It is possible that maternal behaviors such as pup licking-
36 
grooming affect microbiota composition. KO Brattleboro dams have been demonstrated 
to exhibit maternal neglect, spending less time licking and grooming their pups than Het 
dams (Fodor et al., 2012). However, all subjects in this study were raised by Het dams. 
Nevertheless, KO pups may elicit differing levels of maternal licking-grooming behavior 
than Het and WT rats. KO rats exhibit differing levels of ultrasonic calls relative to WT 
and Het rats (Paul et al., 2016) and pup ultrasonic calls may be associated with rates of 
licking and grooming (Brouette-Lahlou et al., 1992), which may potentially affect adult 
gut microbiota composition.  
Moving from behavior to cellular biology, AVP may directly affect microbiota 
composition via receptors present on bacteria that may be structurally similar to host 
neurotransmitter/neuropeptide receptors (Corringer et al., 2012). Indeed, many 
neurotransmitters are suggested to derive from bacterial origins through lateral gene 
transfer into the metazoan lineage (Iyer et al., 2004). An in vitro study found that AVP 
was stable in a colonic environment devoid of fecal microbiota (Wang et al., 2015a). 
Therefore, AVP may be metabolized by the microbiota in a manner that influences their 
growth, cell death, or functional output, and may subsequently affect the host. 
AVP release, potentially both centrally and systemically, modulates the activity of 
immune cells (Shibasaki et al., 1998; Hu et al., 2003) and AVP-producing nuclei are 
responsive to inflammatory stimuli (Nava et al., 2000). Many immune cells also express 
AVP receptors (Russell and Walley, 2010). Similar to AVP, gut microbiota both regulate, 
and are shaped by, the immune system (Lei et al., 2015; Tomkovich and Jobin, 2015). 
Therefore, there may be a bidirectional link between gut microbiota and AVP expression 
mediated by the immune system. Future studies could investigate differences in 
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behavioral and cytokine profiles in germ-free rats administered microbiota from WT vs 
KO Brattleboro rats.  
In summary, we characterized the gut microbiota of wildtype (WT) Long Evans 
rats and Long-Evans rats carrying haploid (heterozygous, Het), or diploid (knockout, 
KO) deletions of the Avp gene, and found a limited but potentially influential subset of 
significantly differentiated taxa that correspond with the immune status and anxiety 
behavior differences observed between WT and KO rats. Rats heterozygous for the Avp 
gene harbor a unique microbiota, that appears to be intermediate to that found in the 
guts of WT and KO rats. Avp gene deletion appears to affect the community 
composition of the gut microbiota of males and females in a sexually differentiated 
manner. Future studies should more fully explore the behavioral phenotype of Het rats 
relative to WT rats, and how sex differences in behavior are altered by Avp gene 
deletion. 
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3 DIETARY EMULSIFIERS CONSUMPTION ALTERS ANXIETY-LIKE AND 
SOCIAL-RELATED BEHAVIORS IN MICE IN A SEX-DEPENDENT MANNER  
Mary K. Holder, Nicole V. Peters, Jack Whylings, Christopher T. Fields, Andrew T. 
Gewirtz, Benoit Chassaing, and Geert J. de Vries 
Slightly modified from Holder, Mary K., et al. “Dietary emulsifiers consumption alters 
anxiety-like and social-related behaviors in mice in a sex-dependent manner” Scientific 
Reports x.x (2018): x-x. 
 
3.1 Abstract 
Dietary emulsifiers carboxylmethylcellulose (CMC) and polysorbate 80 (P80) 
alter the composition of the intestinal microbiota and induce chronic low-grade 
inflammation, ultimately leading to metabolic dysregulations in mice. As both gut 
microbiota and intestinal health can influence social and anxiety-like behaviors, we 
investigated whether emulsifier consumption would detrimentally influence behavior. We 
confirmed that emulsifier exposure induced chronic intestinal inflammation, increased 
adiposity, and altered gut microbiota composition in both male and female mice, 
although the specific microbial taxa altered following emulsifier consumption occurred in 
a sex-dependent manner. Importantly, emulsifier treatment altered anxiety-like 
behaviors in males and reduced social behavior in females. It also changed expression 
of neuropeptides implicated in the modulation of feeding as well as social and anxiety-
related behaviors. Multivariate analyses revealed that CMC and P80 produced distinct 
clustering of physiological, neural, and behavioral effects in male and female mice, 
suggesting that emulsifier treatment leads to a syndrome of sex-dependent changes in 
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microbiota, physiology, and behavior. This study reveals that these commonly used 
food additives may potentially negatively impact anxiety-related and social behaviors 
and may do so via different mechanisms in males and females. 
 
3.2 Introduction 
 The notion that the viscera or gut influences our emotions dates back over 100 
years (James, 1884), and recent studies suggest this influence may be related to 
pathology. Indeed, a high comorbidity exists between gastrointestinal and psychiatric 
illnesses (Finegold et al., 2010; Adams et al., 2011; Dinan et al., 2014). An emerging 
focus of the gut-brain axis is the intestinal microbiota, the large and diverse community 
of microbes that reside in the gut, which has been shown to influence anxiety-like and 
social behaviors in mice. For example, mice reared in the absence of microbiota (germ-
free mice) show lower anxiety-like behavior than conventionally-colonized mice (Diaz 
Heijtz et al., 2011; Neufeld et al., 2011b; Clarke et al., 2013), and introducing microbiota 
around the time of weaning partially normalizes anxiety-like behaviors (Bercik et al., 
2011a; Diaz Heijtz et al., 2011; Neufeld et al., 2011a; Clarke et al., 2013). In addition, 
germ-free mice show reductions in social behavior (Desbonnet et al., 2014), and early 
life exposure to antibiotics also affects anxiety-like and social behaviors (Leclercq et al., 
2017). Oral exposure to pathogenic bacteria increases the number of pro-inflammatory 
bacteria strains in the gut, and gastrointestinal inflammation increases anxiety- and 
depression-like behaviors in mice (Lyte et al., 1998; Lyte et al., 2006; Goehler et al., 
2008; Bercik et al., 2010). In contrast, probiotics, which are anti-inflammatory (Rodes et 
al., 2013), reduce such behaviors (Bercik et al., 2010; Desbonnet et al., 2010; Bercik et 
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al., 2011b; Bravo et al., 2011; Jang et al., 2017a). Prebiotics, which act as food sources 
for anti-inflammatory microbiota, (Monteagudo-Mera et al., 2016) also reduce anxiety- 
and depression-like behaviors in mice (Burokas et al., 2017). 
One potential mechanism for influencing intestinal microbiota, and thereby the 
inflammatory state, is through diet. Western diet is high in sugar, fats, red meats, refined 
grains, and processed foods containing food additives for both preservation and flavor 
and/or texture enhancement (Hu, 2002; Broussard and Devkota, 2016). Adding 
carboxymethylcellulose (CMC) or polysorbate-80 (P80) to the diet, commonly used 
emulsifying food additives, induces low-grade inflammation, obesity, and metabolic 
abnormalities in mice (Chassaing et al., 2015; Chassaing et al., 2017). The same 
treatments also promote microbial encroachment within the intestinal mucus barrier and 
alter microbiota species composition toward a more pro-inflammatory potential. Germ-
free animals are protected from intestinal inflammation and metabolic abnormalities 
following emulsifier exposure, and transplant of microbiota from emulsifier-treated 
animals to germ-free recipient mice is sufficient to confer metabolic alterations, 
indicating that microbiota drive this phenotype (Chassaing et al., 2015). Taken together, 
these data further support the concept that microbiota composition is important for 
health, and that perturbations of the intestinal microbiota by modern stressors, such as 
emulsifiers, can lead to aberrant physiology. 
In the present study, we examined the effects of emulsifier consumption on brain 
and behavior. We found that emulsifier treatment altered anxiety-like and social 
behaviors, as well as neuropeptide systems implicated in these behaviors, and did so in 
a sex-specific manner. Such sex-specific differences were paralleled by emulsifiers 
41 
having sex-specific effects on microbiota composition, inflammation and metabolism. 
These results demonstrate the potential for food additives that impact microbiota to 
broadly impact physiology and behavior.  
  
3.3 Materials and Methods (Excerpt from original publication) 
3.3.1 Animals 
C57Bl/6J dams with litters (3 male and 3 female 14-day-old pups) were 
purchased from Charles River Laboratories. Mice were housed in ventilated transparent 
OptiMouse plastic cages with Bed-O-Cobs® and AlphaDri bedding (35.6 x 48.5 x 
21.8cm; at Georgia State University). Lights were set to a 14h:10h light:dark cycle 
(lights off at 0900 ET), and ambient temperature was maintained at 23°C. Food (Purina 
rodent chow no. 5001) and water were available ad libitum. On postnatal day 21 (P21), 
mice were weighed and placed in a plastic container for approximately 20 minutes to 
collect feces for later analysis. Mice were put into a new cage such that each 
experimental group contained mice from all litters and that each litter was used for all 
experimental groups (Figure 1). Cages were given reverse-osmosis treated Atlanta city 
drinking water with sodium carboxymethylcellulose (CMC; Sigma, St. Louis, MO), or 
with polysorbate-80 (P80; Sigma) (1% in each case), or with no additives. The drinking 
water and emulsifier solutions were changed weekly. Body weights were measured 
weekly and expressed relative to the body weight on P21. All procedures were in 
accordance with the Guide for Care and Use of Laboratory Animals and approved by 
the Animal Care and Use Committee at the Georgia State University (protocol number 
A15002). 
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3.3.2 Behavioral Testing 
Starting on P70, behavioral tests were conducted once a week for 6 weeks, with 
a week between each test (Supplemental Figure 1). Behavioral tests were conducted in 
the following order: Open Field Test, Elevated Plus Maze, Light/Dark Box, Marble 
Burying Task, Three-Chambered Sociability Task, and Porsalt Forced Swim Test. 
Behavioral testing occurred within the first 4h after the start of the dark phase and was 
conducted under dim red light except for the Light/Dark box, which was illuminated by 
overhead lights (between 300-400 lux). Arenas were cleaned with 70% ethanol between 
trials. Behavioral tests were videotaped using a Sony camcorder for later analysis by 
AnyMaze version 4.96 (Stoelting, Co., Wood Dale, IL) or The Observer version XT11 
(Noldus Information Technology Inc., Wageningen, The Netherlands). An experimenter 
blinded to the treatment conditions scored behavioral tests in the Observer. 
 
3.3.2.1 Open Field Test  
Locomotor behavior was assessed in a 43.2 X 43.2 X 30.5cm (WxLxH) Plexiglas 
arena (Med Associates, Inc., St. Albans, VT) containing 2 arrays of infrared transmitters 
strips (16 beams each) located on the bottom of the arena (in the X and Y plane). The 
center zone of the arena was defined as square containing the center 8 beams (e.g., 
beams 4-12) in the X and Y plane. Each mouse was placed into the arena with its nose 
facing the wall and allowed to freely investigate for 10 min. The total distance traveled, 
the total time spent in the center of the arena, and stereotypic circling behavior were 
calculated by Activity Monitor (Med Associates, Inc.,) on a computer connected to the 
open field arenas. 
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3.3.2.2 Elevated Plus Maze 
An elevated plus maze with two open and two closed arms was used. Arms were 
10 cm W X 50 cm L, connected by a 10 X 10 cm2 center chamber. Closed arms had 40 
cm H walls. The maze was elevated 50 cm from the floor. Mice were placed in the 
center of the arena and allowed to explore for 5 min. All trials were video-recorded from 
a digital camera mounted above the maze and connected to a computer. The number of 
entries into and the total time spent in the open arms, closed arms, or center were 
quantified by AnyMaze. 
 
3.3.2.3 Light/dark Box 
A 14.5 cm W X 30 cm L X 14 cm H chamber divided into a light and dark 
compartment was used. The light compartment (20 cm L) was made of white acrylic, 
and the dark compartment (10 cm L) of opaque black acrylic and covered. An opaque 
insert with a 5cm W X 5cm H opening connected the compartments. Mice were placed 
in the light compartment facing away from the entry into the dark chamber and allowed 
to freely investigate the chamber for 5 min. All trials were video recorded from a digital 
camera mounted above the Light/Dark box and connected to a computer. The number 
of entries into the dark chamber and total time spent in the light compartment were 
quantified in AnyMaze. 
 
3.3.2.4 Marble Burying 
A Plexiglas arena (24cm W X 46 cm L) was filled 4 cm deep with Alpha-dri 
bedding (Shepherd Specialty Paper, Fibercore, Cleveland, OH, USA). Mice were placed 
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into the arena, and after a 5 min habituation period, mice were removed and twenty 
marbles (17 mm) were evenly spaced on top of the bedding. Mice were placed in the 
center of the arena and video-recorded for 10 min. The number of marbles buried, as 
defined by being ½ or more covered with bedding, and the latency to bury the first 
marble were quantified using the Observer. 
 
3.3.2.5 Three Chambered Sociability 
A 24 X 74 X 24 cm (L x W x H) polycarbonate apparatus was divided into three 
equally sized chambers with openings 9cm W to allow free movements between 
compartments. At either end of the apparatus was an (9cm W X 10 cm H) opening 
beside which the stimulus cages were placed. The stimulus cages were 10cm W X 10 
cm L X 10 cm H polycarbonate cage with grid (10 X 10) of small holes 0.5cm in 
diameter to allow transfer of visual and olfactory cues, while limiting physical interaction 
to nose contact or whisking. 
 
3.3.2.6 Sociability test 
Following a 5 min habituation period in which the mouse was allowed to explore 
the entire three-chambered apparatus, the experimental animal was removed, and an 
unfamiliar sex- and age-matched C57Bl6/J mouse was placed inside one of the 
stimulus cages beside one of the side chambers. An identical stimulus cage containing 
a novel object was placed beside the opposite chamber. The test animal was returned 
to the middle chamber and allowed to freely investigate the apparatus for 10 min. 
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The location of the novel mouse and the novel object were alternated between 
left and right chambers on consecutive sessions. The time spent and the numbers of 
entries into each chamber were measured using AnyMaze. The time spent sniffing or 
actively investigating the stimulus chambers over the 10 min test was scored in The 
Observer. A preference score was calculated by dividing the time spent investigating 
the novel mouse by the total time spent investigating the novel mouse and the novel 
object. 
 
3.3.2.7 Social Preference test 
Immediately following the 10 min sociability test, the experimental mouse was 
removed from the three-chambered apparatus, and the novel object was replaced with 
an unfamiliar stimulus sex- and age- matched C57Bl6/J mouse. The original stimulus 
mouse used in the sociability portion of the test remained in its cage beside one 
chamber of the apparatus. Identical measures were scored as in the sociability test: 
time spent in each chamber, entries between chambers, and time spent investigating 
each stimulus mouse. 
 
3.3.2.8 Porsolt Forced Swim Test 
A vertical Plexiglas cylinder (40cm H X 18cm diameter) was filled with 3L of 30 
°C (± 2 °C) water. Mice were placed in the center of the cylinder and video recorded for 
5 mins. The latency and duration of immobility were quantified in the Observer. 
Immobility was defined by the absence of movement or only small movements of 
posterior paws that did not result in displacement of the water. At the end of the test, 
46 
mice were removed from the cylinder and placed in a recovery cage on a heating pad 
until they were dry and then returned to their home cage.  
 
3.3.3 Euthanasia and Tissue Collections 
One day following completion of behavioral testing (P105), mice were deeply 
anesthetized under isoflurane (5%v/v) and body weight was recorded. Blood was 
collected from the retrobulbar intraorbital capillary plexus. Mice were euthanized by 
cervical dislocation, and the colons, spleens, livers, adipose, feces, and brains were 
collected for subsequent analysis. Hemolysis-free serum was generated by 
centrifugation blood samples using serum separator tubes (Becton Dickinson, Franklin 
Lakes, NJ). The weight and length of the colon and weights of the spleen, liver, and 
perigonadal adipose fat depot were recorded and normalized to the body weight. Brains 
were removed and fixed in a 5% acrolein in sodium phosphate buffer (0.1M, pH 7.4) at 
4°C, followed by cryoprotection in 30% sucrose in phosphate buffered saline (PBS: 
0.05M, ph7.4).  
 
3.3.4 Immunohistochemistry 
Brains were sectioned (30µm) in the coronal plane with a cryostat and stored in a 
cryoprotectant solution (ethylene glycol/sucrose in sodium phosphate buffer) until 
immunostained. Free-floating sections were rinsed three times in Tris-buffered saline 
(TBS; 0.05 M Tris, 0,9% NaCl, pH 7.6), then incubated for 30 min in 0.05 M sodium 
citrate in TBS. After rinsing in TBS sections were places for 30 min in 0.1 M glycine in 
TBS, rinsed again, and placed into blocking solution (10% normal goat serum (NGS), 
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0.4% Triton-X and 1% H2O2 in TBS) for 30 min. Sections were incubated overnight in 
one of the following primary antibodies diluted in 2% NGS and 0.4% Triton-X in TBS: 
anti-vasopressin (Bachem; 1:32000) anti-oxytocin (Peninsula Labs; 1:32000); anti-
agouti-related peptide (AgRP; Phoenix Pharmaceuticals; 1:250000), anti-alpha-
melanocyte stimulating hormone (MSH; Millipore; 1:100000), and anti-ionized calcium-
binding adaptor protein (Iba1; Wako Laboratoy; 1:30000). The next day, sections were 
rinsed three times in TBS containing 1% NGS and 0.02% Triton-X and incubated in 
biotinylated secondary antiserum [goat anti-rabbit for vasopressin, oxytocin, AgRP, and 
Iba1 immunoreactivity; rabbit anti-sheep for MSH (Vector Laboratories, Burlingame, 
CA)] diluted 1:800 in TBS with 2% NGS and 0.32% Triton-X for 1 h. This was followed 
by rinses in TBS containing 0.4% Triton X, incubated in avidin-biotin complex 
(Vectastain Elite ABC Kit; Vector Laboratories) diluted to 1:800 in TBS for 1 h, followed 
by three TBS rinses and three sodium acetate buffer rinses. Finally, the staining was 
visualized using nickel-enhanced diaminobenzidine (DAB) Substrate Kit (Vector 
Laboratories). Sections were mounted onto gelatin-coated slides and cover-slipped with 
Permount. 
 
3.3.5 Image Analysis 
Slides were anatomically-matched and analyzed by an investigator blinded to the 
experimental groups. Sections were imaged using a Zeiss Axio Imager M2 microscope 
connected to an ORCA-R2 CCD digital camera (Hamamatsu Photonics). Gray-scale 
images of the fiber density in the photomicrographs were analyzed in Image J 1.43u 
(National Institutes of Health, Bethesda, MD). The region of analysis was outlined in 
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each section. Subjects for which the relevant sections were damaged or unavailable 
were dropped from a given analysis. 
 
3.3.6 Fecal microbiota 16s rRNA gene sequencing and sequences analysis 
16S rRNA gene amplification and sequencing were done using the Illumina 
MiSeq technology following the protocol of Earth Microbiome Project with their 
modifications to the MOBIO PowerSoil DNA Isolation Kit procedure for extracting DNA 
(www.earthmicrobiome.org/emp-standard-protocols) (Gilad et al., 1987; de Paz Cabello 
et al., 1988). Bulk DNA was extracted from feces collected on P21 and P105 using a 
PowerSoil-htp kit from MoBio Laboratories (Carlsbad, CA, USA) with mechanical 
disruption (bead-beating). The 16S rRNA genes, region V4, were PCR amplified from 
each sample using a composite forward primer and a reverse primer containing a 
unique 12-base barcode, designed using the Golay error-correcting scheme, which was 
used to tag PCR products from respective samples (de Paz Cabello et al., 1988). We 
used the forward primer 515F 5’- 
AATGATACGGCGACCACCGAGATCTACACTATGGTAATTGTGTGCCAGCMGCCGC
GGTAA-3’: the italicized sequence is the 5’ Illumina adapter B, the bold sequence is the 
primer pad, the italicized and bold sequence is the primer linker and the underlined 
sequence is the conserved bacterial primer 515F. The reverse primer 806R used was 
5’-CAAGCAGAAGACGGCATACGAGAT XXXXXXXXXXXX AGTCAGTCAG CC 
GGACTACHVGGGTWTCTAAT-3’: the italicized sequence is the 3’ reverse complement 
sequence of Illumina adapter, the 12 X sequence is the golay barcode, the bold 
sequence is the primer pad, the italicized and bold sequence is the primer linker and the 
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underlined sequence is the conserved bacterial primer 806R. PCR reactions consisted 
of Hot Master PCR mix (Quantabio, Beverly, MA, USA), 0.2 μM of each primer, 10-100 
ng template, and reaction conditions were 3 min at 95°C, followed by 30 cycles of 45 s 
at 95°C, 60s at 50°C and 90 s at 72°C on a Biorad thermocycler. PCRs products were 
purified with Ampure magnetic purification beads (Agencourt, Brea, CA, USA), and 
visualized by gel electrophoresis. Products were then quantified (BIOTEK Fluorescence 
Spectrophotometer) using Quant-iT PicoGreen dsDNA assay. A master DNA pool was 
generated from the purified products in equimolar ratios. The pooled products were 
quantified using Quant-iT PicoGreen dsDNA assay and then sequenced using an 
Illumina MiSeq sequencer (paired-end reads, 2 x 250 bp) at Cornell University, Ithaca.  
Forward and reverse Illumina reads were joined using the fastq-join method 
(Aronesty, 2011, 2013), sequences were demultiplexed, quality filtered using 
Quantitative Insights Into Microbial Ecology (QIIME, version 1.8.0) software package 
(Giraldo et al., 1985). QIIME default parameters were used for quality filtering (reads 
truncated at first low-quality base and excluded if: (1) there were more than three 
consecutive low quality base calls (2), less than 75% of read length was consecutive 
high-quality base calls (3), at least one uncalled base was present (4), more than 1.5 
errors were present in the bar code (5), any Phred qualities were below 20, or (6) the 
length was less than 75 bases). Sequences were assigned to operational taxonomic 
units (OTUs) using UCLUST algorithm (Edgar, 2010) with a 97% threshold of pairwise 
identity (without the creation of new clusters with sequences that do not match the 
reference sequences), and classified taxonomically using the Greengenes reference 
database 13_8 (Cedar, 1988). A single representative sequence for each OTU was 
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aligned and a phylogenetic tree was built using FastTree (Cowing et al., 1989). The 
phylogenetic tree was used for computing the unweighted UniFrac distances between 
samples (Bergman et al., 1992; Zembrzuski et al., 1992). rarefaction were performed 
and used to compare abundances of OTUs across samples. Principal coordinates 
analysis (PCoA) plots were used to assess the variation between experimental group 
(beta diversity). Alpha diversity curves were determined for all samples using the 
determination of the number of observed species. LEfSE (LDA Effect Size) was used to 
investigate bacterial members that drive differences between groups (Day et al., 1988). 
The threshold on the logarithmic LDA score for discriminative features was set to 2.0, 
and the alpha values for the factorial Kruskal-Wallis test and pairwise Wilcoxon test 
between subclasses were set to 0.05. 
In addition to fecal samples collected from the animals used in this current study, 
the 16s sequences previously generated (from Chassaing et al., 2015) were reanalyzed 
by combining gene sequences from both male and female mice treated with water 
(male: 12; female: 12), CMC (male: 11; female: 12), and P80 (male: 10; female: 9). 
 
3.3.7 Statistical analyses 
Data were analyzed using IBM SPSS Statistics Version 21 (IBM) and visualized 
using GraphPad Prism 7.0c (GraphPad Software, La Jolla, CA). Body weights were 
analyzed by a repeated measure ANOVA, with sex and treatment as factors, followed 
by Fishers’ LSD as post hoc analyses. Anxiety-like and social behaviors were analyzed 
by a two-way ANOVA with treatment and sex as the factors, followed by Fishers’ LSD 
as post hoc analyses.  
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Data were also analyzed by multiple discriminant analysis (MDA) in order to 
reveal patterns in the aggregate behavioral changes. Discriminant analysis is a 
multivariate data analysis technique that employs algorithms used in machine learning 
to reveal the combination of measures that best differentiate sample groups. These 
analyses used a wide array in input variables in order to capture syndromic treatment 
effects across the various experiments. Here, we use it to explore the combination of 
locomotor, anxiety-like, and repetitive behaviors observed in the open field test, and 
also use a select few measures that most intuitively capture locomotor, anxiety-like, and 
repetitive behaviors (e.g. time spent moving, time in center of open field, and time spent 
in stereotypic circling) along with measures for hypothalamic neuropeptide expression 
and measures of metabolic state to explore larger systemic impact of emulsifier 
treatment on our subject mice.  By convention, this algorithm returns five “discriminant 
functions”, each with a unique combination of weights for the input variables. These 
functions are ordered from those that describe most to the least of the variance in the 
data set. Wilk’s lambda is the statistical test that describes which of these successively 
ranked functions significantly differentiate the function groups. The weights of each of 
the measures along each of the discriminant functions is listed in structure matrices, 
which are referenced in the text. Any measure with a weight greater than 0.3 is 
considered to significantly contribute to the described discriminant function.  
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3.4 Results  
3.4.1 Effects of emulsifiers on host physiology and metabolism 
In accord with our previous work, twelve weeks of exposure to emulsifiers 
carboxymethylcellulose (CMC) or polysorbate (P80) via drinking water led to a marked 
increase in abdominal adiposity that was associated with chronic mild intestinal 
inflammation, as revealed by shorter colons and increased spleen weight (Fig. 3.1). 
 
 
Figure 3.1 Dietary emulsifiers promote physiological changes consistent with 
metabolic syndrome.  
Male and female C57Bl/6 mice were exposed to drinking water containing CMC or 
P80 (1%) for 12 weeks. (A) There was a main effect of treatment with emulsifiers on 
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fat-pad mass [F(2,29) = 12.48, p < 0.001]. There is also a main effect of sex on 
adiposity such that males had greater fat mass than did females F (1,29) = 7.65, 
p < 0.01]. Post-hoc comparisons indicate that both CMC and P80 increased fat mass 
in females, but in males only CMC treatment increased fat mass compared to 
respective water-treated controls (*p < 0.05). (B) There was a significant interaction of 
emulsifier treatment and sex on colon weights [F(2,29) = 3.383, p < 0.05], with post-hoc 
comparisons indicating that P80 treatment significantly reduced colon weights in 
female compared to water-treated controls (*p < 0.05). (C) Emulsifier treatment also 
had a significant main effect on colon lengths in male and female mice [F (2,29) = 28.70, 
p < 0.0001] such that females treated with both emulsifiers and males treated with 
P80 had significantly shorter colons compared to their respective water-treated 
controls (*p < 0.05). (D) There was a significant main effect of both emulsifier 
consumption [F(2,29) = 5.312, p < 0.05] and sex on spleen weights [F(1,29) = 43.31, 
p < 0.0001]. Post-hoc comparisons indicate that treatment with both CMC and P80 
increased spleen weight compared to water-controls in males, but not females 
(*p < 0.05). Data are represented as means + SEM (n = 5–6). 
 
3.4.2 Impact of emulsifier consumption on fecal microbiota composition 
We next used 16S rRNA sequencing to determine the effects of emulsifier 
consumption on microbiota composition. Using Principal Coordinate Analysis (PCoA) of 
the unweighted UniFrac distances, we first examined the differences in microbiota 
composition before treatments begin (P21). As expected, the microbiota did not 
differentially cluster prior to treatment (Fig. 3.2A,B). In addition, LefSe analyses 
identified very few operational taxonomic units (OTUs) with an altered abundance 
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between treatment (Supplemental Fig. 2A,B,E,F). Importantly, following twelve weeks of 
emulsifier exposure (P105), male and female animals harbored distinct microbiota 
composition based on treatment (Fig. 3.2C,D, Permanova < 0.001). LefSe analysis 
conducted in males and females separately indicated that several taxa differ based on 
treatment: in males, emulsifier comsumption reduced the abundance of the Firmicutes 
phylum and Oscillospria, Coprococcus, and rc4_4 genera (Supplemental Fig. 2C,D). 
CMC-treated males exhibited higher abundance of the genus Dorea whereas P80-
treatment increased the abundance of the 
genera Bacteroides, Burkholderia, Clostridium, and Veillonella. In females, emulsifier 
treatment reduced abundance of Bacteroides, Sphingomondales, Sphingomonas, and 
Ruminococcus (Supplemental Fig. 2G,H). CMC-treated females showed increases 
in Anaeroplasma; whereas P80 treatment increased the relative abundance of the 
Proteobacteria phylum and of Clostridium and Burkholderia genus. 
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Figure 3.2 Effects of dietary emulsifiers on microbiota.  
Principal coordinates analysis (PCoA) of the unweighted UniFrac distance matrix of 
fecal microbiota in male (A,C) and female (B,D) mice at the time of weaning, P21 (A,B) 
and at the time of collections, P105 (C,D). Treatment of the mouse is indicated by point 
color (blue, water; orange, CMC; purple, P80). 
 
We next analyzed microbiota composition in animals from the current study and 
in animals from our previous work (Fig. 3.3 and Supplemental Fig. 3) in order to 
examine sex differences in the microbial community structure (Chassaing et al., 2015). 
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Such analysis revealed an impact of sex on microbiota composition, for each 
experimental group (water, CMC and P80, Fig. 3.3). When each treatment group was 
examined separately, there were sex differences in community composition. (Fig. 3.3). 
For example, within the water-treated controls, bacteria from 
genera Bacteroides and Clostridium were more abundant in females, whereas bacteria 
within the genera Lactobacillus and Coprococcus were more highly present in males. 
(Fig. 3.3B,D). 
 
Figure 3.3 Sex differences in microbiota in mice treated with dietary 
emulsifiers.  
Male and female C57Bl/6 mice were exposed to drinking water containing CMC 
or P80 (1%) in the present study and in data previously reported in Extended Data Fig. 
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3 in (Chassaing et al., 2015). Principal coordinates analysis (PCoA) of the unweighted 
UniFrac distance matrix of fecal microbiota showing clustering by sex in (A,C) water-, 
(E,G) CMC- and (I,K) P80- treated mice. Sex of the mice is indicated by point color (red, 
female; green, male). Linear discriminant analysis coupled with Effect Size (LEfSe) was 
used to identify taxa that differ significantly between male and female mice within water, 
CMC, and P80 treatments. 
 
Treatment with emulsifiers changed the gut microbiota of males and females 
differently (Fig. 3.3). For example, the sex differences in the 
genera Bacteroides, Closteridium, Lactobacillus and Coprococcus are eliminated 
following CMC treatment. Some new sex differences also emerged: following CMC 
treatment in males, an increased abundance in bacteria pertaining to the 
genera Staphylococcus and Ruminococcus (Fig. 3.3F) was observed, and females 
harbored more bacteria within the phyla Deferribacteres and TM7 (Fig. 3.3H). Following 
P80 treatment, males displayed an increased abundance of the 
genus Pseudomonas (Fig. 3.3J,L). 
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3.4.3 Effects of emulsifiers on behavior 
3.4.3.1 Anxiety-like behavior - Open Field Test 
We next sought to determine the impact that emulsifier consumption and 
associated alterations in microbiota composition might have on behavior. We observed 
that, in male animals, emulsifier treatment reduced the time spent in the center portion 
of the open field (Fig. 3.4A) without affecting the total distance traveled in the apparatus 
(Supplemental Fig. 4A). In addition, there was a trend towards a main effect of sex, 
such that females spent less time in the center, compared to males (p = 0.07; Fig. 3.4A), 
mostly driven by the time spent in the center in the male water group. Multivariate test 
statistics revealed that the behaviors in the open field test separated significantly by sex 
and emulsifier treatment along five discriminant functions (Table 1). Function 1 
explained 43.9% of the variance in the data set (R = 0.898) and the number of 
stereotypic beam breaks maps most highly onto this function (r = 0.383). The canonical 
discriminant function plot reveals the effects of each individual emulsifier treatment on 
each of the sexes for these two functions in the open field behaviors. Emulsifier 
consumption causes a separation of the aggregate open field behaviors from the water-
treated controls. Moreover, the changes in the open field behaviors are similar in P80-
treated male and female mice, whereas, CMC may exert unique effects in male and 
females (Fig. 3.4B). 
While focusing on the unique behavioral effects of each emulsifier treatment 
across each sex, we chose to examine several different measures from the open field 
test. Here, we used MDA across 15 different measures: locomotor (resting time, 
average velocity, ambulatory episodes, ambulatory time, ambulatory counts, and 
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ambulatory distance), repetitive (stereotypic counts, time spent in stereotypic 
movement, jump counts, jump time, clockwise reversals, and counterclockwise 
reversals), and anxiety-like (time-spent in center zone, number of entries into the center 
zone, and time spent in vertical posture). Here, again, we observe that while P80 largely 
maintains sex differences demonstrated in water-treated mice along function 1, CMC 
uniquely affects sex differences across this syndrome of behavioral measures. In 
addition, sex differences are not observed for water-treated mice along function 2, 
however here, P80 and CMC appear to only exert their effects in one given sex each: 
whereas P80 affects females along function 2 most robustly, CMC exerts its greatest 
effects in males. In addition, CMC and P80 appear to exert similar effects within their 
affected sex along function 2. The measures that map on best to function 1 are 
repetitive and locomotor measures, namely (by order of significance) stereotypic counts, 
resting time, average velocity, jump counts, and stereotypic time. The measures that 
map on best to function 2 are locomotor, anxiety-like, and repetitive measures, namely 
(by order of significance) ambulatory episodes, number of entries into the center zone, 
clockwise reversals, jump time, and jump counts. Thus, while P80 does not as robustly 
affect sex differences in patterns of general locomotor and repetitive movements 
(observed in water-treated mice), CMC does disrupt, and perhaps invert, these sex 
differences. In addition, when anxiety-like measures are more fully represented (in 
discriminant function 2), it is clear that each emulsifier has a unique effect on males and 
females, each one mostly affecting one or the other sex. 
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Figure 3.4 Dietary emulsifiers alter anxiety-like behaviors in male and 
female mice.  
(A) There was a main effect of emulsifier treatment to decrease the time spent in 
the center of the open field test [F(2,29) = 4.14, p < 0.05]. Post-hoc analyses indicate that 
in males, treatment with emulsifiers decreases in the time spent in the center, compared 
to water-treated controls (*p < 0.05). (B) Multivariate test statistics measured the impact 
of additional behavioral measures captured in the automated open field apparatus 
(Table 1). The canonical discrimination function plot and Wilk’s lambda revealed a 
significant separation of groups by sex and emulsifier consumption along five 
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discriminant functions [Λ = 0.010, Χ2(30) = 108.204, p < 0.01]. (C) Emulsifier 
consumption increased the total distance traveled in the elevated plus maze 
[F(2,29) = 3.94, p < 0.05]. Post-hoc analyses indicate that in males, treatment with CMC 
significantly increased the distance traveled in the EPM (*p < 0.05). In addition, there 
was a main effect of sex [F(1,29) = 10.42 p < 0.01], such that females traveled a greater 
distance, compared to males, regardless of treatment. (D) There was no significant 
effect of emulsifier treatment on the total number of entries into the light portions of the 
light/dark box. Irrespective of treatment, however, female mice made significantly more 
entries into the light portion of the light/dark box [F(1,29) = 13.76, p < 0.001]. Data are 
represented as means + SEM (n = 5–6). 
 
Table 3.1 Structure Matrix of Discriminant Analysis for Open Field Behavior.  
 
Measured Outcomes 
Function 
1 2 3 4 5 
Circling Counts .383* .118 -.119 .053 .153 
Resting Time (sec) .298* .186 -.023 .160 .214 
Time in Center 
Zone (sec) 
.147* -.109 -.104 .145 -.091 
Number of Entries 
into Center Zone 
.155 .262* .051 .260 .159 
Jump Counts -.259 .213 .435* .138 -.048 
 Average Velocity -.295 .150 .304* .190 -.164 
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 Counter Clockwise 
Reversals 
.057 -.127 .372 .381* -.039 
Ambulatory 
Episodes 
.080 .280 -.071 .304* -.021 
Vertical Time (sec) .062 -.060 -.159 .256* -.141 
 Jump Time (sec) -.007 .235 .112 .043 .450* 
Circling Time (sec) -.210 -.066 .205 .022 .406* 
Ambulatory Time 
(sec) 
-.144 -.090 .181 .057 .401* 
Ambulatory Counts -.179 -.127 .202 -.003 .389* 
Ambulatory 
Distance (cm) 
-.115 -.053 .165 .005 .345* 
 Clockwise 
Reversals 
-.032 .242 .087 -.179 .317* 
Pooled within-group correlations between discriminating variables and standardized 
canonical discriminant functions. The variables are ordered by absolute size of 
correlation within each the functions (*indicates the largest absolute correlation between 
each variable and any discriminant function). 
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3.4.3.2 Anxiety-like behavior - Elevated Plus Maze Test 
Treatment with emulsifiers did not affect time spent in, nor number of entries into, 
either the open or closed arms in the elevated plus maze test (Supplemental Fig. 4). 
Emulsifier consumption did, however, increase the distance travelled in this behavioral 
test (Fig. 3.4C), suggesting that although emulsifier consumption did not increase 
anxiety in this test, it impacted locomotor behavior. 
 
3.4.3.3 Anxiety-like behavior - Light/Dark Box 
Treatment with emulsifiers did not affect time spent in the light nor the number of 
entries into the light (Fig. 3.4D and Supplemental Fig. 4F), suggesting that emulsifiers 
did not impact anxiety in the light/dark box test. Irrespective of treatment, female mice 
made significantly more entries into the light, but the total amount of time spent in the 
light did not differ from male mice (Fig. 3.4D).  
 
3.4.3.4 Anxiety-like behavior - Marble Burying Task 
Treatment with emulsifiers did not significantly affect the number of marbles 
buried (p=0.91; data not shown) or the latency to bury the first marble (p=0.69; data not 
shown).  
 
3.4.3.5 Sociability 
Treatment with emulsifiers did not affect social interaction as measured by the 
percent of time spent investigating a novel mouse when given the choice to investigate 
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that mouse or a novel object (Fig. 3.5A). However, if given a choice between a novel or 
a familiar mouse, emulsifier treatment lowered the preference for the novel mouse 
compared to water-treatment in females (Fig. 3.5B). Indeed, post-hoc comparisons 
indicated that CMC consumption in female mice significantly reduced the preference for 
the novel mouse. In addition, there was a strong trend towards a reduced preference for 
the novel mouse following P80 consumption in female mice (p = 0.06) (Fig. 3.5). 
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Figure 3.5 Dietary emulsifiers decrease preference for social novelty in female 
mice.  
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(A) There was no significant main effect of emulsifier consumption [F (2,28) = 1.08, 
p = 0.35] or sex [F(1,28) = 0.00003 p = 0.99] on the preference for investigating a novel, 
conspecific mouse during the sociability test in the three-chambered sociability 
apparatus. In addition, there was no sex by treatment interaction on this measure 
[F(2,28) = 0.67, p = 0.52] (B). Emulsifier treatment and sex interacted on the preference 
for investigating a second novel, conspecific mouse during the preference for social 
novelty test in the three-chambered sociability apparatus [F(2,29) = 3.71, p < 0.05]. In 
addition, post-hoc comparisons indicate that treatment with CMC significantly 
decreased the preferences of female mice for the novel mouse (*p < 0.05). Data are 
represented as means + SEM (n = 5–6). 
 
3.4.3.6 Depression-like behavior 
Treatment with emulsifiers did not affect the duration of immobility (p=0.92; data 
not shown) or the latency to first bout of immobility (p=0.30; data not shown).  
 
3.4.3.7 Effects of emulsifiers on neural correlates 
We next investigated the effects of emulsifiers on neuropeptides that influence 
feeding and anxiety behaviors. Both agouti-related peptide (AgRP) and α-melanocyte 
stimulating hormone (α-MSH) regulate appetite, energy homeostasis, and anxiety like 
behavior with AgRP stimulating food intake and reducing anxiety-like behaviors and 
αMSH acting in opposition to inhibit food intake and increase anxiety-like behaviors 
(Kokare et al.; Liu et al., 2007; Dietrich et al., 2015). In males, consumption of CMC 
increased AgRP immunoreactivity (IR) in the arcuate nucleus (Fig. 3.6A) and both CMC 
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and P80 consumption increased AgRP IR in the paraventricular nucleus of the thalamus 
of male animals (PVT; p = 0.05, Fig. 3.6B). Emulsifier treatment reduced α-MSH IR in 
the PVT of both male and female animals (Fig. 3.6C). Females also have increased 
αMSH IR compared to males in both the PVT and the arcuate nucleus (p < 0.0001; data 
not shown). Treatment with emulsifiers was without effect on αMSH IR in the arcuate 
nucleus (p = 0.95; data not shown) and the PVN (p = 0.91; data not shown). 
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Figure 3.6 Dietary emulsifiers alter neuropeptide immunoreactivity in male and 
female mice.  
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(A) There was a main effect of emulsifier consumption on agouti-related peptide 
(AgRP)-immunoreactivity (IR) in the arcuate nucleus in both male and female mice 
[F(2,29) = 4.689, p < 0.05], driven, in part, by the significant increase following 
consumption of CMC in males (*p < 0.05). (B) There was a main effect of sex on AgRP-
IR in the paraventricular nucleus of the thalamus (PVT) [F(1,29) = 7.494, p < 0.05], such 
that males had more AgRP-IR than females. In addition, post-hoc analysis indicated 
that consumption of emulsifiers significantly increased AgRP-IR in the PVT of males 
(*p < 0.05). (C) Emulsifiers reduced α-Melanocyte Stimulating Hormone (αMSH)-IR in 
the PVT in male and female mice [F(2,29) = 12.98, p < 0.001]. In addition, there was also 
a main effect of sex with females having more αMSH-IR than males [F(1,29) = 14.42, 
p < 0.001]. Data are represented as means + SEM (n = 5–6). 
 
That dietary emulsifiers induced chronic intestinal low-grade inflammation led us 
to examine whether emulsifier altered microglia by examining Iba1-immunoreactivity. 
Emulsifier treatment did not affect total Iba1-immunoreactivity in the PVT, PVN, Arcuate 
nucleus, or hippocampus (data not shown), suggesting that emulsifier consumption 
does not lead to gross changes in microglia. 
 
3.4.3.8 Multivariate analysis of emulsifier effects 
Next, multivariate tests were used in order to measure the impact of emulsifiers 
on synergistic changes in the behavioral measures, physiological parameters, and 
immunoreactivity of neuropeptides in the PVT. When these measures were analyzed in 
combination, Wilk’s lambda revealed a significant separation of groups by sex and 
emulsifier treatment along five discriminant functions. The variables that map most 
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highly onto these functions are listed in Table 3.2. Functions 1 and 2 explain the 
majority of variance in the data set (cumulatively, 80.0% of the variance), with Function 
1 explaining 53.8% of the variance (R=0.945) and Function 2 explaining 26.2% of the 
variance (R=0.896).  
 
Table 3.2 Structure Matrix of Discriminant Analysis for Physiological, Behavioral, 
and Neuropeptidergic Effects of Emulsifier Treatment.  
 
Measured Outcomes 
Function 
1 2 3 4 5 
Relative Body 
Weight 
.418* -.088 -.098 -.242 .103 
Colon Weight -.102* -.004 .072 .022 .005 
MSH-IR in PVT -.113 .520* .209 -.374 -.013 
Fat Pad Weight .229 .231* -.111 .163 .022 
Stereotypic Counts .044 .105 -.489* .027 -.168 
 Time in Open Arm .011 .008 .236* -.185 -.058 
 Spleen Weight -.081 -.082 .190* -.129 .059 
AgRP-IR in PVT .076 -.264 -.220 -.358* -.082 
Number of Marbles 
Buried 
.101 -.042 .093 -.269* -.172 
 Time in Light .059 -.045 .129 .265* -.253 
Social Preference .050 .015 -.011 .262* -.107 
Social Interaction .003 .084 .147 .169* -.129 
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AVP-IR in PVT .072 -.065 -.261 -.150 .504* 
Time in Center 
Zone 
.058 .095 -.039 .002 -.423* 
 Colon Length .004 .021 .073 .046 .156* 
Pooled within-group correlations between discriminating variables and standardized 
canonical discriminant functions. The variables are ordered by absolute size of 
correlation within each the functions (*indicates the largest absolute correlation between 
each variable and any discriminant function). 
 
Canonical discriminant function plot reveals the effects of each individual 
emulsifier treatment on each of the sexes for these two functions (Fig 3.7). In males, 
emulsifier treatment separates along Function 1 with the group centroid for CMC 
treatment lower in value and the group centroid for P80 treatment greater in value than 
the centroid for the respective water-treated controls (Table 3.3). Furthermore, in 
females, both centroids for CMC and P80 treatment are greater in value than for water 
treatment. However, along Function 2, the group centroids for CMC and P80 are in the 
same direction with respect to the group centroids for water for both males and females. 
Altogether, these data demonstrate that CMC and P80 altered both physiology and 
behavior, with some differential effects in males and females. 
While it is clear that both emulsifiers had a significant effect on both sexes across 
function 2, each emulsifier had a unique effect on sex differences in these measures 
weighted along function 1. While sex differences observed in water-treated controls 
were largely maintained with P80 treatment along function 1, some of these sex 
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differences appear to be reversed by CMC along this axis. Function 2 is most heavily 
weighted by a mixture of behavioral, physiological and neural measures, including 
(listed by significance) MSH and AgRP immunoreactivity in the paraventricular nucleus 
of the thalamus, perigonadal fat pad weight, time spent in the center zone, and body 
weight increase relative to initial weight. Function 1 is most heavily weighted by 
primarily physiological markers, including (listed by significance) body weight increase 
relative to initial weight, perigonadal fat pad weight, MSH immunoreactivity in the 
paraventricular nucleus of the thalamus, colon weight, and spleen weight. However, a 
broader mixture of measures contributed to this analysis, and all measures combine to 
give a full picture of the effects of these emulsifiers on the subject mice. The 
physiological measures included relative body weight, colon weight, fat pad weight, 
spleen weight, and colon length. The neural measures included MSH, AgRP and AVP 
immunoreactivity in the paraventricular nucleus of the thalamus. The behavioral 
measures included time in open arms of elevated plus maze, number of marbles buried, 
time in light portion of the light/dark box, social preference and social interaction time in 
three-chamber social interaction test, and time in center zone and stereotypic counts of 
the open field test. Hints at sexually differential effects of these measures were revealed 
with ANOVAs on individual measures. For example, only males demonstrated a relative 
increase in body weight with emulsifier treatment whereas females maintained the same 
weight throughout. However, both emulsifiers are observed here to increase relative 
body weight equally in males. Nevertheless, combined with observing other 
physiological measures, in concert with examining syndromic effects on neural markers 
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and behavioral output, CMC appears to affect sex differences in a unique pattern to that 
induced by P80 treatment. 
 
 
 
 
Figure 3.7 Dietary emulsifiers induce a syndrome of behavioral, physiological, 
and neural changes.  
Multivariate analysis of the impact of emulsifiers on synergistic changes in behavioral 
measures, physiological parameters, and immunoreactivity of neuropeptides in the PVT. 
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The canonical discriminant function plots and Wilk’s lambda revealed significant 
separation of groups by sex and emulsifier treatment Λ = 0.003, Χ2(138.194) = 73.182, 
p < 0.001. The group centroids for Function 1 are located in opposite directions with 
respect to the water-treated controls. 
 
Table 3.3 Functions at Group Centroids of Physiological, Behavioral, and 
Neuropeptidergic Effects of Emulsifier Treatment.  
Sex by Treatment Label 
Function 
1 2 3 4 5 
Water Male 1.601 2.495 -1.438 .858 -.714 
CMC Male -2.710 -2.215 -1.220 -.663 -.514 
P80 Male 4.344 -1.401 -.619 -.209 .680 
Water Female -2.813 2.266 -.128 -.435 .845 
CMC Female 1.374 .694 1.992 -.810 -.570 
P80 Female -1.528 -1.424 1.175 1.402 .155 
Unstandardized canonical discriminant functions evaluated at group means. 
 
3.5 Discussion 
The increased incidence of disorders related to anxiety and anti-social behavior 
has led to the belief that substances to which humans have been exposed as a result of 
industrialization might impact brain function. Such substances do not need to have 
direct contact with the brain. Rather, substances that impact the gut-brain axis and/or 
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the intestinal microbiome might influence brain function and, consequently, behavior. In 
accord with this notion, we report here that the synthetic dietary emulsifiers CMC and 
P80, which have previously been shown to impact gut microbiota to induce low-grade 
inflammation and metabolic disorders, can also influence behavior. Specifically, we 
observed herein that consumption of CMC and P80 alters anxiety-like and sociability 
behavior. Such differences occurred in a sex-specific manner with distinct patterns of 
change in microbiota, neuropeptide expression, and behavior in male and female mice. 
Taken together, these data suggest that the sex-specific changes to microbiota 
composition induced by emulsifier consumption could drive the sex differences in 
physiological, neural, and behavioral effects of dietary emulsifiers.  
Sex-specific patterns in brain and behavior were paralleled to some extent by 
differences in metabolism. Specifically, despite emulsifiers clearly promoting adiposity in 
male and female mice, an increase in overall weight was only seen in males 
(Supplemental Figure 5). This discrepancy may arise because we only weighed the 
perigonadal (periepididymal in males; periovarian in females) white adipose tissue. 
While mice have several other fat depots (Casteilla et al., 2008; White and 
Tchoukalova, 2014), the perigonadal adipose tissue pad has previously been 
demonstrated to respond to dietary changes (Rodriguez et al., 2004; Benz et al., 2012). 
When male and female mice are placed on calorie restriction following a high fat diet, 
females show a reduction predominantly in the gonadal fat pad size whereas males 
show a reduction in overall fat mass (Benz et al., 2012). Nonetheless, the differences 
observed between the effects of emulsifier treatment on adiposity and the relative body 
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weight in females suggest that emulsifiers induce a sex-specific change in body 
composition.  
Sex-specific changes on spleen and colon weights following emulsifier 
consumption may result from sex-specific alterations of the composition of the gut 
microbiota following emulsifier treatment. The current study found sex differences in the 
microbiota of water-treated controls from both the previous study (Chassaing et al., 
2015) and the present one, consistent with studies demonstrating sex differences in 
microbiota in C57Bl/6J mice (Org et al., 2016). Emulsifier treatment eliminated many of 
these sex differences, demonstrating the strong impact of emulsifiers on microbiota 
composition in yet another way. In addition, we observed sex-specific changes in 
microbiota composition of mice treated with emulsifiers, suggesting that some of the sex 
differences seen in the physiology and behavior may arise from the microbiota. While 
microbiota composition analysis and behavior assessment were performed after 84 and 
49 days of emulsifier exposure, we previously reported that dietary emulsifier effects on 
the microbiota are rapid and seen in vitro after only few days of exposure (Chassaing et 
al., 2017). 
Although emulsifier treatment induced changes in anxiety-like behavior, those 
changes cannot easily be interpreted in terms of changes in anxiety levels. For 
example, in males, emulsifier treatment reduced the time spent in the center portion of 
the open field without altering locomotive behavior or anxiety-like behaviors in the 
elevated plus maze, light/dark box, or marble burying test. This discrepancy between 
these three tests might mean that emulsifier exposure impacts passive coping or normal 
anxiety, for which the open field test has been suggested to be a more sensitive test 
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than for active coping or pathological anxiety (Prut and Belzung, 2003; Nosek et al., 
2008). Moreover, the multivariate analysis showed that the aggregate of behaviors in 
the open field test (e.g, numbers of jumps, ambulatory episodes, circles, etc.) differed in 
emulsifier versus water-treated animals. In addition, emulsifier consumption increased 
the distance travelled in the elevated plus maze but not in the open field test. Although 
these effects cannot easily be interpreted in terms of changes in levels of anxiety or 
activity, they suggest that emulsifier treatment fundamentally impacts the organization 
of behavioral patterns. 
Sex-specific alterations of the microbiota may have led to sex-specific changes in 
behavior, as found, for example, by the emulsifier-induced reduction in time spent in the 
center of the open field in males but not in females, or in social behavior in females but 
not male mice. A recent report indicates that offspring of dams fed on a high fat diet 
have social deficits, and that microbiota transplantation of such dysbiotic microbiota is 
sufficient to transfer such social deficits (Buffington et al., 2016). These data suggest 
that specific alterations of the gut microbiota may be critical for the behavioral effects of 
emulsifier treatment (Buffington et al., 2016). It is important to note that while our 
previous data using an in vitro microbiota system and fecal microbiota transplantation to 
germfree mice demonstrated that the detrimental effects of emulsifiers on metabolism 
are driven by direct effects on the intestinal microbiota (Chassaing et al., 2015; 
Chassaing et al., 2017), we cannot yet rule out that emulsifier-effects on brain and 
behavior are microbiota-independent. 
 Effects of emulsifier treatment on weight gain may be reflected in the increases 
of AgRP-IR in the arcuate nucleus, the location of the AgRP-expressing neuronal cell 
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bodies, and reductions in αMSH-IR in the PVT, an area that projects to key regions that 
contribute to both food intake and anxiety-like behaviors (reviewed in Kirouac, 2015; 
Vertes et al., 2015). AgRP stimulates food intake and reduces anxiety-like behaviors, 
while αMSH inhibits food intake and increases anxiety-like behaviors (Kokare et al.; Liu 
et al., 2007; Dietrich et al., 2015). Therefore, if changes in peptide levels directly 
correlate with changes in peptide release, the changes in AgRP-IR and αMSH-IR are 
consistent with the increase in food intake by emulsifiers noted in our original study 
(Chassaing et al., 2015). Given that we did not observe a general increase in anxiety-
related behaviors across tests in the current study, the relationship of the changes in 
AgRP-IR and αMSH-IR with anxiety-related behaviors is unclear.  
Emulsifier treatment effects on behavior were not reflected in effects on 
vasopressin or on the microglial population, which did not change significantly. It is 
important to note, however, that we only measured the microglial marker Iba1-IR, and 
therefore can not rule out that other neuroinflammatory markers, such as interleukin-6 
(IL-6) or activation of the NFKB pathway, are increased following emulsifiers, as they 
increase following high-fat diet (Thaler et al., 2012). 
While determining the extent to which studies in mice are relevant to humans is 
inherently difficult, even in studies of metabolism where human and mice can be 
assayed by quite similar assays, it is especially hard to do so for behavioral disorders, 
whose complexity and heterogeneity make them difficult to model in mice. This caveat 
notwithstanding, we submit that our data support the general notion that some cases of 
behavioral disorders may be impacted by exposure to modern chemical stressors and, 
more specifically, that synthetic dietary emulsifiers may be one such stressor. Given the 
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ability of behavior to impact metabolic disorders, for example by impacting food 
consumption or energy expenditure, it is very difficult to disassociate CMC and P80’s 
effects on metabolism and behavior. Rather, we submit that such effects are likely 
intertwined, which may generally reflect the increased societal incidence of a broad 
range of diseases associated with inflammation. Our results thus indicate that dietary 
emulsifiers may be one specific perturbant of the gut-brain axis that can promote such 
diseases. Identification of the range of substances that can likewise perturb this axis 
and, subsequently, reducing exposure to such substances may be a means to staunch 
disease states characterized by altered behavior. 
 
3.6 Supplemental Figures 
 
 
Figure 3.8 Supplemental Figure 1. Experimental Timeline.  
Male and female C57Bl/6 mice were weaned on post-natal day 21 (P21), started 
on either water control or a 1% solution of either sodium carboxymethylcellulose (CMC) 
or polysorbate-80 (P80). In addition, feces were collected for microbiota analysis. 
Behavioral testing started at P70, with one test per week in the order indicated. One day 
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after completing the last behavioral test, animals were euthanized and feces, the brain 
and other organs were collected. 
 
 
 
Figure 3.9 Supplemental Figure 2. Effects of dietary emulsifiers on 
microbiota.  
Male and female C57Bl/6 mice were exposed to drinking water containing CMC 
or P80 (1%). Linear discriminant analysis coupled with Effect Size (LEfSe) was of taxa 
that differ significantly between male and female mice within water, CCM, and P80 
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treatments at time of weaning, P21 and at the time of collections, P105. Phylogenetic 
branching that differs by treatment within male (A, B) and female (E, F) mice at P21 and 
within male (C, D) and female (G, H) mice at P105. 
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Figure 3.10 Supplemental Figure 3. Sex differences in microbiota in mice 
treated with dietary emulsifiers.  
Male and female C57Bl/6 mice were exposed to drinking water containing CMC 
or P80 (1%) in data previously reported in Extended Data Figure 3 in Chassaing et al., 
2015. Principal coordinates analysis (PCoA) of the unweighted UniFrac distance matrix 
of fecal microbiota showing clustering by treatment when male and female mice are 
combined into a single PCoA (A). Treatment group is indicated by point color (blue, 
water; orange, CMC; purple, P80). PCoA of the unweighted UniFrac distance matrix of 
fecale microbiota also show clustering by sex in (B). Sex is indicated by point color (red, 
female; green, male). 
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Figure 3.11 Supplemental Figure 4. Additional measures of anxiety-like 
behaviors in mice treated with emulsifiers.  
Male and female C57Bl/6 mice were exposed to drinking water containing 3 CMC 
or P80 (1%) for 12 weeks and tested for anxiety-like behavior weekly starting at P70. 
(A) There was no effect of either emulsifier-treatment [F(2, 29) = 0.106, p=0.90] or sex 
[F(1, 29) = 0.59, p=0.45] on the distance traveled in the open field arena. (B) There was 
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no effect of either emulsifier-treatment [F(2, 29) = 0.1995, p=0.82] or sex [F(1, 29) = 
0.1972, p=0.66] on the time spent on the open arms. (C) The number of entries onto the 
open arms was not affected by either emulsifier treatment [F(2, 29) = 0.006, p=0.99] or 
sex [F(1, 29) = 0.05, p=0.82]. (D) There was no effect of either emulsifier-treatment [F(2, 
29) = 0.11, p=0.90] or sex [F(1, 29) = 0.13, p=0.73]on the time spent in the closed arms. 
(E) The number of entries into the closed arms was not affected by either emulsifier 
treatment [F(2, 29) = 2.18, p=0.13] or sex [F(1, 29) = 3.09, p=0.09]. (F) There was no 
effect of either emulsifier-treatment [F(2, 29) = 0.07, p=0.92] or sex [F(1, 29) = 0.68, 
p=0.41] on the time spent in the light in the light/dark box. Data are represented as 
means + SEM (n=5-6). 
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Figure 3.12 Supplemental Figure 5. Sex difference in relative weight gain in 
mice treated with dietary emulsifiers.  
Male and female C57Bl/6 mice were exposed to drinking water containing CMC 
or P80 (1%) for 12 weeks. There was a significant interaction of time on treatment, 
treatment, and sex on the relative body weights in the mice over time [F(24, 348) = 
1.863, p<0.05]. In addition, post-hoc analyses indicated that 6 weeks of emulsifier 
consumption lead to a greater body weight in male, but not female mice (*p<0.05). Data 
are represented as means + SEM (n=5-6).  
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Figure 3.13 Supplemental Figure 6. Representative photomicrographs of 
Agouti-Related Peptide (AgRP) and alpha-melanocortin stimulation hormone 
(αMSH).  
Photomicrographs showing the immunoreactivity (IR) for AgRP in (A) the 
paraventricular nucleus of the thalamus (PVT) and (B) the arcuate nucleus (Arc). 
Photomicrographs showing αMSH-IR in (C) PVT and (D) Arc. Scale bar: 100µm. 
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4 EFFECTS OF GUT-DERIVED ENDOTOXIN ON ANXIETY-LIKE AND REPETITIVE 
BEHAVIORS IN MALE AND FEMALE MICE 
Christopher T. Fields, Benoit Chassaing, Alexandra Castillo-Ruiz, Remus Osan, Andrew 
T. Gewirtz, and Geert J. de Vries 
Originally published in 
Fields, Christopher T., et al. “Effects of gut-derived endotoxin on anxiety-like and 
repetitive behaviors in male and female mice” Biology of Sex Differences 9.1 (2018): 7. 
 
4.1 Abstract 
Gut dysbiosis is observed in several neuropsychiatric disorders exhibiting 
increases in anxiety behavior, and recent work suggests links between gut inflammation 
and such disorders. One source of this inflammation may be lipopolysaccharide (LPS), 
a toxic component of gram-negative bacteria. Here, we (1) determine whether oral 
gavage of LPS, as a model of gut-derived endotoxemia, affects anxiety-like and/or 
repetitive behaviors; (2) test whether these changes depend on TLR4 signaling; and (3) 
test the extent to which gut-derived endotoxin and TLR4 antagonism affects males and 
females differently. 
In experiment 1, male wild-type (WT) and Tlr4-/- mice were tested for locomotor, 
anxiety-like, and repetitive behaviors in an automated open field test apparatus, 2 h 
after oral gavage of LPS or saline. In experiment 2, male and female WT mice received 
an oral gavage of LPS and an injection of one or two TLR4 antagonists that target 
different TLR4 signaling pathways ((+)-naloxone and LPS derived from R. sphaeroides 
89 
(LPS-RS)). Univariate and multivariate analyses were used to identify effects of 
treatment, sex, and genotype and their interaction. 
In experiment 1, oral gavage of LPS increased anxiety-like behavior in male WT 
mice but not in Tlr4-/- mice. In experiment 2, oral gavage of LPS increased anxiety-like 
and decreased repetitive behaviors in WT mice of both sexes. Neither antagonist 
directly blocked the effects of orally administered LPS. However, treatment with (+)-
naloxone, which blocks the TRIF pathway of TLR4, had opposing behavioral effects in 
males and females (independent of LPS treatment). We also identified sex differences 
in the expression of interleukin-6, a pro-inflammatory cytokine, in the gut both in basal 
conditions and in response to LPS. 
In spite of the ubiquitous nature of LPS in the gut lumen, this is the first study to 
demonstrate that intestinally derived LPS can initiate behavioral aspects of the sickness 
response. While an increased enteric load of LPS increases anxiety-like behavior in 
both sexes, it likely does so via sex-specific mechanisms. Similarly, TLR4 signaling may 
promote baseline expression of repetitive behavior differently in males and females. 
This study lays the groundwork for future interrogations into connections between gut-
derived endotoxin and behavioral pathology in males and females. 
 
4.2 Introduction 
Dysbiosis of the gut microbiota, defined as a shift toward pathological, pro-
inflammatory microbial species, has been linked to a number of neuropsychiatric 
disorders associated with increased expression of anxiety behavior, including autism 
(Finegold et al., 2012; Mayer et al., 2014b; Mayer et al., 2014a), ADHD (Petra et al., 
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2015), and psychological pathologies co-morbid with inflammatory bowel disease (IBD) 
(Bannaga and Selinger, 2015; Ray and Dittel, 2015). Microbiota-induced gut 
inflammation may mediate these behavioral pathologies. An important agent in these 
effects is likely to be lipopolysaccharide (LPS), a pathogenic component of gram-
negative bacteria, which is endogenous to the gut microbiota (Marshall, 2005). When 
injected systemically, LPS produces well-documented behavioral alterations collectively 
called “sickness behavior,” which include an increase in anxiety-like behaviors (Dantzer, 
2001, 2009) and suppression of compulsive and repetitive behaviors (Liblau et al., 
1995; Gentile et al., 2016; Sung et al., 2016).  
Intraperitoneal injections of LPS allow direct exposure of LPS to extra-intestinal 
peritoneal leukocytes that produce systemic cytokines that will provoke a sickness 
response. Likewise, intravenous injections of LPS facilitate its fast and robust interaction 
with splenic immune cells and circulating leukocytes. However, it is unknown whether 
elevations of serum LPS levels originating from gut barrier dysfunction, observed in 
rodent models of gut dysbiosis (such as emulsifier-fed mice (Chassaing et al., 2015), 
mice with dextran sodium sulfate (DSS)-induced colitis (Gabele et al., 2011; Chassaing 
et al., 2014b), high fat diet fed mice (Bruce-Keller et al., 2015), and toll-like receptor 2 
knockout (Tlr2-/-) mice (Caricilli et al., 2011)), are responsible for increases in anxiety-
like behavior observed in these models. These studies reliably demonstrate a 2- to 3-
fold increase in serum LPS levels in experimental subjects relative to controls, a 
condition termed “metabolic endotoxemia” (Cani et al., 2007).  As even a 10μg/kg dose 
of LPS (10 times lower than in most published studies) is sufficient to increase serum 
levels of LPS to 25X above baseline (Hansen et al., 2000), it is questionable whether 
91 
intraperitoneal injections recapitulate the dynamics of LPS-induced inflammation 
observed in “metabolic endotoxemia”. Furthermore, the site of action may make a 
difference, as an inflammatory stimulus injected intraperitoneally may differ in its 
neurobehavioral effects from an inflammatory stimulus administered orally.  
Under most circumstances, LPS present on gut bacteria does not cause 
pathology. However, increased intestinal loads of LPS may breach the intestinal lining, 
activate intestinally-associated innate immune cells, and produce metabolic 
endotoxemia (Cani et al., 2007). Elevated gut levels of gram-negative bacteria have 
been reported in clinical populations, such as children with autism or individuals with 
celiac disease (Nadal et al., 2007; Finegold et al., 2010). Furthermore, the severity of 
gastrointestinal conditions correlates positively with levels of anxiety behavior in autistic 
children (Mazurek et al., 2013; Hsiao, 2014; Gracie et al., 2016; Reigada et al., 2016b). 
In addition, elevated fecal levels of LPS are reported for rodent models of diseases such 
as diet- and emulsifier-induced obesity, as well as colitis; microbiota transfer from each 
of these disease models into control subjects causes similar immune and/or behavioral 
deficits to those observed in the respective disease model (Bruce-Keller et al., 2015; 
Jang et al., 2017b; Lim and Kim, 2017; Viennois et al., 2017). However, whether gut-
derived LPS influences anxiety behavior remains untested. 
 The purpose of this study is to: 1) determine whether oral gavage of LPS, as a 
model of gut dysbiosis, affects anxiety-like and/or repetitive behaviors, 2) test whether 
these changes depend on TLR4 signaling, and 3) test the extent to which gut-derived 
endotoxin and TLR4 antagonism affects males and females differently. Here we show 
that LPS triggers behavioral changes in males as well as females, but the underlying 
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signaling mechanisms may differ. Furthermore, the effects of gut-derived LPS may not 
depend on systemic TLR4 signaling. 
 
4.3 Materials and Methods 
4.3.1 Animals 
 Three-month old C57Bl/6J mice were used to test the effects of gut-derived LPS 
on anxiety-like and repetitive behaviors. For Experiment 1, 14 male wildtype (C57Bl/6J) 
mice and 8 male Tlr4-/- (Tlr4lps-del on C57Bl/6 background) mice were randomly selected 
from a colony bred in-house. Founder mice for this colony were sourced from Jackson 
Labs (Bar Harbor, ME). As this colony contained a negligible number of females, female 
subjects were not used in this experiment. For Experiment 2, 64 male and 64 female 
C57Bl/6J mice were purchased at 10 weeks of age (Jackson Labs) and housed in our 
facility for two weeks prior to study. For both experiments, all subjects were housed in 
same-sex pairs prior to the beginning of the study. The mice were housed in a room 
maintained in a 12:12 light dark cycle, at 68-72°F and approximately 50% humidity and 
were fed ProLab 5001 Diet ad libitum (LabDiet, St. Louis, MO). All experimental 
protocols were approved by the Institutional Animal Care and Use Committee at 
Georgia State University and were performed in accordance with the National Institutes 
of Health Guidelines for the Care and Use of Laboratory Animals. All procedures were 
designed to minimize subject discomfort and use the fewest animals necessary for 
statistical analysis.  
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4.3.2 Experiment 1 
 On the day of testing, mice were single-housed and fasted for two hours to 
ensure gastric emptying (Firpo et al., 2005) and were then administered 300µg/kg LPS 
in a total volume of 200µl saline (LPS from Escherichia coli [O111:B4]; Sigma, St. Louis, 
MO) or saline alone by oral gavage (7 per treatment group for WT mice and 4 per 
treatment group for Tlr4-/- mice). The tip of the gavage needle was dipped in a 30% 
sucrose solution to decrease gavage-related stress response (Hoggatt et al., 2010). 
Two hours after gavage treatment, subjects were transferred to an automated open field 
apparatus for 10 minutes to measure locomotor parameters (ambulatory episodes, 
ambulatory counts, ambulatory time, ambulatory distance, resting time, and average 
velocity), anxiety-like behaviors (time spent in the center zone, zone entries, number of 
rears, and time spent rearing), and repetitive behaviors (time spent in stereotypic 
circling, number of stereotypic counts, jump counts, jump time, number of clockwise 
reversals, and number of counter-clockwise reversals). After behavior testing, serum 
samples were collected by terminal cardiac puncture blood collection under isoflurane 
anesthesia.  
 
4.3.3 Experiment 2 
 To determine which TLR4 signaling cascade is responsible for the anxiogenic 
effects of orally administered LPS, we used (+)-naloxone (NIDA Drug Supply), which 
blocks the TLR4/TRIF cascade and has low affinity for mu-opioid receptors (1/1000 to 
1/10000 the affinity of (-)-naloxone for mu-opioid receptors) (Iijima et al., 1978; Marcoli 
et al., 1989), and LPS-RS Ultrapure (InVivoGen, San Diego, CA) (LPS derived from 
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Rhodobacter sphaeroides, hereafter simply referred to as LPS-RS), which blocks the 
TLR4/MyD88 cascade(Li et al., 2014). LPS molecules, sourced from different bacterial 
species and strains, differ in level of immunogenicity, ranging from TLR4 agonists, such 
as E. coli derived LPS, that produce robust inflammation, to TLR4 antagonists, such as 
LPS derived from R. sphaeroides (LPS-RS), that block the inflammatory effects of pro-
inflammatory LPS species (Coats et al., 2005; Vatanen et al., 2016). We selected a 
dose of 60mg/kg of (+)-naloxone, administered 30 minutes prior to LPS challenge, as 
applying this dose and timing blocks sedation and motor impairments induced by acute 
exposure to ethanol, a condition associated with increased intestinal permeability (Wu 
et al., 2012; Corrigan et al., 2015). We selected a dose of 800μg/kg of LPS-RS, injected 
30 minutes prior to oral gavage of LPS, as intrathecal injection of this dose and timing 
has been demonstrated to block neuropathic pain induced by LPS (Sorge et al., 2011).  
To ensure gastric emptying, male and female mice were single-housed and 
fasted for two hours (Firpo et al., 2005). Ultimately, 8 mice of each sex were assigned to 
each 2 (gavage treatment) x 2 ((+)-naloxone treatment) x 2 (LPS-RS treatment) group. 
Ninety minutes into the fast, mice received 60mg/kg (+)-naloxone in 200µl saline, 800 
μg/kg LPS-RS in 200 µl saline, (+)-naloxone and LPS-RS together in 200µl saline, or 
200µl saline by i.p. injection. Thirty minutes later, subjects received saline or 300µg/kg 
LPS by oral gavage. As in Experiment 1, the tip of the gavage needle was dipped in a 
30% sucrose solution prior to insertion. Two hours after the oral gavage, mice were 
tested on an automated open field apparatus as above. Directly after behavior testing, 
mice were euthanized for serum and intestinal tissue collection.  
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4.3.4 Serum LPS 
 Hemolysis-free serum was generated by centrifugation of blood using serum 
separator tubes (Becton Dickerson, Franklin Lakes, NJ). Serum was stored at -20°C in 
silanized tubes. On the day of analysis, serum was diluted 1/40 in LPS-free saline, and 
residual plasma proteins were degraded via a 10 minute 70°C incubation (Caricilli et al., 
2011). Serum LPS concentrations were determined using a kit based on a Limulus 
amebocyte extract (GenScript, Piscataway, NJ) according to manufacturer’s 
instructions, with samples run in duplicate.  
 
4.3.5 RT-qPCR for intestinal tissue 
We examined the expression of pro-inflammatory (IL-1β, IL-6, TNF-α) and anti-
inflammatory (IL-10) cytokines in the gut in response to oral LPS exposure. To do so, 
one inch of jejunum tissue was homogenized in trizol (Invitrogen, Carlsbad, CA) for 
RNA extraction. Reverse transcription was performed with a SuperScript IV First-Stand 
Synthesis Kit (Invitrogen) in a thermal cycler (Applied Biosystems Inc., Foster City, CA) 
and real time PCR was performed in the LightCycler 96 System (Roche, Mannheim, 
Germany) using FastStart Essential DNA Green Master Kit (Roche) according to the 
manufacturer’s instructions and as previously described (Castillo-Ruiz et al., 2017). 
Primers used targeted messenger RNA for IL-10, IL-1β, TNF-α, IL-6, and 
glyceraldehyde 3-phosphate dehydrogenase (GAPDH) as reference gene (all validated 
primers from Qiagen Inc., Valencia, CA).  
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4.3.6 Luminex cytokine assay 
 BioRad (Hercules, CA) 4-plex mouse Luminex kits were used to measure serum 
cytokine levels. The cytokines assayed were TNF-α, IL-1β, IL-6, and IL-10. Assays were 
performed according to the manufacturer’s instructions, and samples were run in 
duplicate.  
 
4.3.7 Statistical Analyses 
Using SPSS (version 23), Univariate (ANOVA) and Multivariate Analysis of 
Variance (MANOVA) were performed on the data obtained from the automated open 
field test apparatus. Following ANOVAs, planned contrasts were performed on 
individual outcome variables to identify directionality between group differences. 
Multivariate statistics are useful to detect relationships between outcome variables and 
identify syndromes of behavioral effects, particularly in outcomes with statistically non-
significant univariate ANOVAs (Cooley, 1971). Like ANOVA, which tests whether mean 
differences between groups on a single dependent variable occurs by chance, 
MANOVA tests whether mean differences for a combination of dependent variables 
occur by chance. Discriminant analysis ranks outcome variables by their contribution to 
group separation along the combination of all dependent behavioral variables used in 
the ANOVA analyses. The same group of behavioral measures were used in all 
discriminant analyses across Experiments 1 and 2. Only behavioral measures that 
differentiate the discriminant functions are listed in the structure matrix. Discriminant 
functions were validated with both original group case classification tests and leave-
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one-out cross-validation tests, which gives a more unbiased estimate of the 
generalizability of the discriminant functions (Bishop, 1995; Ghani, 2009). 
Effect sizes for sex, genotype, and treatment effects were reported as sample 
means with 95% confidence intervals. In addition, using SPSS, partial eta squared 
(“partial η2“) were reported as effect size measurements of variance within the ANOVA 
and MANOVA tests. Estimation of population means and 95% confidence intervals were 
calculated for WT males across Experiments 1 and 2 using random effects meta-
analysis. All confidence interval estimates were calculated with Exploratory Software for 
Confidence Intervals or ESCI (Wolfe and Cumming, 2004; Perezgonzalez, 2015). 
Two-way ANOVAs (sex by treatment) were performed for the analysis of gut 
cytokine expression using GraphPad Prism version 6.01. Significant effects were 
followed by Fisher’s LSD tests. 
 
4.4 Results 
4.4.1 Experiment 1: Role of TLR4 in behavioral response to oral gavage of LPS  
In line with other models of metabolic endotoxemia (Cani et al., 2007; Caricilli et 
al., 2011), oral gavage of LPS in male WT mice increased serum levels of LPS 1.5-fold, 
two hours after gavage treatment, t(8)=16.96, p<0.05 (one-tailed), n=5/group, η2=0.34 
(Cani et al., 2007; Caricilli et al., 2011) (Fig. 4.1). 
2 x 2 (genotype x gavage treatment) univariate ANOVAs across all behavioral 
measures showed that oral gavage of LPS significantly increased anxiety-like behavior 
in WT mice, but not Tlr4-/- mice (n=7/group for WT mice and n=4/group for Tlr4-/- mice). 
In comparison to vehicle treatment, LPS decreased time spent in the center for WT 
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mice, p<0.01, but not in Tlr4-/- mice, (genotype x gavage treatment interaction: 
F(1,18)=14.051, p<0.01). If anything, LPS tended to increase time spent in the center 
for Tlr4-/- mice, although this did not reach significance, p=0.107 (Fig. 4.2a). When 
collapsing across gavage treatment, WT mice had a higher jump time, p<0.001 (Fig. 
4.2e), whereas Tlr4-/- mice had a higher average velocity, p<0.01 (Fig. 4.2b), spent 
more time in stereotypic circling, p<0.001 (Fig. 4.2c), and had a higher number of 
stereotypic counts, p<0.001 (Fig. 4.2d). Supplemental Table 1 lists ANOVA statistics 
for all measures across main effects and interactions, including locomotor parameters 
(ambulatory episodes, ambulatory counts, ambulatory time, ambulatory distance, 
resting time, and average velocity), anxiety-like behaviors (time spent in the center 
zone, zone entries, number of rears, and time spent rearing), and repetitive behaviors 
(time spent in stereotypic circling, number of stereotypic counts, jump counts, jump 
time, number of clockwise reversals, and number of counter-clockwise reversals). 
A 2 x 2 (genotype x gavage treatment) Multivariate Analysis of Variance 
(MANOVA) was performed on all behavioral measures, wherein all main effects and 
interactions were non-significant (not reported). The observed power for the main effect 
of gavage treatment (power=20.9%), the main effect of genotype (power=46.1%), and 
the gavage treatment by genotype interaction effect (power=43.2%) were all under the 
nominal 80% level. This suggests that this experimental cohort may have been 
underpowered for a factorial MANOVA. 
Although MANOVA didn’t reveal significant effects of genotype or gavage 
treatment, discriminant analysis revealed the contribution of behavioral outcome 
variables to group separation by genotype and gavage treatment. When subjects were 
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designated to four groups based on genotype and gavage treatment, discriminant 
analysis revealed three discriminant functions that maximize group separation based on 
genotype, gavage treatment, or the interaction between these two factors. Function 1 
explains 60.0% of the variance, canonical R2=0.975, Function 2 explains 35.6% of the 
variance, canonical R2=0.959, and Function 3 explains 4.4% of the variance, canonical 
R2=0.765. Collectively, these discriminant functions significantly differentiated the 
treatment groups, Λ=0.006, Χ2(42)=77.077, p<0.001. The structure matrix in Table 1 
reveals the correlations between outcome variables and the discriminant functions. In 
the discriminant function plot (Fig. 4.3), Function 1 demonstrates the opposing effects of 
gavage treatment on behavioral outcomes via the two genotypes, and the structure 
matrix shows this is predominantly driven by time spent in center zone (r=-0.154), jump 
time (r=-0.138), and jump counts (r=-0.070) (Table 4.1). Function 2 separates groups by 
genotype, and this is driven predominantly by time spent in stereotypic circling (r=-
0.458), number of stereotypic counts (r=-0.454), and time spent in the center zone (r=-
0.279) (Table 4.1). This suggests that while the genotypes are best distinguished on the 
basis of repetitive behaviors, gavage treatment affects anxiety-like and repetitive 
behavior differently in male WT and Tlr4-/- mice. Supplemental Table 2 demonstrates 
the results of a classification test to verify the validity of the discriminant functions 
plotted in Figure 4.3. Using the original discriminant functions, 100% of the original 
grouped cases are correctly classified. These functions were further validated by a 
leave-one-out cross-validation procedure. Discriminant functions were re-computed with 
all subjects excluding one and this procedure was repeated for all subjects. Across all 
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analyses, 63.6% of cross-validated group cases were correctly classified, 38.6% above 
chance.  
 
Table 4.1 Experiment 1 Structure Matrix (Genotype by Gavage Treatment).  
Function numbers match the order of the percentage of the variance explained by the 
respective functions. Each function maximizes separation between groups based on 
main effect of genotype, main effect of gavage treatment, or an interaction between 
these two factors, on the listed behaviors. Boldfaced numbers indicated the highest 
three correlations, and therefore deemed most important for the discriminant function. 
Measured Outcome 
Function 
1 2 3 
Jump Counts -0.070 0.070 -0.026 
Number of Stereotypic Counts 0.003 -0.458 0.186 
Time Spent in Stereotypic Circling 0.000 -0.454 0.231 
Time Spent Jumping -0.138 0.300 -0.129 
Ambulatory Time 0.038 0.102 -0.028 
Time Spent Rearing -0.015 -0.099 -0.020 
Number of Ambulatory Counts 0.025 0.069 0.045 
Ambulatory Distance 0.032 0.044 0.024 
Time Spent Resting 
Average Velocity 
Time Spent in Center Zone 
-0.017 
-0.031 
-0.154 
-0.024 
-0.216 
-0.279 
-0.014 
0.390 
0.333 
Number of Clockwise Reversals -0.029 0.019 0.171 
Number of Zone Entries -0.020 -0.098 0.153 
Ambulatory Episodes 0.019 -0.025 0.120 
Number of Counter-Clockwise Reversals -0.017 0.069 -0.075 
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Figure 4.1 Oral gavage of LPS produces low-grade endotoxemia.  
Serum LPS levels in WT mice treated with saline (blue bar) or LPS (green bar). LPS 
treatment significantly increased LPS levels 1.5-fold, 2 h after gavage. Bars indicate 
mean and 95% confidence intervals. *p < 0.05  
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Figure 4.2 Effects of oral gavage of LPS on male WT and Tlr4−/− mice.  
Experiment 1: effects of oral gavage of LPS on open field test behavioral outcomes in 
male WT and Tlr4−/− mice. a LPS significantly decreased time in the center zone for 
male WT mice, but there was a slight trend toward increased time spent in the center 
zone for male Tlr4−/− mice. b Male Tlr4−/− mice had significantly increased average 
velocity, ctime spent in stereotypic circling, and d number of stereotypic counts 
compared with male WT mice. e However, male WT mice had a significantly higher 
jump time compared to male Tlr4−/− mice. Error bars are 95% confidence intervals. 
*p < 0.05; #p = 0.107 
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Figure 4.3 Canonical discriminant function plot for experiment 1.  
Experiment 1 discriminant function plot. Correlations between outcome variables and 
discriminant functions are listed in Table 1. Function 1 demonstrates an interaction 
between gavage treatment and genotype, mostly based on the differential effect of LPS 
on time spent in the center zone, time spent jumping, and jump counts in Tlr4−/− and 
WT mice, whereas function 2 separates groups based on genotype, largely driven by 
differences in number of stereotypic counts, time spent in stereotypic circling, and time 
spent in the center zone. Group centroids indicate the mean discriminant function value 
of each of the designated groups. 
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4.4.2 Experiment 2: Sex differences in TLR4 agonism and antagonism on anxiety-
like and repetitive behavior. 
In this experiment, we observed that oral gavage of LPS significantly increased 
anxiety behavior in both males and females, but a specific TLR4 antagonist (+)-
naloxone, had opposing effects on anxiety and repetitive behavior in males and 
females. Full factorial 2 (sex) x 2 (gavage treatment: LPS or saline) x 2 (i.p. injection: 
LPS-RS or saline) x 2 (i.p. injection: (+)-naloxone or saline) MANOVA was performed on 
the same dependent variables analyzed in Experiment 1 (n=8/group). There were 
significant main effects of sex (F(16,96)=9.751, p<0.001) and gavage treatment 
(F(16,96)=2.111, p<0.05), and a sex by (+)-naloxone interaction effect (F(16,96)=2.176, 
p<0.05). All remaining main effects and interactions, including effects of LPS-RS 
treatment, were non-significant (not reported). ANOVAs revealed these main effects 
and interactions across a number of behavioral parameters (Supplemental Table 3), of 
which subsequent planned contrasts indicated directionality.  
These planned contrasts revealed that LPS suppressed repetitive and increased 
anxiety-like behaviors in males and females. Since no significant sex by LPS treatment 
effects were found in any of the ANOVAs or MANOVA, males and females were 
grouped together for subsequent analyses. LPS treatment decreased number of zone 
entries, p<0.05 (Fig. 4.4a), and increased number of rears, p<0.05 (Fig. 4.4b). Across 
both sexes, LPS treatment decreased time spent in stereotypic circling, p=0.05 (Fig. 
4.4c), stereotypic counts, p<0.05 (Fig. 4.4d), and jump counts, p<0.05 (Fig. 4.4e).  
When planned contrasts were run for the effects of (+)-naloxone in each sex 
separately,  time spent in stereotypic circling (Fig. 4.5a), stereotypic counts (Fig. 4.5b), 
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and jump counts (Fig. 4.5d) were significantly affected in females (p<0.05, in each 
case) but not in males (p>0.1 in each case).  
Discriminant analysis confirms that LPS increased anxiety behavior similarly in 
males and females, while (+)-naloxone had different effects in males and females. As 
for gavage treatment, discriminant analysis revealed three discriminant functions on 
data from subjects grouped by sex and gavage treatment. Function 1 explains 80.6% of 
the variance, canonical R2=0.758, Function 2 explains 13.8% of the variance, canonical 
R2=0.433, and Function 3 explains 5.6% of the variance, canonical R2=0.292. 
Collectively, these discriminant functions significantly differentiated the treatment 
groups, Λ=0.317, Χ2(45)=133.937, p<0.001. The discriminant function plot (Fig. 4.6) 
shows that Function 1 separates groups based on sex, and the structure matrix (Table 
4.2) reveals this is predominantly driven by sex differences in jump counts (r=-0.616), 
jump time (r=-0.508), and ambulatory time (r=-0.392). Function 2 separates groups 
based on gavage treatment, and LPS appears to affect males and females in a similar 
fashion along outcome variables, predominantly number of rears (r=0.453), zone entries 
(r=-0.429), and stereotypic counts (r=-0.400). Supplemental Table 4 displays results of 
the original grouping and leave-one-out classification tests. 64.6% of original grouped 
cases were correctly classified, and 45.7% of cross-validated grouped cases were 
correctly classified, 20.7% above chance. (The same group of behavioral measures 
used in Experiment 1 were also used in discriminant analyses performed for Experiment 
2. Only behavioral measures that differentiate the discriminant functions are listed in the 
structure matrix.) 
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Discriminant analysis also indicates that (+)-naloxone affected repetitive and 
locomotor behaviors differently in males and females, revealing three discriminant 
functions (Fig. 4.7, Table 4.3). Rear count is automatically excluded from the 
discriminant analysis, based on its lack of contribution to the discriminant functions. 
Function 1 explains 81.5% of the variance, canonical R2=0.764, Function 2 explains 
11.8% of the variance, canonical R2=0.410, and Function 3 explains 6.7% of the 
variance, canonical R2=0.322. Collectively, these discriminant functions significantly 
differentiated the treatment groups, Λ=0.311, Χ2(45)=136.022, p<0.001. As shown in the 
discriminant analysis where subjects are grouped by sex and gavage treatment, the 
discriminant function plot shows that function 1 separates groups based on sex and the 
structure matrix reveals this is predominantly driven by sex differences in jump counts 
(r=-0.623), jump time (r=-0.496), and ambulatory time (r=-0.416). Function 2 separates 
groups based on (+)-naloxone treatment, and (+)-naloxone appears to affect males and 
females differently along outcome variables, predominantly stereotypic counts 
(r=0.545), ambulatory episodes (r=0.526), and time spent in stereotypic circling 
(r=0.523). Supplemental Table 5 displays results of the original grouping and leave-
one-out classification tests. 65.4% of original grouped cases were correctly classified, 
and 48.0% of cross-validated grouped cases were correctly classified, 23.0% above 
chance.  
Since neither TLR4 antagonist blocked the specific effects of LPS, we sought to 
identify the systemic and intestinal inflammatory effects of the oral LPS treatment in WT 
mice not treated with TLR4 antagonists. Gavage treatment resulted in non-significant 
elevation of serum endotoxin levels in male subjects in a meta-analysis across 
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Experiments 1 and 2 (p>0.05) (Supplemental Fig. 1), and there were no significant 
main effects of sex or gavage treatment, or interactions between sex and gavage 
treatment, on serum LPS levels in Experiment 2 (data not shown). In addition, cytokine 
Luminex was performed on serum samples from Experiment 2. There were no 
significant effects of gavage treatment on serum levels of TNF-α, IL-1β, IL-6, or IL-10 
(data not shown). However, oral gavage of LPS did modulate IL-6 expression levels in 
intestinal tissue in a sexually differentiated manner (sex-by-treatment interaction: 
F(1,21)= 12.38, p= 0.002), increasing IL-6 expression in females (p= 0.04) while 
decreasing it in males (p= 0.009; Fig. 4.8a). IL-10, TNF-α, and IL-1β expression levels 
were not significantly altered by the oral LPS treatment (Fig 4.8b-d). 
Table 4.2 Experiment 2 Structure Matrix (Sex by Gavage Treatment). 
Measured Outcome 
Function 
1 2 3 
Jump Counts -0.616 -0.354 0.124 
Jump Time -0.508 -0.270 0.139 
Ambulatory Time -0.392 -0.193 -0.108 
Ambulatory Counts -0.368 -0.283 -0.116 
Ambulatory Distance -0.345 -0.270 -0.060 
Resting Time 
0.344 0.295 0.014 
Ambulatory Episodes -0.330 -0.204 -0.120 
Average Velocity -0.171 -0.161 0.160 
Number of Rears 0.018 0.453 0.276 
Zone Entries 0.057 -0.429 0.338 
Stereotypic Counts 
-0.028 -0.400 0.189 
Time Spent in Stereotypic Circling 
0.086 -0.372 0.154 
Time Spent Rearing 0.144 0.285 0.223 
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Counter Clockwise Reversals -0.114 -0.252 -0.055 
Time Spent in Center Zone 0.024 -0.094 0.463 
Clockwise Reversals -0.042 -0.080 -0.081 
 
Function numbers match the order of the percentage of the variance explained by the 
respective functions. Each function maximizes separation between groups based on 
main effect of sex, main effect of gavage treatment, or an interaction between these two 
factors, on the listed behaviors. Boldfaced numbers indicated the highest three 
correlations, and therefore deemed most important for the discriminant function. 
 
Table 4.3 Experiment 2 Structure Matrix (Sex by (+)-Naloxone Treatment) 
Measured Outcome 
Function 
1 2 3 
Jump Counts -0.623 0.319 -0.057 
Jump Time -0.496 0.123 0.122 
Ambulatory Time -0.416 0.414 -0.134 
Counter Clockwise Reversals -0.106 0.086 0.090 
Stereotypic Counts -0.046 0.545 -0.008 
Ambulatory Episodes -0.363 0.526 -0.140 
Time Spent in Stereotypic Circling 0.070 0.523 0.044 
Time Spent Resting 0.367 -0.485 0.068 
Ambulatory Counts -0.390 0.442 -0.166 
Ambulatory Distance -0.369 0.439 -0.188 
Average Velocity -0.180 0.397 0.345 
Number of Rears 0.020 -0.285 0.174 
Time Spent Rearing 0.144 -0.086 0.327 
Clockwise Reversals -0.042 0.181 0.197 
Zone Entries 0.058 0.075 -0.138 
Time Spent in Center Zone 0.022 -0.061 -0.104 
Function numbers match the order of the percentage of the variance explained by the 
respective functions. Each function maximizes separation between groups based on 
main effect of sex, main effect of (+)-naloxone treatment, or an interaction between 
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these two factors, on the listed behaviors. Boldfaced numbers indicated the highest 
three correlations, and therefore deemed most important for the discriminant function. 
 
Figure 4.4 Effects of oral gavage of LPS on male and female WT mice.  
Experiment 2: effects of intraperitoneal injection of TLR4 antagonists and oral gavage of 
LPS on open field test behavioral outcomes in male and female WT mice. Data 
presented as sex by gavage treatment. LPS significantly a decreased zone entries 
and b increased the number of rears in males and females relative to saline-treated 
subjects. Furthermore, LPS significantly decreased the number of c time spent in 
stereotypic circling, d stereotypic counts, and e jump counts relative to saline-treated 
subjects. In addition, females had a higher jump count than males. Error bars are 95% 
confidence intervals. *p < 0.05; (*) significant main effect of sex, p < 0.05  
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Figure 4.5 Effects of TLR4 antagonist (+)-naloxone treatment on male and female 
WT mice.  
Experiment 2: effects of intraperitoneal injection of TLR4 antagonists and oral gavage of 
LPS on open field test behavioral outcomes in male and female WT mice. Data 
presented as sex by (+)-naloxone treatment. aOverall, males spent significantly more 
time in stereotypic circling than females; however, (+)-naloxone significantly increased 
time in stereotypic circling in female mice. b In addition, (+)-naloxone significantly 
increased the number of stereotypic counts in female mice. For jumping behavior, (c) 
females jumped more than males, and d (+)-naloxone significantly increased jump 
counts in females. Error bars are 95% confidence intervals. *p < 0.05 
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Figure 4.6 Canonical discriminant function plot for experiment 2 (sex × gavage 
treatment).  
Experiment 2 discriminant function plot (sex by gavage treatment). Correlations 
between outcome variables and discriminant functions are listed in Table 4.2. Function 
1 separates groups based on sex, largely driven by differences in time spent jumping, 
jump time, and ambulatory time, whereas function 2 separates groups by gavage 
treatment, mostly driven by number of rears, zone entries, and stereotypic counts. LPS 
affects males and females in a similar fashion across discriminant function 2. Group 
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centroids indicate the mean discriminant function value of each of the designated 
groups. 
 
 
 
Figure 4.7 Canonical discriminant function plot for experiment 2 (sex × (+)-
naloxone treatment).  
Experiment 2 discriminant function plot (sex by (+)-naloxone treatment). Correlations 
between outcome variables and discriminant functions are listed in Table 4.3. Function 
1 separates groups based on sex, largely driven by differences in time spent jumping, 
jump time, and ambulatory time, whereas function 2 demonstrates an interaction 
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between sex and (+)-naloxone treatment, mostly based on the sexually differential effect 
of (+)-naloxone on stereotypic counts, ambulatory episodes, and time spent in 
stereotypic circling. Group centroids indicate the mean discriminant function value of 
each of the designated groups. 
 
 
 
Figure 4.8 Effects of oral gavage of LPS on gut cytokine expression in female and 
male mice.  
a Expression levels of IL-6 showed a sex-dependent effect, with LPS causing a 
reduction of IL-6 in males and an increase in females. b–d However, the expression 
of IL-10, TNF-α, and IL-1β did not depend on sex or experimental treatment. Data are 
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expressed relative to levels of saline-treated males. Error bars are 95% confidence 
intervals. *p < 0.05; **p < 0.01 
 
Meta-analyses across Experiments 1 and 2 
 A random effects meta-analysis was performed across experimental cohorts in 
order to obtain more general estimates of the effects of oral gavage of LPS on behavior. 
As both experiments used WT males, all WT males from Experiment 1 and WT males 
not treated with TLR4 antagonists in Experiment 2 were used for the meta analyses 
(total n=15/group). Across Experiments 1 and 2, there were significant effects of LPS on 
time spent in the center zone (p<0.01), time spent in stereotypic circling (p<0.01), and 
stereotypic counts (p<0.01) (Figure 4.9). There were non-significant effects of LPS on 
parameters of locomotion, including ambulatory counts (p>0.1), ambulatory episodes 
(p>0.10), ambulatory time (p>0.1), ambulatory distance (p>0.10), resting time (p>0.10), 
and average velocity (p>0.10). All other behavioral parameters were also non-significant 
(Supplemental Fig. 2-12, Supplemental Table 6).  
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Figure 4.9 Meta-analyses of behavior in WT males of experiments 1 and 2.  
Forest plots of meta-analyses of a time spent in center zone, b time spent in stereotypic 
circling, c stereotypic counts, and d ambulatory counts measured in experiment 1 (top 
green bar) and experiment 2 (bottom green bar). The result of the meta-analysis is 
indicated by the red diamond. The width of the green bars and the red diamond indicate 
the range of the 95% confidence intervals for each, with the center representing the 
mean. WT males not treated with TLR4 antagonists were used for these analyses 
(total n = 15/group). See Supplemental Table 7 for statistics. 
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4.5 Discussion 
Here, we observe that gut-derived LPS elicits various aspects of the canonical 
sickness behavior response, with the exception of lethargy. In our first experiment, LPS 
increased anxiety-like behavior in male WT mice whereas no such effect was found in 
male Tlr4-/- mice. In the second experiment, LPS similarly increased anxiety-like 
behaviors in WT males and females. Neither TLR4 antagonist ((+)-naloxone nor LPS-
RS) blocked the effects of gavage treatment. However, (+)-naloxone, a TLR4/TRIF 
specific antagonist, which does not interact with opioid receptors (Iijima et al., 1978; 
Marcoli et al., 1989), affected behavior differently in males and females. Furthermore, 
LPS-RS did not significantly alter behavior, suggesting that the MyD88 pathway may not 
be involved in anxiety-like and repetitive behaviors generated by gut-derived endotoxin. 
With the presented data, we offer oral administration of LPS as a model of gut dysbiosis 
that may result from overgrowth of pathogenic gram-negative bacteria in gut microbiota.  
While LPS increased anxiety behavior two hours after treatment, it did not 
increase lethargy (indexed as hypolocomotion), as seen 2-6 hours after systemic 
injections of LPS. Importantly, oral gavage of LPS induced similar increases in anxiety-
like behavior to those observed after direct injection (Lacosta et al., 1999; Swiergiel and 
Dunn, 2007; Juszczak et al., 2008; Painsipp et al., 2008; Zager et al., 2009; Haba et al., 
2012; Sulakhiya et al., 2015; Ghisoni et al., 2016; Sulakhiya et al., 2016; Mayerhofer et 
al., 2017; Zager et al., 2017). This suggests that oral gavage of LPS specifically induced 
anxiety-like behavior without inducing a generalized sickness response. 
In Experiment 1, an oral gavage of LPS increased anxiety-like behaviors in male 
WT mice, as measured by decreased time spent in the center zone of the open field 
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test. In Experiment 2, the oral gavage of LPS did not strongly affect time spent in the 
center zone in subject mice. This may be a result of increased anxiety stemming from 
the additional manipulations (e.g., intraperitoneal injection) in this experiment as both 
gavage and injections can increase anxiety (Meijer et al., 2006; Hoggatt et al., 2010) or 
from behavioral variability across experimental cohorts. Nevertheless, multivariate 
analyses from Experiment 2 indicate that gut-derived LPS produced a syndrome of 
behavioral alterations that includes increases in anxiety-like behaviors (increased 
incidence of vertical stretch posture and decreased zone entries) and decreases in 
repetitive behaviors (decreased jump time and jump counts), albeit along a slightly 
different combination of measures from that found in Experiment 1. In support of the 
conclusion from the multivariate analyses that LPS affects anxiety-like behaviors in both 
experiments, meta-analysis of LPS effects in WT males indicates that the observed 
reduction in time spent in the center zone, a highly-used index of anxiety-like 
behavior(Calabrese, 2008; Campos et al., 2013), is similar to the reported range of 
reduced time spent in the center zone for male mice injected intraperitoneally or 
intravenously with LPS (20 to 60 second difference per 5 minute segment) (Lacosta et 
al., 1999; Swiergiel and Dunn, 2007; Juszczak et al., 2008; Painsipp et al., 2008; Zager 
et al., 2009; Haba et al., 2012; Sulakhiya et al., 2015; Ghisoni et al., 2016; Sulakhiya et 
al., 2016; Mayerhofer et al., 2017; Zager et al., 2017). Overall, these data demonstrate 
the utility of multivariate analyses to highlight similar behavioral effects across differing 
contexts.  
Our data indicate that the behavioral effects of gut-derived LPS are mediated 
through TLR4. Oral administration of LPS significantly increased anxiety-like behavior in 
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WT mice, but not in Tlr4-/- mice. If anything, there was a trend toward LPS increasing 
time spent in the center zone in Tlr4-/- mice, suggesting that LPS may interact with 
other innate immune receptors to decrease anxiety. TLR4 antagonists, however, did not 
directly block the effects of LPS gavage on behavior. It is unlikely that this is due to 
ineffective dosage, as we chose dosages of antagonists based on the literature (Sorge 
et al., 2011; Wu et al., 2012; Corrigan et al., 2015; Li et al., 2015a), and (+)-naloxone 
affected behavior regardless of LPS treatment in this study. Measurement of cytokines 
suggests that LPS acted primarily at the level of the gut, as we did not find elevation of 
inflammatory markers in serum but did find a significant elevation of IL-6 expression in 
the gut. If so, it may be that the TLR4 antagonists did not intervene effectively at the site 
of action of the LPS. Orally-administered LPS likely interacts with TLR4 present on the 
apical surface of intestinal epithelial cells. It is plausible that our antagonists, when 
injected intraperitoneally, do not have sufficient access to these receptors.  
Our data suggest that there may be sex differences in constitutive TLR4 activity 
and its downstream effects on locomotor and repetitive behaviors. The antagonist (+)-
naloxone, which blocks the TLR4/TRIF signaling pathway, increased stereotypic circling 
time and ambulatory episodes in females while decreasing these behaviors in males, 
regardless of gavage treatment. This suggests that the TLR4/TRIF pathway differently 
modulates these behaviors in males and females. This is in line with literature that 
shows (+)-naloxone more effectively blocks TLR4-modulated nociception in female than 
in male rats (Doyle et al., 2017). In our study, oral LPS treatment increased intestinal IL-
6 expression in females and suppressed it in males. As IL-6 expression depends on the 
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TLR4/TRIF pathway (Shen et al., 2008), it is possible that sex differences in this 
pathway contributed to sex differences in LPS effects on IL-6 observed in this study.  
Our data also demonstrate that TLR4 activation may suppress repetitive 
behaviors. Genetic deletion of TLR4 in males and blockade of TLR4 signaling (with (+)-
naloxone) in females both increase stereotypic circling. These effects may possibly be 
driven by the suppression of allergic-type (Th2-driven) immune profiles by TLR4, as 
Tlr4-/- mice are reported to show enhanced allergic responses (Bashir et al., 2004; 
Berin et al., 2006). In line with this prediction, a number of studies demonstrate that 
allergic-type immune profiles increase repetitive behaviors (Tuomisto, 1986; Mills et al., 
2000; Mazmanian et al., 2005; Thomas et al., 2009; Nishino et al., 2013; Desbonnet et 
al., 2014; Balazsfi et al., 2015; Fodor et al., 2016). It is notable that the TLR4 antagonist 
(+)-naloxone decreased stereotypic circling in males, while enhancing it in females. 
There are documented sex differences in cytokine responses to TLR4 activation 
(Santos-Galindo et al., 2011; Doyle et al., 2017). Our data further suggest potential sex 
differences in the TLR4/TRIF pathway in males and females, and these differences may 
contribute to the sex difference we observed in stereotypic circling among saline-treated 
mice. Alignment of the effects of TLR4 genetic mutation in males and effects of (+)-
naloxone in females, and contrary effects of (+)-naloxone in males, suggest that TLR4 
may play the same role in males and females, but the underlying signaling pathways 
may differ between the sexes. 
In summary, in spite of the ubiquitous nature of LPS in the gut lumen, this is the 
first study to demonstrate that gut-derived LPS can initiate behavioral aspects of the 
sickness response. Our results suggest that an increased intestinal load of LPS similarly 
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increases anxiety-like behavior and suppresses repetitive behavior in males and 
females. However, to the extent this is mediated through TLR4 activation, this may 
occur via differing mechanisms. Furthermore, different actions of the TLR4/TRIF 
pathway may drive baseline differences in repetitive behaviors in males and females.  
 
4.6 Supplemental Material 
 
Figure 4.10 Supplemental Figure 1. Meta-analysis of serum endotoxin levels in 
WT males of Experiments 1 and 2.  
Forest plot of difference in serum endotoxin levels between male WT subjects gavaged 
with saline or LPS, measured from Experiment 1 (top green bar) and Experiment 2 
(bottom green bar). The result of the meta-analysis is indicated by the red diamond. The 
width of the green bars and the red diamond indicate the range of the 95% confidence 
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intervals for each, with the center representing the mean. WT males not treated with 
TLR4 antagonists were used for these analyses (total n = 15/group). 
 
Figure 4.11 Supplemental Figure 2. Meta-analysis of ambulatory episodes in WT 
males of Experiments 1 and 2.  
Forest plot of difference in ambulatory episodes between male WT subjects gavaged 
with saline or LPS, measured from Experiment 1 (top green bar) and Experiment 2 
(bottom green bar). The result of the meta-analysis is indicated by the red diamond. The 
width of the green bars and the red diamond indicate the range of the 95% confidence 
intervals for each, with the center representing the mean. WT males not treated with 
TLR4 antagonists were used for these analyses (total n = 15/group). See Supplemental 
Table 7 for statistics. 
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Figure 4.12 Supplemental Figure 3. Meta-analysis of ambulatory time in WT males 
of Experiments 1 and 2.  
Forest plot of difference in ambulatory time between male WT subjects gavaged with 
saline or LPS, measured from Experiment 1 (top green bar) and Experiment 2 (bottom 
green bar). The result of the meta-analysis is indicated by the red diamond. The width of 
the green bars and the red diamond indicate the range of the 95% confidence intervals 
for each, with the center representing the mean. WT males not treated with TLR4 
antagonists were used for these analyses (total n = 15/group). See Supplemental Table 
7 for statistics. 
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Figure 4.13 Supplemental Figure 4. Meta-analysis of ambulatory distance in WT 
males of Experiments 1 and 2.  
Forest plot of difference in ambulatory distance between male WT subjects gavaged 
with saline or LPS, measured from Experiment 1 (top green bar) and Experiment 2 
(bottom green bar). The result of the meta-analysis is indicated by the red diamond. The 
width of the green bars and the red diamond indicate the range of the 95% confidence 
intervals for each, with the center representing the mean. WT males not treated with 
TLR4 antagonists were used for these analyses (total n = 15/group). See Supplemental 
Table 7 for statistics. 
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Figure 4.14 Supplemental Figure 5. Meta-analysis of resting time in WT males of 
Experiments 1 and 2.  
Forest plot of difference in resting time between male WT subjects gavaged with saline 
or LPS, measured from Experiment 1 (top green bar) and Experiment 2 (bottom green 
bar). The result of the meta-analysis is indicated by the red diamond. The width of the 
green bars and the red diamond indicate the range of the 95% confidence intervals for 
each, with the center representing the mean. WT males not treated with TLR4 
antagonists were used for these analyses (total n = 15/group). See Supplemental Table 
7 for statistics. 
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Figure 4.15 Supplemental Figure 6. Meta-analysis of average velocity in WT males 
of Experiments 1 and 2.  
Forest plot of difference in average velocity between male WT subjects gavaged with 
saline or LPS, measured from Experiment 1 (top green bar) and Experiment 2 (bottom 
green bar). The result of the meta-analysis is indicated by the red diamond. The width of 
the green bars and the red diamond indicate the range of the 95% confidence intervals 
for each, with the center representing the mean. WT males not treated with TLR4 
antagonists were used for these analyses (total n = 15/group). See Supplemental Table 
7 for statistics. 
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Figure 4.16 Supplemental Figure 7. Meta-analysis of zone entries in WT males of 
Experiments 1 and 2.  
Forest plot of difference in zone entries between male WT subjects gavaged with saline 
or LPS, measured from Experiment 1 (top green bar) and Experiment 2 (bottom green 
bar). The result of the meta-analysis is indicated by the red diamond. The width of the 
green bars and the red diamond indicate the range of the 95% confidence intervals for 
each, with the center representing the mean. WT males not treated with TLR4 
antagonists were used for these analyses (total n = 15/group). See Supplemental Table 
7 for statistics. 
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Figure 4.17 Supplemental Figure 8. Meta-analysis of stretch posture in WT males 
of Experiments 1 and 2.  
Forest plot of difference in time in stretch posture between male WT subjects gavaged 
with saline or LPS, measured from Experiment 1 (top green bar) and Experiment 2 
(bottom green bar). The result of the meta-analysis is indicated by the red diamond. The 
width of the green bars and the red diamond indicate the range of the 95% confidence 
intervals for each, with the center representing the mean. WT males not treated with 
TLR4 antagonists were used for these analyses (total n = 15/group). See Supplemental 
Table 7 for statistics. 
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Figure 4.18 Supplemental Figure 9. Meta-analysis of jump counts in WT males of 
Experiments 1 and 2.  
Forest plot of difference in jump counts between male WT subjects gavaged with saline 
or LPS, measured from Experiment 1 (top green bar) and Experiment 2 (bottom green 
bar). The result of the meta-analysis is indicated by the red diamond. The width of the 
green bars and the red diamond indicate the range of the 95% confidence intervals for 
each, with the center representing the mean. WT males not treated with TLR4 
antagonists were used for these analyses (total n = 15/group). See Supplemental Table 
7 for statistics. 
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Figure 4.19 Supplemental Figure 10. Meta-analysis of jump time in WT males of 
Experiments 1 and 2.  
Forest plot of difference in jump time between male WT subjects gavaged with saline or 
LPS, measured from Experiment 1 (top green bar) and Experiment 2 (bottom green 
bar). The result of the meta-analysis is indicated by the red diamond. The width of the 
green bars and the red diamond indicate the range of the 95% confidence intervals for 
each, with the center representing the mean. WT males not treated with TLR4 
antagonists were used for these analyses (total n = 15/group). See Supplemental Table 
7 for statistics. 
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Figure 4.20 Supplemental Figure 11.  Meta-analysis of clockwise reversals in WT 
males of Experiments 1 and 2.  
Forest plot of difference in clockwise reversals between male WT subjects gavaged with 
saline or LPS, measured from Experiment 1 (top green bar) and Experiment 2 (bottom 
green bar). The result of the meta-analysis is indicated by the red diamond. The width of 
the green bars and the red diamond indicate the range of the 95% confidence intervals 
for each, with the center representing the mean. WT males not treated with TLR4 
antagonists were used for these analyses (total n = 15/group). See Supplemental Table 
7 for statistics. 
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Figure 4.21 Supplemental Figure 12. Meta-analysis of counter-clockwise reversals 
in WT males of Experiments 1 and 2.  
Forest plot of difference in counter-clockwise reversals between male WT subjects 
gavaged with saline or LPS, measured from Experiment 1 (top green bar) and 
Experiment 2 (bottom green bar). The result of the meta-analysis is indicated by the red 
diamond. The width of the green bars and the red diamond indicate the range of the 
95% confidence intervals for each, with the center representing the mean. WT males 
not treated with TLR4 antagonists were used for these analyses (total n = 15/group). 
See Supplemental Table 7 for statistics. 
 
Table 4.4 Supplemental Table 1. Independent ANOVAs from Experiment 1 suggest 
outcome variables that contribute to group differences highlighted by Pillai’s 
trace. 
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Source Dependent Variable F Sig. 
Partial 
η^2 
Gavage 
Treatment Time in Center Zone 0.25 
0.62
3 0.014 
  
Number of Center Zone Entries 0.040 
0.84
3 0.002 
Time Spent in Stereotypic Circling 0.489 
0.49
3 0.026 
  Number of Clockwise Reversals 0.459 
0.50
7 0.025 
  
Time Spent in Vertical Stretch 
Posture 0.32 
0.57
9 0.017 
  Jump Counts 0.078 
0.78
3 0.004 
  
Number of Counterclockwise 
Reversals 0.032 0.86 0.002 
  Time Spent Jumping 0.08 
0.78
1 0.004 
  Incidence of Vertical Stretch Posture . . . 
  Ambulatory Episodes 0.327 
0.57
4 0.018 
  
Ambulatory Counts 0.393 
0.53
9 0.021 
Ambulatory Distance 0.229 
0.63
8 0.013 
Genotype Time in Center Zone 
10.74
2 
0.00
4 0.374 
 Number of Center Zone Entries 1.857 
0.19
0 0.094 
  Time Spent in Stereotypic Circling 
40.59
7 0 0.693 
  Number of Clockwise Reversals 0.068 
0.79
7 0.004 
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Time Spent in Vertical Stretch 
Posture 1.564 
0.22
7 0.08 
  Jump Counts 1.813 
0.19
5 0.091 
  
Number of Counterclockwise 
Reversals 1.197 
0.28
8 0.062 
  Time Spent Jumping 
24.08
9 0 0.572 
  Incidence of Vertical Stretch Posture . . . 
  Ambulatory Episodes 0.302 
0.58
9 0.017 
  
Ambulatory Counts 0.591 
0.45
2 0.032 
Ambulatory Distance 0.168 
0.68
7 0.009 
Gavage 
Treatment Time in Center Zone 
14.05
1 
0.00
1 0.438 
by Genotype Numbe of Center Zone Entries 0.865 
0.36
5 0.046 
 
Time Spent in Stereotypic Circling 2.187 
0.15
6 0.108 
  Number of Clockwise Reversals 0.86 
0.36
6 0.046 
  
Time Spent in Vertical Stretch 
Posture 0.106 
0.74
9 0.006 
  Jump Counts 0.682 0.42 0.036 
  
Number of Counterclockwise 
Reversals 0.01 
0.92
2 0.001 
  Time Spent Jumping 1.231 
0.28
2 0.064 
  Incidence of Vertical Stretch Posture . . . 
  Ambulatory Episodes 0.018 
0.89
4 0.001 
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Ambulatory Counts 0.121 
0.73
2 0.007 
Ambulatory Distance 0.216 
0.64
7 0.012 
Individual ANOVAs on outcome variables measured in Experiment 1. Significant results 
are boldfaced. F values are indicated in the “F” column, p values are indicated in the 
"Sig." column and effect sizes (partial eta squared) are indicated in the "Partial η^2" 
column. For each ANOVA, hypothesis degrees of freedom is 1 and error degrees of 
freedom is 18. 
 
Table 4.5 Supplemental Table 2. Original classification and cross-validation of 
discriminant functions for Experiment 1. 
  
Complete 
Label Code 
Predicted Group Membership 
Total 
  WT 
saline 
WT 
LPS 
Tlr4-/- 
saline 
Tlr4-/- 
LPS 
Original Count WT saline 7 0 0 0 7 
WT LPS 0 7 0 0 7 
Tlr4-/- saline 0 0 4 0 4 
Tlr4-/- LPS 0 0 0 4 4 
% WT saline 100.0 .0 .0 .0 100.0 
WT LPS .0 100.0 .0 .0 100.0 
Tlr4-/- saline .0 .0 100.0 .0 100.0 
Tlr4-/- LPS .0 .0 .0 100.0 100.0 
Cross-
validated 
Count WT saline 4 0 0 3 7 
WT LPS 0 6 0 1 7 
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Tlr4-/- saline 0 0 2 2 4 
Tlr4-/- LPS 1 0 1 2 4 
% WT saline 57.1 .0 .0 42.9 100.0 
WT LPS .0 85.7 .0 14.3 100.0 
Tlr4-/- saline .0 .0 50.0 50.0 100.0 
Tlr4-/- LPS 25.0 .0 25.0 50.0 100.0 
Validation of discriminant functions for Experiment 1 by original case classification and 
leave-one-out cross validation. 100% of the original grouped cases are correctly 
classified by the discriminant functions. In the leave-one-out cross-validation test, the 
discriminant functions are recalculated excluding one case, and all cases are 
recalculated. This algorithm is repeated for the exclusion of each case. In the leave-
one-out test, 63.6% of cross-validated grouped cases were correctly classified. 
 
 
Table 4.6 Supplemental Table 3. Independent ANOVAs from Experiment 2 suggest 
outcome variables that contribute to group differences highlighted by Pillai’s 
trace.  
Source Dependent Variable F Sig. 
Partial Eta 
Squared 
Sex Jump Counts 
62.3
54 0 0.36 
  Jump Time 
39.2
81 0 0.261 
  Ambulatory Episodes 
18.0
94 0 0.14 
  Ambulatory Counts 
21.6
66 0 0.163 
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Time Spent in Stereotypic 
Circling 1.47 
0.22
8 0.013 
  
Incidence of Vertical Stretch 
Posture 
0.00
3 0.96 0 
  
Time Spent in Vertical Stretch 
Posture 
2.79
5 
0.09
7 0.025 
  Time in Center Zone 
0.08
4 
0.77
2 0.001 
  Number of Center Zone Entries 0.71 
0.40
1 0.006 
  Number of Clockwise Reversals 
0.25
5 
0.61
4 0.002 
  
Number of Counter-Clockwise 
Reversals 
1.74
6 
0.18
9 0.015 
  Ambulatory Distance 
19.0
35 0 0.146 
  Average Velocity 4.76 
0.03
1 0.041 
  Ambulatory Time 
24.9
05 0 0.183 
  Stereotypic Counts 
0.06
4 0.8 0.001 
  Resting Time 
19.2
84 0 0.148 
Gavage_Treatme
nt Jump Counts 
6.31
5 
0.01
3 0.054 
  Jump Time 
3.61
1 0.06 0.032 
  Ambulatory Episodes 
1.69
4 
0.19
6 0.015 
  Ambulatory Counts 
3.03
1 
0.08
4 0.027 
  
Time Spent in Stereotypic 
Circling 
3.91
1 0.05 0.034 
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Incidence of Vertical Stretch 
Posture 
4.64
5 
0.03
3 0.04 
  
Time Spent in Vertical Stretch 
Posture 
1.98
2 
0.16
2 0.018 
  Time in Center Zone 
0.60
1 0.44 0.005 
  Number of Center Zone Entries 5.69 
0.01
9 0.049 
  Number of Clockwise Reversals 
0.15
9 
0.69
1 0.001 
  
Number of Counter-Clockwise 
Reversals 
1.74
6 
0.18
9 0.015 
  Ambulatory Distance 
2.86
6 
0.09
3 0.025 
  Average Velocity 
1.24
2 
0.26
7 0.011 
  Ambulatory Time 
1.68
4 
0.19
7 0.015 
  Stereotypic Counts 
5.11
4 
0.02
6 0.044 
  Resting Time 
3.50
7 
0.06
4 0.031 
Naloxone_Treatm
ent Jump Counts 
1.22
4 
0.27
1 0.011 
  Jump Time 
0.05
1 
0.82
1 0 
  Ambulatory Episodes 
1.15
3 
0.28
5 0.01 
  Ambulatory Counts 
1.45
7 0.23 0.013 
  
Time Spent in Stereotypic 
Circling 0.03 
0.86
2 0 
  
Incidence of Vertical Stretch 
Posture 
0.56
5 
0.45
4 0.005 
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Time Spent in Vertical Stretch 
Posture 
1.98
2 
0.16
2 0.018 
  Time in Center Zone 
0.10
9 
0.74
2 0.001 
  Number of Center Zone Entries 
0.21
4 
0.64
5 0.002 
  Number of Clockwise Reversals 
0.37
4 
0.54
2 0.003 
  
Number of Counter-Clockwise 
Reversals 0.03 
0.86
3 0 
  Ambulatory Distance 
1.57
2 
0.21
3 0.014 
  Average Velocity 1.04 0.31 0.009 
  Ambulatory Time 
1.22
8 0.27 0.011 
  Stereotypic Counts 
0.03
3 
0.85
7 0 
  Resting Time 
0.67
3 
0.41
4 0.006 
LPSRS_Treatmen
t Jump Counts 
0.81
8 
0.36
8 0.007 
  Jump Time 
0.15
2 
0.69
8 0.001 
  Ambulatory Episodes 
0.27
2 
0.60
3 0.002 
  Ambulatory Counts 
0.22
3 
0.63
8 0.002 
  
Time Spent in Stereotypic 
Circling 
1.18
9 
0.27
8 0.011 
  
Incidence of Vertical Stretch 
Posture 
0.56
5 
0.45
4 0.005 
  
Time Spent in Vertical Stretch 
Posture 
0.03
1 
0.86
1 0 
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  Time in Center Zone 
1.93
2 
0.16
7 0.017 
  Number of Center Zone Entries 
0.45
3 
0.50
2 0.004 
  Number of Clockwise Reversals 
0.03
5 
0.85
3 0 
  
Number of Counter-Clockwise 
Reversals 
0.99
1 
0.32
2 0.009 
  Ambulatory Distance 
0.31
3 
0.57
7 0.003 
  Average Velocity 
2.91
8 0.09 0.026 
  Ambulatory Time 0.52 
0.47
2 0.005 
  Stereotypic Counts 
0.46
3 
0.49
8 0.004 
  Resting Time 
0.65
6 0.42 0.006 
Sex *  Jump Counts 
0.22
1 
0.63
9 0.002 
Gavage_Treatme
nt Jump Time 
0.05
1 
0.82
2 0 
  Ambulatory Episodes 
0.83
1 
0.36
4 0.007 
  Ambulatory Counts 
1.02
9 
0.31
3 0.009 
  
Time Spent in Stereotypic 
Circling 
0.01
5 
0.90
2 0 
  
Incidence of Vertical Stretch 
Posture 
2.11
3 
0.14
9 0.019 
  
Time Spent in Vertical Stretch 
Posture 
1.30
9 
0.25
5 0.012 
  Time in Center Zone 
1.97
5 
0.16
3 0.017 
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  Number of Center Zone Entries 
0.41
4 
0.52
1 0.004 
  Number of Clockwise Reversals 
0.15
9 
0.69
1 0.001 
  
Number of Counter-Clockwise 
Reversals 
0.28
8 
0.59
3 0.003 
  Ambulatory Distance 
0.63
1 
0.42
9 0.006 
  Average Velocity 
0.05
6 
0.81
4 0.001 
  Ambulatory Time 
0.80
2 
0.37
2 0.007 
  Stereotypic Counts 
0.01
5 
0.90
4 0 
  Resting Time 
0.45
5 
0.50
1 0.004 
Sex *  Jump Counts 
7.13
3 
0.00
9 0.06 
Naloxone_Treatm
ent Jump Time 
2.13
7 
0.14
7 0.019 
  Ambulatory Episodes 
10.0
18 
0.00
2 0.083 
  Ambulatory Counts 
7.88
8 
0.00
6 0.066 
  
Time Spent in Stereotypic 
Circling 
6.01
5 
0.01
6 0.051 
  
Incidence of Vertical Stretch 
Posture 
2.11
3 
0.14
9 0.019 
  
Time Spent in Vertical Stretch 
Posture 
0.37
9 
0.53
9 0.003 
  Time in Center Zone 
0.13
3 
0.71
6 0.001 
  Number of Center Zone Entries 
0.06
9 
0.79
3 0.001 
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  Number of Clockwise Reversals 
0.96
8 
0.32
7 0.009 
  
Number of Counter-Clockwise 
Reversals 
0.37
4 
0.54
2 0.003 
  Ambulatory Distance 
7.52
5 
0.00
7 0.063 
  Average Velocity 
5.31
5 
0.02
3 0.046 
  Ambulatory Time 
7.32
6 
0.00
8 0.062 
  Stereotypic Counts 
7.63
5 
0.00
7 0.064 
  Resting Time 
9.05
8 
0.00
3 0.075 
Sex *  Jump Counts 
0.98
1 
0.32
4 0.009 
LPSRS_Treatmen
t Jump Time 
0.12
2 
0.72
8 0.001 
  Ambulatory Episodes 
0.72
3 
0.39
7 0.006 
  Ambulatory Counts 
0.59
6 
0.44
2 0.005 
  
Time Spent in Stereotypic 
Circling 
0.18
8 
0.66
5 0.002 
  
Incidence of Vertical Stretch 
Posture 
2.11
3 
0.14
9 0.019 
  
Time Spent in Vertical Stretch 
Posture 0.07 
0.79
2 0.001 
  Time in Center Zone 
1.34
9 
0.24
8 0.012 
  Number of Center Zone Entries 
0.09
9 
0.75
4 0.001 
  Number of Clockwise Reversals 
0.59
5 
0.44
2 0.005 
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Number of Counter-Clockwise 
Reversals 0.15 
0.69
9 0.001 
  Ambulatory Distance 
0.57
8 
0.44
9 0.005 
  Average Velocity 
2.81
9 
0.09
6 0.025 
  Ambulatory Time 
0.63
3 
0.42
8 0.006 
  Stereotypic Counts 0.27 
0.60
4 0.002 
  Resting Time 
0.61
8 
0.43
4 0.006 
Gavage_Treatme
nt *  Jump Counts 
0.63
2 
0.42
8 0.006 
Naloxone_Treatm
ent Jump Time 
0.61
1 
0.43
6 0.005 
  Ambulatory Episodes 
0.02
3 
0.87
9 0 
  Ambulatory Counts 
0.12
2 
0.72
8 0.001 
  
Time Spent in Stereotypic 
Circling 
0.14
1 
0.70
8 0.001 
  
Incidence of Vertical Stretch 
Posture 
0.42
5 
0.51
6 0.004 
  
Time Spent in Vertical Stretch 
Posture 
0.27
9 
0.59
9 0.003 
  Time in Center Zone 0.03 
0.86
2 0 
  Number of Center Zone Entries 
0.07
5 
0.78
4 0.001 
  Number of Clockwise Reversals 0.68 
0.41
1 0.006 
  
Number of Counter-Clockwise 
Reversals 0.15 
0.69
9 0.001 
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  Ambulatory Distance 
0.12
4 
0.72
6 0.001 
  Average Velocity 
2.16
8 
0.14
4 0.019 
  Ambulatory Time 
0.09
8 
0.76
1 0.001 
  Stereotypic Counts 
0.11
9 
0.73
1 0.001 
  Resting Time 
0.21
8 
0.64
2 0.002 
Gavage_Treatme
nt *  Jump Counts 
0.57
1 
0.45
1 0.005 
LPSRS_Treatmen
t Jump Time 
0.37
6 
0.54
1 0.003 
  Ambulatory Episodes 0.44 
0.50
9 0.004 
  Ambulatory Counts 
0.23
4 
0.62
9 0.002 
  
Time Spent in Stereotypic 
Circling 
0.22
2 
0.63
8 0.002 
  
Incidence of Vertical Stretch 
Posture 
0.42
5 
0.51
6 0.004 
  
Time Spent in Vertical Stretch 
Posture 0 1 0 
  Time in Center Zone 0.68 
0.41
1 0.006 
  Number of Center Zone Entries 
1.39
2 
0.24
1 0.012 
  Number of Clockwise Reversals 0.68 
0.41
1 0.006 
  
Number of Counter-Clockwise 
Reversals 
0.91
8 0.34 0.008 
  Ambulatory Distance 
0.36
7 
0.54
6 0.003 
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  Average Velocity 
0.12
2 
0.72
7 0.001 
  Ambulatory Time 
0.47
9 0.49 0.004 
  Stereotypic Counts 
0.15
7 
0.69
3 0.001 
  Resting Time 
0.57
9 
0.44
8 0.005 
Naloxone_Treatm
ent *  Jump Counts 0.02 
0.88
7 0 
LPSRS_Treatmen
t Jump Time 
0.00
2 
0.96
3 0 
  Ambulatory Episodes 
1.00
4 
0.31
8 0.009 
  Ambulatory Counts 
0.43
1 
0.51
3 0.004 
  
Time Spent in Stereotypic 
Circling 
0.16
4 
0.68
7 0.001 
  
Incidence of Vertical Stretch 
Posture 
0.42
5 
0.51
6 0.004 
  
Time Spent in Vertical Stretch 
Posture 
0.03
1 
0.86
1 0 
  Time in Center Zone 
0.17
4 
0.67
7 0.002 
  Number of Center Zone Entries 
1.06
2 
0.30
5 0.009 
  Number of Clockwise Reversals 
0.01
8 
0.89
4 0 
  
Number of Counter-Clockwise 
Reversals 0.26 
0.61
1 0.002 
  Ambulatory Distance 
0.30
5 
0.58
2 0.003 
  Average Velocity 
0.61
1 
0.43
6 0.005 
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  Ambulatory Time 
0.64
2 
0.42
5 0.006 
  Stereotypic Counts 
0.22
4 
0.63
7 0.002 
  Resting Time 
0.53
8 
0.46
5 0.005 
Sex *  Jump Counts 
1.84
6 
0.17
7 0.016 
Gavage_Treatme
nt *  Jump Time 
0.32
8 
0.56
8 0.003 
Naloxone_Treatm
ent Ambulatory Episodes 
0.73
3 
0.39
4 0.007 
  Ambulatory Counts 
1.06
6 
0.30
4 0.01 
  
Time Spent in Stereotypic 
Circling 
0.01
1 
0.91
6 0 
  
Incidence of Vertical Stretch 
Posture 
0.00
3 0.96 0 
  
Time Spent in Vertical Stretch 
Posture 
0.37
9 
0.53
9 0.003 
  Time in Center Zone 
0.36
9 
0.54
5 0.003 
  Number of Center Zone Entries 
0.01
3 
0.90
8 0 
  Number of Clockwise Reversals 
0.01
8 
0.89
4 0 
  
Number of Counter-Clockwise 
Reversals 
0.38
7 
0.53
5 0.003 
  Ambulatory Distance 
0.67
5 
0.41
3 0.006 
  Average Velocity 
0.19
9 
0.65
6 0.002 
  Ambulatory Time 
0.61
1 
0.43
6 0.005 
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  Stereotypic Counts 
0.14
3 
0.70
6 0.001 
  Resting Time 
0.42
1 
0.51
8 0.004 
Sex *  Jump Counts 
0.63
4 
0.42
7 0.006 
Gavage_Treatme
nt *  Jump Time 
0.77
1 
0.38
2 0.007 
LPSRS_Treatmen
t Ambulatory Episodes 
0.53
1 
0.46
8 0.005 
  Ambulatory Counts 
0.35
1 
0.55
5 0.003 
  
Time Spent in Stereotypic 
Circling 
0.08
2 
0.77
5 0.001 
  
Incidence of Vertical Stretch 
Posture 
0.00
3 0.96 0 
  
Time Spent in Vertical Stretch 
Posture 
0.19
4 
0.66
1 0.002 
  Time in Center Zone 
0.75
7 
0.38
6 0.007 
  Number of Center Zone Entries 
0.00
1 
0.98
1 0 
  Number of Clockwise Reversals 
0.01
8 
0.89
4 0 
  
Number of Counter-Clockwise 
Reversals 
0.32
9 
0.56
7 0.003 
  Ambulatory Distance 
0.44
8 
0.50
5 0.004 
  Average Velocity 
0.17
2 
0.67
9 0.002 
  Ambulatory Time 
0.40
9 
0.52
4 0.004 
  Stereotypic Counts 
0.00
7 
0.93
2 0 
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  Resting Time 
0.28
7 
0.59
3 0.003 
Sex *  Jump Counts 
0.13
2 
0.71
7 0.001 
Naloxone_Treatm
ent *  Jump Time 
0.03
4 
0.85
4 0 
LPSRS_Treatmen
t Ambulatory Episodes 
0.35
1 
0.55
5 0.003 
  Ambulatory Counts 0.16 
0.68
9 0.001 
  
Time Spent in Stereotypic 
Circling 
0.61
1 
0.43
6 0.005 
  
Incidence of Vertical Stretch 
Posture 
1.83
1 
0.17
9 0.016 
  
Time Spent in Vertical Stretch 
Posture 
0.37
9 
0.53
9 0.003 
  Time in Center Zone 
0.00
9 
0.92
5 0 
  Number of Center Zone Entries 
3.99
3 
0.04
8 0.035 
  Number of Clockwise Reversals 
0.59
5 
0.44
2 0.005 
  
Number of Counter-Clockwise 
Reversals 
1.20
4 
0.27
5 0.011 
  Ambulatory Distance 
0.13
3 
0.71
6 0.001 
  Average Velocity 
0.04
6 0.83 0 
  Ambulatory Time 
0.17
5 
0.67
7 0.002 
  Stereotypic Counts 
0.43
2 
0.51
2 0.004 
  Resting Time 
0.33
6 
0.56
4 0.003 
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Gavage_Treatme
nt *  Jump Counts 
1.44
5 
0.23
2 0.013 
Naloxone_Treatm
ent *  Jump Time 1 0.32 0.009 
LPSRS_Treatmen
t Ambulatory Episodes 1.24 
0.26
8 0.011 
  Ambulatory Counts 
0.37
6 
0.54
1 0.003 
  
Time Spent in Stereotypic 
Circling 2.32 
0.13
1 0.02 
  
Incidence of Vertical Stretch 
Posture 
0.56
5 
0.45
4 0.005 
  
Time Spent in Vertical Stretch 
Posture 
1.11
5 
0.29
3 0.01 
  Time in Center Zone 
0.11
7 
0.73
3 0.001 
  Number of Center Zone Entries 
0.13
3 
0.71
6 0.001 
  Number of Clockwise Reversals 
0.20
4 
0.65
2 0.002 
  
Number of Counter-Clockwise 
Reversals 
0.10
4 
0.74
7 0.001 
  Ambulatory Distance 
0.69
7 
0.40
6 0.006 
  Average Velocity 
2.65
3 
0.10
6 0.023 
  Ambulatory Time 
0.50
3 0.48 0.005 
  Stereotypic Counts 
2.49
9 
0.11
7 0.022 
  Resting Time 
1.32
3 
0.25
3 0.012 
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Sex *  Jump Counts 0 
0.99
4 0 
Gavage_Treatme
nt *  Jump Time 
0.15
9 
0.69
1 0.001 
Naloxone_Treatm
ent *  Ambulatory Episodes 
0.85
9 
0.35
6 0.008 
LPSRS_Treatmen
t Ambulatory Counts 0.51 
0.47
7 0.005 
  
Time Spent in Stereotypic 
Circling 
1.30
5 
0.25
6 0.012 
  
Incidence of Vertical Stretch 
Posture 
0.00
3 0.96 0 
  
Time Spent in Vertical Stretch 
Posture 
3.41
5 
0.06
7 0.03 
  Time in Center Zone 
0.00
9 
0.92
6 0 
  Number of Center Zone Entries 
0.75
9 
0.38
6 0.007 
  Number of Clockwise Reversals 
1.18
9 
0.27
8 0.011 
  
Number of Counter-Clockwise 
Reversals 0.13 
0.71
9 0.001 
  Ambulatory Distance 
0.65
4 0.42 0.006 
  Average Velocity 0.01 
0.92
1 0 
  Ambulatory Time 
0.88
9 
0.34
8 0.008 
  Stereotypic Counts 
1.36
8 
0.24
5 0.012 
  Resting Time 
1.24
8 
0.26
6 0.011 
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Individual ANOVAs on outcome variables measured in Experiment 2. Significant results 
are boldfaced. Trends are italicized. F values are indicated in the “F” column, p values 
are indicated in the "Sig." column and effect sizes (partial eta squared) are indicated in 
the "Partial η^2" column. For each ANOVA, hypothesis degrees of freedom is 1 and 
error degrees of freedom is 111. 
 
Table 4.7 Supplemental Table 4. Original classification and cross-validation of 
discriminant functions for Experiment 2 for cases grouped by gavage treatment 
and sex.  
  
SexByGavage 
Predicted Group Membership 
Total 
  Male 
Saline 
Male 
LPS 
Female 
Saline 
Female 
LPS 
Original Count Male Saline 22 9 1 0 32 
Male LPS 9 20 1 2 32 
Female Saline 3 2 21 5 31 
Female LPS 0 4 9 19 32 
% Male Saline 68.8 28.1 3.1 .0 100.0 
Male LPS 28.1 62.5 3.1 6.3 100.0 
Female Saline 9.7 6.5 67.7 16.1 100.0 
Female LPS .0 12.5 28.1 59.4 100.0 
Cross-
validated 
Count Male Saline 15 13 3 1 32 
Male LPS 13 14 2 3 32 
Female Saline 5 3 14 9 31 
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Female LPS 1 5 11 15 32 
% Male Saline 46.9 40.6 9.4 3.1 100.0 
Male LPS 40.6 43.8 6.3 9.4 100.0 
Female Saline 16.1 9.7 45.2 29.0 100.0 
Female LPS 3.1 15.6 34.4 46.9 100.0 
Validation of discriminant functions for Experiment 2, for cases grouped by gavage 
treatment and sex, by original case classification and leave-one-out cross validation. 
64.6% of the original grouped cases are correctly classified by the discriminant 
functions. In the leave-one-out cross-validation test, the discriminant functions are 
recalculated excluding one case, and all cases are recalculated. This algorithm is 
repeated for the exclusion of each case. In the leave-one-out test, 45.7% of cross-
validated grouped cases were correctly classified. 
 
Table 4.8 Supplemental Table 5. Original classification and cross-validation of 
discriminant functions for Experiment 1.  
  
SexByNaloxone 
Predicted Group Membership 
Total 
  
Male 
Saline 
Male (+)-
naloxone 
Female 
Saline 
Female 
(+)-
naloxone 
Original Count Male Saline 20 10 2 0 32 
Male (+)-
naloxone 
9 22 1 0 32 
Female Saline 2 3 20 7 32 
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Female (+)-
naloxone 
2 1 7 21 31 
% Male Saline 62.5 31.3 6.3 .0 100.0 
Male (+)-
naloxone 
28.1 68.8 3.1 .0 100.0 
Female Saline 6.3 9.4 62.5 21.9 100.0 
Female (+)-
naloxone 
6.5 3.2 22.6 67.7 100.0 
Cross-
validated 
Count Male Saline 18 11 3 0 32 
Male (+)-
naloxone 
15 14 3 0 32 
Female Saline 5 3 14 10 32 
Female (+)-
naloxone 
3 2 11 15 31 
% Male Saline 56.3 34.4 9.4 .0 100.0 
Male (+)-
naloxone 
46.9 43.8 9.4 .0 100.0 
Female Saline 15.6 9.4 43.8 31.3 100.0 
Female (+)-
naloxone 
9.7 6.5 35.5 48.4 100.0 
Validation of discriminant functions for Experiment 2, for cases grouped by (+)-naloxone 
treatment and sex, by original case classification and leave-one-out cross validation. 
65.4% of the original grouped cases are correctly classified by the discriminant 
functions. In the leave-one-out cross-validation test, the discriminant functions are 
recalculated excluding one case, and all cases are recalculated. This algorithm is 
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repeated for the exclusion of each case. In the leave-one-out test, 48.0% of cross-
validated grouped cases were correctly classified. 
 
Table 4.9 Supplemental Table 6. Meta analysis of behavioral outcomes for WT 
males not treated with TLR4 antagonists (n=15/group). 
Measure Mean - Exp 1 UL - Exp 1 LL - Exp 1 
Time in Center Zone (sec) -35.279 -49.205 -8.662 
Time Spent in Stereotypic 
Circling (sec) -7.507 -14.94 -0.075 
Stereotypic Counts -122.29 -248.4 3.827 
Ambulatory Counts 181.43 -366.53 729.388 
Ambulatory Episodes 5.572 -29.281 40.424 
Ambulatory Time (sec) 16.914 -18.596 52.425 
Ambulatory Distance (cm) 235.66 -489.47 960.787 
Resting Time (sec) -6.764 -42.879 29.351 
Avg Velocity (cm/sec) -1.462 -4.527 1.603 
Zone Entries 38.121 19.832 56.411 
Time in Stretch Posture (sec) -0.093 -0.391 0.206 
Jump Counts -11.143 -39.197 16.911 
Jump Time (sec) -2.65 -8.241 2.941 
Clockwise Reversals -0.429 -5.304 4.447 
Counter-Clockwise Reversals -0.143 -4.901 4.615 
  Mean - Exp 2 UL - Exp 2 LL - Exp 2 
Time in Center Zone (sec) -12.075 -50.105 25.955 
Time Spent in Stereotypic 
Circling (sec) -8.112 -18.754 2.529 
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Stereotypic Counts -173 -355.79 9.787 
Ambulatory Counts -219.13 -536.6 98.354 
Ambulatory Episodes -39.5 -105.7 26.705 
Ambulatory Time (sec) -14.338 -37.113 8.438 
Ambulatory Distance (cm) -346.34 -804.57 111.894 
Resting Time (sec) 26.231 -5.972 58.434 
Avg Velocity (cm/sec) 0.24 -4.106 3.626 
Zone Entries -17.5 -30.366 -4.635 
Time in Stretch Posture (sec) -0.019 -0.139 0.102 
Jump Counts -53.25 -109.91 3.407 
Jump Time (sec) -7.564 -17.68 2.555 
Clockwise Reversals -3 -13.19 7.19 
Counter-Clockwise Reversals 3 -9.357 15.357 
  
Mean - Meta 
Analysis 
UL - Meta 
Analysis 
LL - Meta 
Analysis 
Time in Center Zone (sec) -7.507 -14.94 -0.075 
Time Spent in Stereotypic 
Circling (sec) -7.701 -13.211 -2.192 
Stereotypic Counts -138.29 -232.14 -44.447 
Ambulatory Counts -70.45 -449.73 308.832 
Ambulatory Episodes -9.233 -50.721 32.256 
Ambulatory Time (sec) -1.157 -31.406 29.091 
Ambulatory Distance (cm) -111.28 -670.99 448.426 
Resting Time (sec) 10.481 -21.821 42.782 
Avg Velocity (cm/sec) -0.999 -3.173 1.174 
Zone Entries 10.001 -44.504 64.505 
Time in Stretch Posture (sec) -0.029 -0.131 0.072 
155 
Jump Counts -25.879 -65.241 13.484 
Jump Time (sec) -3.772 -8.19 0.646 
Clockwise Reversals -0.895 -4.863 3.072 
Counter-Clockwise Reversals 0.252 -3.75 4.254 
95% confidence interval values for Experiment 1, Experiment 2, and the meta analysis. 
UL=Upper Limit. LL=Lower Limit. 
 
Table 4.10 Supplemental Table 7. Meta analysis of behavioral outcomes for WT 
males not treated with TLR4 antagonists (n=15/group). 
Measure Mean - Exp 1 UL - Exp 1 LL - Exp 1 
Time in Center Zone (sec) -35.279 -49.205 -8.662 
Time Spent in Stereotypic 
Circling (sec) -7.507 -14.94 -0.075 
Stereotypic Counts -122.29 -248.4 3.827 
Ambulatory Counts 181.43 -366.53 729.388 
Ambulatory Episodes 5.572 -29.281 40.424 
Ambulatory Time (sec) 16.914 -18.596 52.425 
Ambulatory Distance (cm) 235.66 -489.47 960.787 
Resting Time (sec) -6.764 -42.879 29.351 
Avg Velocity (cm/sec) -1.462 -4.527 1.603 
Zone Entries 38.121 19.832 56.411 
Time in Stretch Posture (sec) -0.093 -0.391 0.206 
Jump Counts -11.143 -39.197 16.911 
Jump Time (sec) -2.65 -8.241 2.941 
Clockwise Reversals -0.429 -5.304 4.447 
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Counter-Clockwise Reversals -0.143 -4.901 4.615 
  Mean - Exp 2 UL - Exp 2 LL - Exp 2 
Time in Center Zone (sec) -12.075 -50.105 25.955 
Time Spent in Stereotypic 
Circling (sec) -8.112 -18.754 2.529 
Stereotypic Counts -173 -355.79 9.787 
Ambulatory Counts -219.13 -536.6 98.354 
Ambulatory Episodes -39.5 -105.7 26.705 
Ambulatory Time (sec) -14.338 -37.113 8.438 
Ambulatory Distance (cm) -346.34 -804.57 111.894 
Resting Time (sec) 26.231 -5.972 58.434 
Avg Velocity (cm/sec) 0.24 -4.106 3.626 
Zone Entries -17.5 -30.366 -4.635 
Time in Stretch Posture (sec) -0.019 -0.139 0.102 
Jump Counts -53.25 -109.91 3.407 
Jump Time (sec) -7.564 -17.68 2.555 
Clockwise Reversals -3 -13.19 7.19 
Counter-Clockwise Reversals 3 -9.357 15.357 
  
Mean - Meta 
Analysis 
UL - Meta 
Analysis 
LL - Meta 
Analysis 
Time in Center Zone (sec) -7.507 -14.94 -0.075 
Time Spent in Stereotypic 
Circling (sec) -7.701 -13.211 -2.192 
Stereotypic Counts -138.29 -232.14 -44.447 
Ambulatory Counts -70.45 -449.73 308.832 
Ambulatory Episodes -9.233 -50.721 32.256 
Ambulatory Time (sec) -1.157 -31.406 29.091 
157 
Ambulatory Distance (cm) -111.28 -670.99 448.426 
Resting Time (sec) 10.481 -21.821 42.782 
Avg Velocity (cm/sec) -0.999 -3.173 1.174 
Zone Entries 10.001 -44.504 64.505 
Time in Stretch Posture (sec) -0.029 -0.131 0.072 
Jump Counts -25.879 -65.241 13.484 
Jump Time (sec) -3.772 -8.19 0.646 
Clockwise Reversals -0.895 -4.863 3.072 
Counter-Clockwise Reversals 0.252 -3.75 4.254 
Legend: 95% confidence interval values for Experiment 1, Experiment 2, and the meta 
analysis. UL=Upper Limit. LL=Lower Limit. 
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5 DISCUSSION 
 
The three projects discussed in this dissertation all converge to highlight the 
potential impact of gut microbiota on the function of the gut barrier, which is the first 
direct interface the gut microbiota has with the host. Gut barrier function modulates 
several key mechanisms via which the microbiota can influence brain function and 
behavior, including, for example, type and level of local immune activity, alteration of 
systemic short-chain fatty acid levels and afferent vagal activity, all of which have been 
linked to modifying behavior (Heyman, 2005; Marietta et al., 2018; Spielman et al., 
2018). Within this discussion, I will outline how gut microbiota may have influenced gut 
barrier function across these three projects. These studies highlight the need for a 
broader methodological approach to gut microbiota analysis that will provide more 
investigative traction in the future, which may put less emphasis on gut microbiota 
analysis and more on identifying core functional consequences of “dysbiosis”.  
 
5.1 Core Factors Influence Gut Microbiota In Differing Conditions: LPS and Gut 
Barrier Dysfunction as Recurring Themes 
Chapter 2 focused on identifying differences in microbiota in Brattleboro (Avp-/-) 
and Long Evans (WT) rats, which differ in behavior (Brattleboro rats are less social and 
less anxious than their WT Long Evans counterparts (Feifel et al., 2009; Balazsfi et al., 
2015; Paul et al., 2016)). Most researchers attribute this to the absence of systemically 
and centrally-released vasopressin, which affects hydration status, influences the 
immune system, and acts as a neuromodulator in the CNS. All of these can affect 
behavior. We sought to identify potential alterations in gut microbiota in Brattleboro rats 
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that may also influence their behavioral status. For this, we needed an analysis that 
could identify genera and species that may have been altered. Prior work by our 
collaborators Chassaing and colleagues used QIIME and a machine-learning algorithm 
called nearest-shrunken centroid to identify broad changes in gut microbiota and to 
identify which specific microbial species best represent each of the designated groups, 
respectively in identifying changes in microbiota that might explain various effects of gut 
dysfunction on physiology (e.g., (Chassaing et al., 2015)). QIIME is able to identify 
population-wide differences in microbial samples between groups, using an unbiased 
principle components analysis approach. However, while this platform is able to 
determine phylum-level differences in gut microbiota, it is not designed to investigate 
genus- and species-level differences between groups. For this, they used the nearest 
shrunken centroid classification approach, which is a machine-learning approach that 
identifies the microbial species that best characterize sample groups (Choi et al., 2017). 
However, this statistical approach does not present information on the size of the 
abundance disparity between groups for species identified to be differentially abundant 
(Dabney, 2005). We needed to identify a more rigorous approach to identifying 
differentiated taxa. For this, we used LEfSe (Linear Discriminant Analysis coupled with 
Effect Size)--a tool developed to address this specific problem of identifying and ranking 
which microbial taxa associate most closely with each sample group. Other tools used 
to identify marker genes and biomarkers have been adapted for the purposes of gut 
microbiota analysis, including DESeq and EdgeR, however, a comparison of these tools 
revealed that LefSe was one of the most conservative in identifying differentiated taxa 
160 
(Paulson et al., 2013). This was important as we wanted to identify the few microbial 
taxa that most robustly associate with each treatment condition. 
The most salient differentiated taxa across the various AVP genotypes was that 
of the genus Lactobacillus between male WT, heterozygous, and homozygous Avp 
knockout genotypes, being most abundant in KO rats and least abundant in WT rats. 
This may be a significant change as Lactobacilli improve multiple aspects of gut barrier 
protection, which may impact baseline behavioral profile of the host. Certain 
Lactobacillus strains have been reported to increase the expression of anti-inflammatory 
cytokine IL-10 in innate immune cells and to counteract TLR4 cell signaling pathways in 
vitro (Villena and Kitazawa, 2014). Lactobacilli have also been shown to upregulate the 
expression of intestinal epithelial tight junction protein, thereby increasing gut barrier 
protection against gut luminal microbiota (Anderson et al., 2010; Karczewski et al., 
2010). This has been replicated in vivo, as two species of Lactobacillus have also been 
shown to protect against an experimental model of necrotizing enterocolitis by 
upregulating tight junction protein expression (Blackwood et al., 2017). In addition to 
increasing intestinal epithelial tight junction protein levels and upregulating anti-
inflammatory cytokine expression, Lactobacilli also increase immunoglobulin A (IgA) 
levels (Kim et al., 2016). IgA is an antibody predominantly produced in the lamina 
propria that binds to gut luminal microbiota along the mucus lining of the gut, reducing 
its entry in the lamina propria. Decreasing the magnitude and immunological impact of 
gut microbiota that cross the intestinal epithelial barrier is a key function of Lactobacilli 
and differing levels of this crucial gut microbe may impact baseline levels of gut 
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inflammation that may impact a wide assortment of body systems, including the brain 
and host behavior. 
While Lactobacillus was not found to be significantly different across genotypes 
in female rats, a couple other bacterial taxa linked with immune status were also found 
to be differentiated across the females. Lachnospira spp. were found to be most 
abundant in heterozygous rats and Holdemania spp. were most abundant in WT rats. 
As discussed in Chapter 2, both of these taxa are associated with increased 
inflammation. In addition, they have both been associated with conditions of increased 
gut permeability. Emerging connections between gut barrier dysfunction, systemic LPS 
burden, and kidney dysfunction have implicated Lachnospira as one of the most salient 
pro-inflammatory bacterial taxa to drive chronic kidney disease (Lun et al., 2018; Meijers 
et al., 2018). However, a clearer link has emerged for Holdemania: Abundance of 
Holdemania spp. decrease upon alcohol withdrawal, when alcohol-induced increases in 
gut permeability abate (Leclercq et al., 2014). Thus, while changes in gut microbiota 
across genotypes may be sex-specific, changes observed across both sexes converge 
on taxa that may influence gut barrier function and baseline states of systemic 
inflammation. Future studies could be directed to identifying which aspects of gut barrier 
function are altered and the functional consequences of such alterations.  
In Chapter 3, we asked whether adding emulsifiers to the diet, which induces 
changes in the microbiota and thereby systemic inflammation, also influences behavior. 
To obtain a more robust view on the effects of two differing emulsifier treatments 
(carboxymethylcellulose [CMC] and polysorbate-80 [P80]) on behavior in male and 
female mice, we used multivariate analysis. Gut microbiota have cumulative and 
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pleitropic effects on host physiology and behavior. While it is important to identify robust 
effects on individual measures, it is also informative to investigate the effects of gut 
microbial manipulations on behavioral syndromes, and more broadly, syndromic effects 
across host physiology, brain function, and behavioral output. This provides insight into 
a more holistic understanding of the effects of gut microbiota on the host. We adopted 
the approach of utilizing multiple discriminant analysis (MDA) to identify significantly 
cumulative effects of gut microbiota on the host. MDA identifies features that contribute 
to significant differences between groups across multiple dimensions. Figure 5.1 
illustrates the basic principles of MDA across two dimensions. Herein, there are two 
separate sample populations, represented by ellipses A and B, demonstrated across 
two dimensions—axis x and axis y. Along axis x, the sample groups nearly completely 
overlap, sharing over 50% overlap. Along axis y, the sample groups completely overlap. 
However, it is clear that, when taken across both dimensions, the sample groups 
represent two separate populations. One useful method of conceptualizing the brain’s 
own use of such a high-dimensional approach to classification is with facial recognition. 
When looking at individual features such as eye color, hair color, nose size, etc., it may 
be very difficult to differentiate between individual faces. However, the subtle 
differences in the combination of all of these features combine to help classify a face to 
a specific person.  
Likewise, we used multiple discriminant analysis to reveal interesting sex-specific 
effects of emulsifier treatment on behavioral and physiological syndromes. While the 
two emulsifier treatments largely converge to produce similar behavioral changes in 
subject mice, namely altered anxiety-related and social behavior, they have unique 
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effects on gut microbiota composition that may affect unique aspects of anxiety 
behavior. For example, while anxiety behavior is increased by both P80 and CMC, the 
collective syndrome of anxiety-related behaviors (thigmotaxis, rearing, stereotypic 
circling, etc.) is affected differently by the two emulsifiers. This may be due to differing 
strengths in the bond formation properties of these emulsifiers.  P80 is a nonionic 
surfactant which inhibits biofilm formation of P aeruginosa and other gram-negative and 
gram-positive bacterial species (Toutain-Kidd et al., 2009).  Sodium carboxymethyl 
cellulose is an anionic surfactant, which, like sodium dodecyl sulfate, may 
predominantly affect gram-positive bacteria (Galbraith et al., 1971; Walton et al., 2008; 
Toutain-Kidd et al., 2009). Indeed, as shown in Chapter 3, the two emulsifiers uniquely 
impact sex differences in abundance of certain subsets of microbial taxa. CMC 
treatment roughly maintained the number of taxa that are sexually differentiated, and 
P80 treatment appeared to greatly reduce the number of sexually differentiated taxa. 
Also, the two emulsifier treatments uniquely impacted sex differences in behavior 
relative to that observed in WT mice, where P80 largely maintained these sex 
differences while CMC appeared to reverse sex differences across a certain subset of 
anxiety-like and repetitive behaviors. Therefore, the lower number of sexually 
differentiated taxa induced by P80 treatment may be important for maintaining sex 
differences in behavior. Investigation of the sexually differential microbiota induced by 
CMC treatment may yield additional clues to understanding the effects of gut microbiota 
on sexually differentiated behavior. 
Emulsifier treatment had been shown to erode the mucus lining, thereby allowing 
the luminal gut microbiota to encroach upon the intestinal epithelial lining (Chassaing et 
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al., 2015). While the two emulsifiers may uniquely impact the specific compositional 
changes in gut microbiota observed in male and female mice, they both converge to 
increase systemic burdern of LPS in both sexes (Chassaing et al., 2015). Increased 
antibodies against LPS were observed in the serum and increased levels of LPS was 
also detected in the feces.  This may be the result of either increased abundance of 
gram-negative bacteria or increased shedding of LPS by gut-resident gram-negative 
bacteria. LPS may be a key player by way of its ability to increase intestinal permeability 
and gut immune activation. The differing consortia of gut microbiota induced by each 
emulsifier treatment in each sex may elicit, for example, unique immune effects and 
uniquely stimulate the vagus nerve in such a manner to elicit differing effects on 
behavior, thus providing a potential hypothesis for how increased LPS observed across 
treatments with differing effects can elicit unique outcomes. 
The studies conducted in Chapter 3 suggest that a shift to a more gram-negative 
microbiota profile resulting from both CMC and P80 treatment (or at least increased 
shedding of LPS by the gut microbiota) may be responsible for the metabolic and 
behavioral changes observed in emulsifier-fed mice. I tested the plausibility of LPS as a 
core gut-derived factor influencing anxiety-related behavior in the gut-derived endotoxin 
study discussed in Chapter 4. Oral administration of LPS models acute changes in gut 
microbiota that may be observed in various conditions exhibiting gut dysbiosis, such as 
the emulsifier-induced increases in serum and fecal LPS levels. We found that oral 
administration of LPS increased anxiety-related behaviors in subject mice, and that this 
depended on systemic TLR4 expression as Tlr4-/- mice were protected from the effects 
of LPS treatment. While LPS increased anxiety-related behaviors in both male and 
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female mice, it may have done so via sexually different TLR4 signaling mechanisms, as 
an antagonist that blocks the TRIF pathway in TLR4, (+)-naloxone, independently 
reversed sex differences for a unique subset of locomotor and anxiety behaviors relative 
to those observed in untreated mice. 
 
Figure 5.1 Multiple discriminant analysis (MDA) identifies syndromic effects 
across multiple dimensions 
Two separate sample population, denoted as ellipses A and B, which represent two 
separate populations, demonstrated across two dimensions—axis x and axis y. Along 
axis x, the sample groups nearly completely overlap, sharing approximately 50% 
overlap. Along axis y, the sample groups completely overlap. However, it is clear that, 
166 
when taken across both dimensions, the sample groups represent two separate 
populations. 
 
5.2 The Gut Inflammation-Brain Connection 
As mentioned in the Introduction, one of the mechanisms whereby TLR4-induced 
gut inflammation may affect brain activity is via immune signaling transmitted through 
the vagus nerve. Vagus nerve activity directly influences brain transcriptomes with 
behavioral implications for psychiatic disorders such as schizophrenia (Klarer et al., 
2018), and resection of the vagus nerve (vagotomy) is often used to demonstrate the 
central importance of vagal nerve communication to changes in the brain and 
behavioral output (Forsythe et al., 2014). Relevant to anxiety-related disorders, 
vagotomy prevented increases in anxiety behavior induced by DSS colitis (Bercik et al., 
2011b). In addition, germ-free mice also demonstrate changes in brain neurotransmitter 
and receptor levels that may be driven by changes in vagal tone (Diaz Heijtz et al., 
2011). The vagus nerve has a rich network of innervations within the lamina propria 
(Powley et al., 2011), expresses innate immune receptors (Goehler et al., 1997), and is 
critical to certain aspects of sickness behavior response induced by intraperitoneal 
injections of LPS or IL-1 (Bluthe et al., 1996). Further work on how the vagus nerve 
responds to gut-derived inflammation, what signals are conveyed, and how these 
signals specifically affect CNS function and behavioral output is still needed. 
Barrier defenses maintain the distance between commensal gut microbiota and 
the lamina propria, which houses vagus nerve efferents. One important component of 
this defense system involves a wide selection of innate immune receptors expressed on 
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the intestinal epithelial cells. One such immune receptor is toll-like receptor 5 (TLR5). 
Deletion of TLR5 from intestinal epithelial cells (TLR5ΔIEC) alters the composition of gut 
microbiota in such a manner that allows for the growth of microbes typically targeted by 
TLR5 activation, particularly bacteria bearing the inflammagen “flagellin”-the protein 
building block of flagellum, a whip-like appendage that facilitates bacterial locomotion 
(Chassaing et al., 2014a). This compositional change, which can be classified as 
“dysbiosis”, facilitates thinning of the mucus layer and encroachment of gut microbiota 
toward the intestinal epithelium, provoking more robust activation of intestinal epithelial 
innate immune receptors which promotes gut inflammation. Just as emulsifiers promote 
recomposition of gut microbiota, gut inflammation, and various aspects of metabolic 
syndrome (increased adiposity, impairments in glucose control), so does intestinal 
deletion of TLR5 (Chassaing et al., 2014a). TLR5 also has an impact on LPS, as 
increased levels of fecal LPS are observed in TLR5ΔIEC mice (Chassaing et al., 2014a). 
Preliminary data from my colleague Nicole Peters suggest that global TLR5 deletion 
impacts social and anxiety behavior, and future investigation of the behavioral effects of 
TLR5 deletion from intestinal epithelial cells is warranted. Outside of identifying broad-
scale effects on gut inflammation, identifying core consequences of gut microbial 
changes observed in TLR5ΔIEC provides a handle on mechanisms that may drive the 
physiological and behavioral effects observed in TLR5-KO mice. Here, again, although 
it is unlikely to be the sole component driving the physiological effects observed in 
TLR5ΔIEC mice, overgrowth of pathogenic gram-negative bacteria resulting in shedding 
excess LPS and contributing to metabolic endotoxemia, may be important factors 
contributing to metabolic and behavioral dysregulation found in TLR5-KO mice. 
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With respect to gut microbiota and gut physiology, while the effects of gut 
bacteria on TLR4 have received a lot of attention, and the importance of TLR5 in 
recognizing bacterial flagellin as an important regulator of gut barrier integrity is gaining 
recognition, different TLRs expressed by intestinal epithelial cells recognize other 
microbial kingdoms and cross-talk with other non-TLR innate immune receptors that 
contribute to gut homeostasis. TLR4 not only recognizes LPS but is also activated by 
fungal mannan oligosaccharides, a component of their cell wall, and glycoinositol 
phospholipids produced by certain parasites (Kawai and Akira, 2011). As discussed in 
Chapter 4, TLR4 has two separate signaling cascades, and while LPS may 
predominantly activate the Myd88 pathway, mannan activation of TLR4 predominantly 
activates the TRIF pathway (Netea et al., 2005). While TLR4-KO mice do not exhibit 
signs of intestinal inflammation, they do exhibit alterations in gut microbiota that likely 
spill over to non-bacterial microbial kingdoms such as alterations in fungal composition 
and load (Perez-Pardo et al., 2018). Activation of the two TLR4 pathways and activation 
of other TLRs by LPS may yield downstream effects on cytokine profile and subsequent 
vagal and CNS activation unique to a specific microbiota composition. Indeed, this may 
explain the opposing effects of LPS on behavior in WT versus Tlr4-/- mice discussed in 
Chapter 4.  
Other innate immune receptors also recognize important components of gut 
microbiota. For example, certain subsets of immune receptors, including TLR3, TLR5, 
TLR9, and some of the NOD-like receptors, evolved to recognize viruses, as they 
respond to RNA and DNA sequestered in the endoplasmic reticulum of damaged and 
infected cells engulfed by epithelial and immune cells (Kawai and Akira, 2011). 
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However, receptors such as TLR2 and dectin-1, evolved to recognize conserved 
components of fungi (Kawai and Akira, 2011). There is also a division of labor in the 
recognition of gram-positive and gram-negative bacteria, with TLR4 recognizing LPS on 
gram-negative bacteria and TLR2 recognizing cell wall components present on gram-
positive bacteria (Takeuchi et al., 1999). Activation of each individual receptor triggers a 
unique inflammatory cascade that has unique effects on the host, some broadly “anti-
inflammatory” and some “pro-inflammatory” (Kawai and Akira, 2011). Also, through 
cross-talk of induced cytokines and receptor oligomerization, receptors interact with 
each other to propagate specific anti-microbial responses. How these various subsets of 
the immune system affect the adult CNS and specifically vagal efferents is unknown, as 
very little work to-date has characterized immune receptor signaling and proximal and 
distal vagus nerve activation by various non-TLR4 gut innate immune receptor 
stimulation. As was shown in Chapter 4, LPS produced identifiable behavioral effects in 
TLR4-KO mice, suggesting that LPS activated other innate immune receptors, such as 
TLR2, that signal to the vagus nerve and CNS. Which specific immune receptors are 
responsible and what those signals are will be the focus of future investigation. 
 
5.3 Non-bacterial Microbial Components Affect Gut Barrier and Brain Function 
While gut bacteria strongly influence host physiology and behavior, there are 
other components of gut microbiota that may signal along the gut-brain axis, including 
viruses, fungi, archaea and parasites. Species across all of these microbial kingdoms 
activate a wide variety of innate immune receptors that may have unique effects on the 
vagus nerve and the CNS. Future investigation of the gut-brain axis will need to 
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broaden investigation into these other kingdoms. For example, are there significant 
differences in the gut fungal communities between WT and Brattleboro rats that may 
also contribute to behavioral differences between the two strains? Differences in viral, 
parasite, and archaeal communities may also contribute to differences in metabolites, 
vagal signaling, and immune activation that all signal back to the CNS. 
Bacteria serve as a reservoir for a specific type of viruses, namely bacteriophage 
(Fischetti, 2005). One means by which viruses may affect CNS function and behavior is 
through their ability to modulate the gut bacterial landscape. The mucus layer of the 
intestinal lining is especially enriched in bacteriophages, which contributes to barrier 
defense against commensal bacteria (Barr et al., 2013). A bacteriophage can infect and 
kill their bacterial hosts but can also serve to transmit genetic information between 
bacterial hosts (Columpsi et al., 2016). In this way, bacteriophages may either serve to 
maintain homeostasis by preventing overgrowth of certain species and also may help to 
maintain biological diversity within bacterial species (Columpsi et al., 2016). In addition 
to serving as defense against mucosal encroachment of gut bacteria, bacteriophages 
also function as antiviral defense mechanisms against host-infecting viruses by 
producing proteins that block cell entry or upregulate interferon gamma production 
(Miedzybrodzki et al., 2005). Bacteriophages are not the only viruses present in gut 
bacteria. There are also viruses that infect fungi, archaea, and eukaryotic host cells. 
Some of these viruses may modulate the gut barrier, such as adenoviruses, which may 
trigger Celiac disease (Kahrs et al., 2019). Additionally, while bacteriophages are mostly 
touted for their protective capacity, they can also infect human host cells and may be a 
causative agent in some diseases (Tetz and Tetz, 2018). Likewise, groups of viruses 
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known to traditionally infect human cells are studied as disease agents, little is known 
regarding the possible existence of beneficial commensal human-infecting viruses that 
may also be transmitted by the gut microbiome. Such viruses may be transmitted 
directly to the brain, and unpublished data presented at a recent Society for 
Neuroscience conference suggests that the presence or absence of gut microbiota (that 
is, comparing conventionally-colonized and germ-free mice) may influence the presence 
of viruses and bacteria in the brain. To date, little is known about the composition of the 
gut virome, as there does not exist a conserved biomarker between viruses similar to 
16S rRNA in bacteria (Columpsi et al., 2016). However, advances in metagenomics are 
beginning to facilitate basic surveys into gut viral composition. 
Another component of the gut microbiome is the fungus kingdom, comprising the 
gut “mycobiome”. Again, to date, relatively little attention has been paid to the gut 
mycobiome, let alone to its effects on the brain. While there are studies on the effects of 
exogenous mold exposure on brain function and behavior (Crago et al., 2003), what 
remains to be explored are the typical endogenous fungal compositional profile (which 
may include both commensal and pathogenic fungi) and its specific effects on the host. 
While they account for a relatively small portion of the gut microbiome, they may still 
exert a powerful impact on host physiology and behavior. For example, Candida 
albicans, just as any opportunistic pathogen, accounts for a very small percentage of 
the total biomass of the gut microbiota, but still has important consequences for the 
immune system, CNS, and host behavior (Underhill and Iliev, 2014; Neville et al., 2015). 
There are challenges with sequencing this community. One salient point is that while 
conserved evolutionary biomarkers (barcodes) exist to discern fungal species (namely 
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conserved fragments of 18S and 28S rRNA, as well as internal transcribed spacer 
regions [ITS1 and ITS2]), reference databases are far less extensive than those 
developed for bacterial communities. Some of these barcodes also do not allow 
discrimination beyond the genus level (Nilsson et al., 2019). Again, this community does 
not exist in isolation, and has dynamic links both across fungal species and between 
fungi and bacteria which may affect the bacterial landscape and have downstream 
signaling effects on the CNS (Witherden et al., 2017). Independent of its effects on 
bacteria, fungi also activate innate immune receptors that promote type-2 inflammation 
(dectin-2, TLR2, etc.), which may have effects on brain function and behavior distinct 
from those induced by LPS and gram-negative bacteria (Kawai and Akira, 2011). One 
example is the potential opposing effects of LPS-induced inflammation and type-2 
inflammation on repetitive and compulsive-like behavior. 
Fungi and bacteria may have opposing effects on behavior given their opposing 
effects on inflammation. “Type 1” inflammation, or the canonical inflammatory response 
(which includes the response to injected LPS), and “type 2” inflammation, or the allergic 
immune response produce cytokines that counteract each other—type 1 inflammation 
typically downregulates type 2 inflammation, and vice versa (Kidd, 2003). As the 
sickness response involving type 1 inflammation includes a “sickness behavior” 
response, which consists of lethargy, social withdrawal, and increases in anxiety 
behavior (Dantzer, 2009), type-2 inflammation may trigger a different behavioral 
response, including increases in repetitive behavior and compulsive-like grooming 
designed to limit tic, fungal, parasite exposure (Hart, 1994; Reber et al., 2011). For 
example, mouse strains that mount robust type 1 immune responses exhibit lower 
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levels of repetitive behavior than strains that mount type 2 immune responses (Thomas 
et al., 2009). Behavioral differences between mouse strains exhibiting differing immune 
biases may also be transmitted via fecal microbiota transfer (Bercik et al., 2011a). 
Widening the scope beyond the bacterial component of gut microbiota may help 
address some of the mysteries surrounding the behavioral effects of gut microbiota 
transfer. Most gut microbiota transfer procedures are not performed anaerobically, and 
a large majority of transferred fecal species are dead upon transfer to the new host 
(Chu et al., 2017). Gut fungal species which are predominantly facultative anaerobes, 
however, survive. Fungi may also impact bacterial signaling to the host through 
influencing the gut barrier—some fungal components, such as zymosan, downregulate 
intestinal tight junction protein expression (Li et al., 2015b), which may increase 
metabolic endotoxemia and associated downstream effects on host physiology and 
behavior. However, in this situation, fungal-induced biases in inflammation may alter the 
response to LPS, promoting an enhanced type-2 response (perhaps by enhancing the 
TLR4-TRIF pathway over TLR4-Myd88). Again, this may have contributed to the 
opposing effects of orally-administered LPS in WT and Tlr4-/- mice described in Chapter 
4.  
 
5.4 Collapsing Complexity by Assessing the Functional Impact of Microbiota 
Complexity within gut microbiota is not limited to the impact of less studied 
kingdoms, but also to the extensive functional redundancy across highly divergent 
microbial populations. An example of this complexity lies in variations of gut “dysbiosis” 
that have been shown to transmit metabolic syndrome. First, as described in Chapter 3, 
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two separate food emulsifiers that induce separate and very sex-specific alterations in 
the gut microbiome both increase body weight and other signs of metabolic syndrome in 
subject mice. Second, fecal microbiota collected from a genetic model of obesity, leptin-
deficient ob/ob mice, was the first example that showed that obesity can be transmitted 
via fecal microbiota transfer (Ley et al., 2005; Turnbaugh et al., 2006). Third, later 
studies using microbiota from high-fat diet fed mice showed similar results (Turnbaugh 
et al., 2008). Comparing gut microbiota across all three models will undoubtedly yield 
very distinct microbial population clusters. Attempts to identify individual taxa associated 
with the three separate obesity models may show interesting candidates but will likely 
not be present in all subjects. An example of this is the difficulty of some researchers to 
replicate the Firmicutes-to-Bacteriodetes ratio originally observed in obese mice and 
humans (Ley et al., 2005). Subsequent work either found no changes in this ratio 
(Duncan et al., 2008; Million et al., 2013; Rosenbaum et al., 2015) or an inverse of this 
ratio in obese subjects (Schwiertz et al., 2010; Ignacio et al., 2016), along with more 
fine-grained increases and decreases of species within both the Firmicutes and 
Bacteroidetes phyla within obese subjects (Bruce-Keller et al., 2015; Jung et al., 2018). 
Nevertheless, later work also confirmed the finding of an increased Firmicutes-to-
Bacteroidetes ratio in some obese subjects, suggesting that this compositional change 
may serve as a significant factor in a subset of the disease (Koliada et al., 2017). 
Nevertheless, transfer of microbiota from all of these models of obesity into 
metabolically healthy mice induces metabolic syndrome in the subject (Turnbaugh et al., 
2006; Turnbaugh et al., 2008; Chassaing et al., 2015). 
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Investigation of core functional effects of varied dysbiotic changes observed 
within a disorder, as opposed to attempting to identify and isolate individual culprits 
within the gut microbiome, will provide a critical window into therapeutic targets. As 
highlighted in this Discussion, one potential core mechanism may be increases in gut 
permeability, which can be triggered by a wide assortment of bacteria, viruses, and 
fungi. For example, both clinical subjects and rodent models of autism exhibit increases 
in intestinal permeability, alterations in gut microbiota, and increases in anxiety-related 
behaviors (Hsiao et al., 2013; Fiorentino et al., 2016). Decreases in Prevotella are noted 
as constituting one of the most robust microbial taxa changes associated with autistic 
subjects (Kang et al., 2013; Kang et al., 2018). However, Prevotella is observed to be 
increased in the maternal immune activation model of autism (Hsiao et al., 2013). 
However, this model also exhibits increased intestinal permeability (Hsiao et al., 2013). 
Even when there are consistent trends across studies, this may not reveal the whole 
story. Parkinson’s disease is another condition where the contributions of gut microbiota 
are becoming more apparent (Sampson et al., 2016). Here, too, gut barrier dysfunction 
is also associated with disease progression (Houser and Tansey, 2017). Overgrowth of 
Proteobacteria in Parkinson’s subjects is consistently noted across studies (Forsyth et 
al., 2011; Keshavarzian et al., 2015; Scheperjans et al., 2015; Unger et al., 2016; Li et 
al., 2017; Qian et al., 2018). Increases in Proteobacteria are also associated with autism 
(Williams et al., 2012; Wang et al., 2013) and obesity (Cani et al., 2007). As mentioned 
earlier, Proteobacteria can increase intestinal permeability (Jakobsson et al., 2015), 
primarily mediated through activation of innate immune receptor TLR4 by its cell surface 
antigen lipopolysaccharide (Guo et al., 2015). However, here too, noting increases 
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in Proteobacteria is insufficient to infer functional consequences, as even different 
strains of Escherichia coli, a species in the Proteobacteria phylum, carry 
lipopolysaccharide molecules with differing levels of immunogenicity, with some serving 
as TLR4 agonists and others as TLR4 antagonists (Coats et al., 2005). Current high-
throughput gut microbiota sequencing efforts, which identify bacteria by a portion of its 
16S rRNA signature, cannot distinguish between strains, and some sequence tags fail 
to discriminate beyond the genus or family level (Fukuda et al., 2016). The complexities 
imposed by gut microbiota analysis demands an investigative focus on core 
mechanisms and consolidated functional consequences.  
A specific etiologic trigger, such as gut barrier dysfunction, which may be 
precipitated by several different changes in bacterial composition, likely interacts with 
several environmental and genetic risk factors to precipitate specific disease outcomes. 
This model is highlighted in Figure 5.2. Increases in gut barrier dysfunction may alter 
other gut microbial communication pathways to the brain, which may include modifying 
systemic short-chain fatty acid levels and afferent vagal activity. For example, both rare 
mutations and ingestion of environmental toxins have been suggested to contribute to 
disease onset in PD patients, perhaps both triggering gut barrier dysfunction that 
increases host exposure to gut microbiota-derived prions that trigger α-synuclein 
misfolding along the vagus nerve (Smith and Parr-Brownlie, 2018; Zeng et al., 2018).  
Sex differences in various host systems, such as the immune system (Klein and 
Flanagan, 2016), may combine with dysbiotic changes in gut microbiota to exacerbate 
disease outcomes in one or the other sex. For example, bacterial antigens may activate 
differing types of inflammation in males and females (e.g., generate a more pro-allergic 
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immune profile in males) (Kelly and Gangur, 2009), which promote differing types of 
neuroinflammation with potentially different behavioral effects. On the other hand, my 
study described in Chapter 4 revealed that a common microbial antigen elicited similar 
behavioral but differential immune responses in males and females. Only a few studies 
have directly investigated how gut microbiota and host sex factors interact. For 
example, one landmark study by (Markle et al., 2013) identified robust sex differences in 
gut microbiota in adult mice and revealed that gut microbiota from males when 
transferred to females may elevate testosterone levels in females (Markle et al., 2013). 
The recent National Institutes of Health mandate to include both female and male 
subjects in biomedical research should undoubtedly be applied to the study of gut 
microbiota, which is likely to reveal many more sex-specific effects of gut microbiota on 
the host. 
Gut barrier dysfunction is not the only gut microbiota-associated factor that has 
context-specific effects. Short chain fatty acids have been associated with both 
proinflammatory and anti-inflammatory effects, based on host context (Kuo et al., 2014; 
Zhang et al., 2016). These are not likely the only gut microbiota-associated factors that 
affect host biology differently based on context. Furthermore, these gut microbial effects 
are likely to both converge and cancel each other out, so identifying dominant factors 
within each disease state will be key to identifying prominent mechanisms of action. 
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Figure 5.2 Genetic and environmental factors interact with gut microbiota to 
induce specific effects on the host. 
Gut microbial alterations occur within the context of genetic and environmental 
factors that shape basal ganglia-associated disease susceptibility. These host factors 
affect both gut microbial composition and basal ganglia function. Common microbial 
alterations associated with increased disease risk include increases in Proteobacteria, 
decreases in Prevotella, and alterations in Clostridia, which are all associated with 
increased gut barrier dysfunction. Other risk factors, such as altered short-chain fatty 
acid levels, increased vagal activation, and other mechanisms (e.g., the release of other 
bacterial metabolites) may also result from gut microbial alteration. Increased systemic 
inflammation and neuro-inflammation are common endpoints of all of these alterations, 
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but other gut-to-brain mechanisms also contribute to basal ganglia disease etiology. 
Ultimately, gut-derived factors that alter basal ganglia function interact with other 
preexisting genetic and environmental susceptibility factors to shape specific disease 
outcomes. Copied with permission from Fields et al. (2018) Defining dysbiosis in 
disorders of movement and motivation. J Neurosci. 
 
5.5 Utilizing Multidimensional Analyses to Explore Complex Systems 
Multidimensional analyses reveal emergent patterns within biological data not 
available from analyzing individual measures, reflecting the multidimensional nature of 
these complex systems. Here, we use multidimensional analyses to explore 
compositional patterns of bacterial populations within gut microbiota and to explore 
emergent behavioral syndromes across treatment groups. An example of the 
requirement for dimensional approaches to analysis is exemplified in the various levels 
of analysis pursued in biological disciplines such as neuroscience, where patterns of 
activity observed in individual neurons are best contextualized within larger patterns of 
chemical and electrical activity within and across brain regions. For example, neuronal 
firing during the encoding or retrieval of memory events may appear stochastic when 
observed in the individual neuron, but recognizable patterns of activity emerge when 
brain activity is measured at the regional or whole brain level (Johnson et al., 2009).  
When multidimensionality is taken into consideration, the robustness of biological 
systems is often revealed. Complex systems can be redundant and systems that 
appear similar can have widely diverging functions/effects. This point was demonstrated 
in Chapter 3, where gut microbiota populations were compared for emulsifier treatments 
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across two different studies. As demonstrated by LefSe, the treatments elicited differing 
population compositions across the two studies, but emulsifiers impacted the subjects’ 
metabolic state in a similar fashion across studies. In Chapter 2, we used LefSe to 
identify core taxa that are associated with the Brattleboro rat genotype. Here, we found 
a select few taxa that correlated with genotype, but other compositional changes in 
microbial community structure may also result from the observed genotypic changes. 
Dimensions such as circadian fluctuations in microbial populations, microbe-to-microbe 
interactions, strain differences across bacteria, and environmental subniches that alter 
the functional output of the same bacterial strain are also unexplored. Additionally, other 
kingdoms that constitute the gut microflora, such as fungi, viruses, parasites, and 
archaea, are not surveyed by 16S rRNA biomarker sequencing, which only enumerates 
bacterial populations. These other kingdoms elicit categorically differing immune 
responses, and likely have unique effects on other host systems as well. As a result, 
there are entire categories of interactions missing from most modern microbiome 
analyses, which will also likely exhibit time, strain, and micro-environment specific 
complexity. As a wider array of dimensions are captured of gut microbiota and their 
effects on the host CNS, important and unintuitive system dynamics will likely emerge 
that may help define core principles of gut microbiota to brain signaling. 
While multivariate analyses are routinely used in psychology, most prominently in 
survey studies, this approach remains under-utilized in preclinical rodent behavior 
analyses. In a survey, individual questions are meant to capture an aspect of a larger 
construct. In rodent studies, individual tests are designed to stand alone as measures of 
a particular psychological attribute (e.g. anxiety), demonstrating face validity (apparent 
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similarity to human emotional construct) and predictive validity (clinically validated 
psychiatric drugs have predicted effects on animal subjects) (Chadman et al., 2009). 
However, there are a number of tests that are said to measure the same psychological 
attribute, but these tests are often inconsistent, varying between treatments, subjects, 
and trials. Other confounds such as prior experience, housing conditions, and 
environment contribute to inconsistencies in these data (Chadman et al., 2009; 
Silverman et al., 2010; Kazdoba et al., 2016). However, multivariate approaches to 
behavioral analysis may provide a means to compare similar behavioral syndromic 
effects across study cohorts. This was demonstrated in Chapter 4 where LPS treatment 
elicited significantly different effects in separate groups of anxiety-like behavior between 
study cohorts (Experiment 1 vs Experiment 2), but multivariate analysis demonstrated 
that LPS induced an anxiety-related behavioral syndrome across both cohorts. 
Comparing results across one or two primary measures from only one test, as is 
traditionally done with rodent behavioral studies, may yield similar inconsistencies from 
cohort to cohort that may be standardized by multivariate analysis.  
From vagal stimulation to systemic breach of gut-derived toxins and from 
stimulation of systemic inflammation to systemic release of bacterial metabolic 
byproducts, such as short chain fatty acids, these mechanisms of action can be driven 
by multiple compositional profiles and can have differential effects based on host 
biology. Future studies will need to further identify not only compositional differences in 
gut microbiota associated with health and disease, but also the context-specific 
functional effects of these microbial alterations. This will serve as a critical step toward 
developing psychiatric treatments leveraging gut microbial manipulation.  
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